<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="https://www.alzforum.org"  xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Alzforum - Papers of the Week: 4-10 Sep 2026</title>
 <link>https://www.alzforum.org</link>
 <description></description>
 <language>en</language>
<item>
 <title>Data-driven subtyping of Alzheimer&#039;s emergency presentations using unsupervised machine learning.</title>
 <link>https://www.alzforum.org/papers/data-driven-subtyping-alzheimers-emergency-presentations-using-unsupervised-machine-learning</link>
 <description>IBRO Neurosci Rep. 2026 Dec;21:687-697.  Epub 2026 Aug 21&lt;br&gt;Authors: Alkam T, Tarshizi E, Van Benschoten AH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698748&quot;&gt;42698748&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/data-driven-subtyping-alzheimers-emergency-presentations-using-unsupervised-machine-learning#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/data-driven-subtyping-alzheimers-emergency-presentations-using-unsupervised-machine-learning#comments</comments>
</item>
<item>
 <title>Effect of MALT1 inhibition by MI‑2 on the microglial phenotype switch, inflammatory cytokine secretion, neuronal loss and oxidative stress in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/effect-malt1-inhibition-mi-2-microglial-phenotype-switch-inflammatory-cytokine-secretion</link>
 <description>Int J Mol Med. 2026 Nov;58(5) Epub 2026 Sep 4&lt;br&gt;Authors: Li Y, Fan H, Han X, Ni M, Hou X, Xia H, Shi Y, Zhang L, Sun J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42695408&quot;&gt;42695408&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-malt1-inhibition-mi-2-microglial-phenotype-switch-inflammatory-cytokine-secretion#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-malt1-inhibition-mi-2-microglial-phenotype-switch-inflammatory-cytokine-secretion#comments</comments>
</item>
<item>
 <title>Early vs Delayed Steroid Treatment in Cerebral Amyloid Angiopathy-Related Inflammation: A Retrospective Cohort Study.</title>
 <link>https://www.alzforum.org/papers/early-vs-delayed-steroid-treatment-cerebral-amyloid-angiopathy-related-inflammation</link>
 <description>Neurol Neuroimmunol Neuroinflamm. 2026 Nov;13(6):e200639.  Epub 2026 Sep 9&lt;br&gt;Authors: Negro G, Rossi M, Cavarsaschi E, Orsani G, Storti B, Losa M, Dell&amp;#039;Orto N, Moscatelli E, Francia A, Marinoni G, Donniaquio A, Del Sette M, Pardini M, Bersano A, DiFrancesco JC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715498&quot;&gt;42715498&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-vs-delayed-steroid-treatment-cerebral-amyloid-angiopathy-related-inflammation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-vs-delayed-steroid-treatment-cerebral-amyloid-angiopathy-related-inflammation#comments</comments>
</item>
<item>
 <title>Time Matters in Cerebral Amyloid Angiopathy-Related Inflammation, but How Much?</title>
 <link>https://www.alzforum.org/papers/time-matters-cerebral-amyloid-angiopathy-related-inflammation-how-much</link>
 <description>Neurol Neuroimmunol Neuroinflamm. 2026 Nov;13(6):e200656.  Epub 2026 Sep 9&lt;br&gt;Authors: Arauz A, Serrano Arias FE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715495&quot;&gt;42715495&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/time-matters-cerebral-amyloid-angiopathy-related-inflammation-how-much#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/time-matters-cerebral-amyloid-angiopathy-related-inflammation-how-much#comments</comments>
</item>
<item>
 <title>Reader Response: High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study.</title>
 <link>https://www.alzforum.org/papers/reader-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25</link>
 <description>Neurology. 2026 Oct 13;107(7):e214790.  Epub 2026 Sep 4&lt;br&gt;Authors: McCaulley ME&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696687&quot;&gt;42696687&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reader-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reader-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25#comments</comments>
</item>
<item>
 <title>Author Response: High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study.</title>
 <link>https://www.alzforum.org/papers/author-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25</link>
 <description>Neurology. 2026 Oct 13;107(7):e214897.  Epub 2026 Sep 4&lt;br&gt;Authors: Du Y, Sonestedt E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696686&quot;&gt;42696686&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/author-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/author-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25#comments</comments>
</item>
<item>
 <title>Author Response: High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study.</title>
 <link>https://www.alzforum.org/papers/author-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-0</link>
 <description>Neurology. 2026 Oct 13;107(7):e214844.  Epub 2026 Sep 4&lt;br&gt;Authors: Du Y, Sonestedt E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696685&quot;&gt;42696685&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/author-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/author-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-0#comments</comments>
</item>
<item>
 <title>Editors&#039; Note: High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study.</title>
 <link>https://www.alzforum.org/papers/editors-note-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-year</link>
 <description>Neurology. 2026 Oct 13;107(7):e218488.  Epub 2026 Sep 4&lt;br&gt;Authors: Siegler JE, Galetta SL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696684&quot;&gt;42696684&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/editors-note-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-year#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/editors-note-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-year#comments</comments>
</item>
<item>
 <title>Reader Response: High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study.</title>
 <link>https://www.alzforum.org/papers/reader-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-0</link>
 <description>Neurology. 2026 Oct 13;107(7):e214849.  Epub 2026 Sep 4&lt;br&gt;Authors: Kawada T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696683&quot;&gt;42696683&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reader-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reader-response-high-and-low-fat-dairy-consumption-and-long-term-risk-dementia-evidence-25-0#comments</comments>
</item>
<item>
 <title>The Crosstalk Between Diabetes and Alzheimer&#039;s Disease: A Molecular Perspective.</title>
 <link>https://www.alzforum.org/papers/crosstalk-between-diabetes-and-alzheimers-disease-molecular-perspective</link>
 <description>Basic Clin Pharmacol Toxicol. 2026 Oct;139(4):e70294. &lt;br&gt;Authors: Catakli D, Ozen-Basoglu O, Tuncgovde EB, Ozsarlak-Sozer G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693696&quot;&gt;42693696&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/crosstalk-between-diabetes-and-alzheimers-disease-molecular-perspective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/crosstalk-between-diabetes-and-alzheimers-disease-molecular-perspective#comments</comments>
</item>
<item>
 <title>Microglia-targeted Panax notoginseng polysaccharide nanoparticles alleviate Alzheimer&#039;s disease via AMPK-mTOR/HIF-1α-mediated immunometabolic reprogramming.</title>
 <link>https://www.alzforum.org/papers/microglia-targeted-panax-notoginseng-polysaccharide-nanoparticles-alleviate-alzheimers</link>
 <description>Mater Today Bio. 2026 Oct;40:103620.  Epub 2026 Aug 28&lt;br&gt;Authors: Zhang G, Kong L, Guo RB, Ding SW, Liu Y, Zang J, Zheng Y, Wei B, Chen ZC, Yang Y, Li XT, Yu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701403&quot;&gt;42701403&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglia-targeted-panax-notoginseng-polysaccharide-nanoparticles-alleviate-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglia-targeted-panax-notoginseng-polysaccharide-nanoparticles-alleviate-alzheimers#comments</comments>
</item>
<item>
 <title>Genetic Screening of Colombian Patients With Early-Onset Parkinson Disease.</title>
 <link>https://www.alzforum.org/papers/genetic-screening-colombian-patients-early-onset-parkinson-disease</link>
 <description>Neurol Genet. 2026 Oct;12(5):e200427.  Epub 2026 Sep 1&lt;br&gt;Authors: Franz TM, Gavrielatos M, Wijaya Y, Beasley AI, Kim-Hellmuth S, Strongosky AJ, Moreno-López CL, Ross OA, Wszolek ZK, Cerquera-Cleves C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42699711&quot;&gt;42699711&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/genetic-screening-colombian-patients-early-onset-parkinson-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/genetic-screening-colombian-patients-early-onset-parkinson-disease#comments</comments>
</item>
<item>
 <title>Longitudinal associations of serum MCP-1 with cognitive decline and psychological stress in biomarker-confirmed Alzheimer&#039;s disease: A pilot study.</title>
 <link>https://www.alzforum.org/papers/longitudinal-associations-serum-mcp-1-cognitive-decline-and-psychological-stress-biomarker</link>
 <description>Brain Behav Immun Health. 2026 Oct;56:101333.  Epub 2026 Aug 22&lt;br&gt;Authors: Yasuno F, Kimura Y, Yamauchi Y, Minami H, Kasuga K, Ikeuchi T, Takeda A, Sakurai T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42699398&quot;&gt;42699398&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/longitudinal-associations-serum-mcp-1-cognitive-decline-and-psychological-stress-biomarker#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/longitudinal-associations-serum-mcp-1-cognitive-decline-and-psychological-stress-biomarker#comments</comments>
</item>
<item>
 <title>Clinical pathways for cognitively unimpaired individuals with Alzheimer&#039;s disease neuropathological change.</title>
 <link>https://www.alzforum.org/papers/clinical-pathways-cognitively-unimpaired-individuals-alzheimers-disease-neuropathological</link>
 <description>Lancet Neurol. 2026 Oct;25(10):952-964. &lt;br&gt;Authors: Graff-Radford J, Karliner L, Barnes DE, Frisoni GB, Sperling R, Villain N, Benzinger TL, Teunissen C, Jack CR Jr&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716047&quot;&gt;42716047&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-pathways-cognitively-unimpaired-individuals-alzheimers-disease-neuropathological#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-pathways-cognitively-unimpaired-individuals-alzheimers-disease-neuropathological#comments</comments>
</item>
<item>
 <title>Neuroimaging in the era of biologically defined Alzheimer&#039;s disease and disease-modifying therapy.</title>
 <link>https://www.alzforum.org/papers/neuroimaging-era-biologically-defined-alzheimers-disease-and-disease-modifying-therapy</link>
 <description>Lancet Neurol. 2026 Oct;25(10):939-951. &lt;br&gt;Authors: Benzinger TL, Cogswell PM, Arani A, Chaney AM, Hutson K, Glasser MF, Graff-Radford J, McConathy J, Raji CA, Teunissen C, Vemuri P, Zaharchuk G, Jack CR Jr&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716046&quot;&gt;42716046&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroimaging-era-biologically-defined-alzheimers-disease-and-disease-modifying-therapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroimaging-era-biologically-defined-alzheimers-disease-and-disease-modifying-therapy#comments</comments>
</item>
<item>
 <title>Fluid biomarkers in the evolving care landscape of Alzheimer&#039;s disease and related disorders.</title>
 <link>https://www.alzforum.org/papers/fluid-biomarkers-evolving-care-landscape-alzheimers-disease-and-related-disorders</link>
 <description>Lancet Neurol. 2026 Oct;25(10):926-938. &lt;br&gt;Authors: Teunissen CE, Vermunt L, Barthélemy NR, Benzinger TL, Graff-Radford J, Verberk IM, Zetterberg H, Schindler SE, Jack CR Jr&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716045&quot;&gt;42716045&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/fluid-biomarkers-evolving-care-landscape-alzheimers-disease-and-related-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/fluid-biomarkers-evolving-care-landscape-alzheimers-disease-and-related-disorders#comments</comments>
</item>
<item>
 <title>Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.</title>
 <link>https://www.alzforum.org/papers/safety-tolerability-and-efficacy-ripk1-inhibitor-sar443820-amyotrophic-lateral-sclerosis</link>
 <description>Lancet Neurol. 2026 Oct;25(10):900-910. &lt;br&gt;Authors: Cudkowicz ME, Shefner J, van den Berg LH, Chio A, Fan D, Großkreutz J, Lunetta C, Tsai RM, Li Y, Wallstroem E, Xiong L, Chen Y, Atassi N, HIMALAYA Phase 2 Study Group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716044&quot;&gt;42716044&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/safety-tolerability-and-efficacy-ripk1-inhibitor-sar443820-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/safety-tolerability-and-efficacy-ripk1-inhibitor-sar443820-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Charting the future of biomarkers and therapy in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/charting-future-biomarkers-and-therapy-alzheimers-disease</link>
 <description>Lancet Neurol. 2026 Oct;25(10):879-880. &lt;br&gt;Authors: Lan G, Guo T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716036&quot;&gt;42716036&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/charting-future-biomarkers-and-therapy-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/charting-future-biomarkers-and-therapy-alzheimers-disease#comments</comments>
</item>
<item>
 <title>HIMALAYA: learning from another negative phase 2 trial in ALS.</title>
 <link>https://www.alzforum.org/papers/himalaya-learning-another-negative-phase-2-trial-als</link>
 <description>Lancet Neurol. 2026 Oct;25(10):875-877. &lt;br&gt;Authors: Hardiman O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716035&quot;&gt;42716035&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/himalaya-learning-another-negative-phase-2-trial-als#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/himalaya-learning-another-negative-phase-2-trial-als#comments</comments>
</item>
<item>
 <title>Alzheimer&#039;s disease testing needs evidence, ethics, and equity.</title>
 <link>https://www.alzforum.org/papers/alzheimers-disease-testing-needs-evidence-ethics-and-equity</link>
 <description>Lancet Neurol. 2026 Oct;25(10):873. &lt;br&gt;Authors: The Lancet Neurology&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716034&quot;&gt;42716034&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimers-disease-testing-needs-evidence-ethics-and-equity#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimers-disease-testing-needs-evidence-ethics-and-equity#comments</comments>
</item>
<item>
 <title>Advances in phytochemical modulation of protein aggregation in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/advances-phytochemical-modulation-protein-aggregation-neurodegenerative-diseases</link>
 <description>3 Biotech. 2026 Oct;16(10):416.  Epub 2026 Sep 8&lt;br&gt;Authors: Kumari N, Anand S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719278&quot;&gt;42719278&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/advances-phytochemical-modulation-protein-aggregation-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/advances-phytochemical-modulation-protein-aggregation-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation.</title>
 <link>https://www.alzforum.org/papers/herbal-nanoparticles-treatment-neurodegeneration-molecular-mechanisms-therapeutic-translation</link>
 <description>3 Biotech. 2026 Oct;16(10):420.  Epub 2026 Sep 9&lt;br&gt;Authors: Mittal D, Solanki P, Jain GK, Jhawat V, Kesharwani P, Dutt R, Arora S, Singh RP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719214&quot;&gt;42719214&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/herbal-nanoparticles-treatment-neurodegeneration-molecular-mechanisms-therapeutic-translation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/herbal-nanoparticles-treatment-neurodegeneration-molecular-mechanisms-therapeutic-translation#comments</comments>
</item>
<item>
 <title>Coincidence of L1 retrotransposition and DNA repair deficiency elicits synthetic lethality in S-phase mature neurons.</title>
 <link>https://www.alzforum.org/papers/coincidence-l1-retrotransposition-and-dna-repair-deficiency-elicits-synthetic-lethality-s</link>
 <description>iScience. 2026 Sep 18;29(9):117335.  Epub 2026 Aug 25&lt;br&gt;Authors: Takahashi F, Yamamura T, Oki S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698704&quot;&gt;42698704&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/coincidence-l1-retrotransposition-and-dna-repair-deficiency-elicits-synthetic-lethality-s#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/coincidence-l1-retrotransposition-and-dna-repair-deficiency-elicits-synthetic-lethality-s#comments</comments>
</item>
<item>
 <title>Size-tailored nanoparticle-antibody conjugates overcome hepatic sequestration in Alzheimer&#039;s disease treatment.</title>
 <link>https://www.alzforum.org/papers/size-tailored-nanoparticle-antibody-conjugates-overcome-hepatic-sequestration-alzheimers</link>
 <description>Proc Natl Acad Sci U S A. 2026 Sep 15;123(37):e2603034123.  Epub 2026 Sep 8&lt;br&gt;Authors: Du X, Liu N, Zhang T, Yang C, Luo H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709795&quot;&gt;42709795&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/size-tailored-nanoparticle-antibody-conjugates-overcome-hepatic-sequestration-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/size-tailored-nanoparticle-antibody-conjugates-overcome-hepatic-sequestration-alzheimers#comments</comments>
</item>
<item>
 <title>SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential.</title>
 <link>https://www.alzforum.org/papers/sirt1-neurodegenerative-diseases-molecular-mechanisms-disease-relevance-and-therapeutic</link>
 <description>FASEB J. 2026 Sep 15;40(17):e72288. &lt;br&gt;Authors: Duan J, Liu J, Meng Q, Liu J, Yang S, Zhou F, Cao J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714849&quot;&gt;42714849&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sirt1-neurodegenerative-diseases-molecular-mechanisms-disease-relevance-and-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sirt1-neurodegenerative-diseases-molecular-mechanisms-disease-relevance-and-therapeutic#comments</comments>
</item>
<item>
 <title>Comparison table: Amyloid beta-directed antibodies for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/comparison-table-amyloid-beta-directed-antibodies-alzheimers-disease-0</link>
 <description>Med Lett Drugs Ther. 2026 Sep 14;68(1763):e151. &lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709903&quot;&gt;42709903&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparison-table-amyloid-beta-directed-antibodies-alzheimers-disease-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparison-table-amyloid-beta-directed-antibodies-alzheimers-disease-0#comments</comments>
</item>
<item>
 <title>In brief: Subcutaneous lecanemab (Leqembi Iqlik) for initial treatment of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/brief-subcutaneous-lecanemab-leqembi-iqlik-initial-treatment-alzheimers-disease</link>
 <description>Med Lett Drugs Ther. 2026 Sep 14;68(1763):151. &lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709901&quot;&gt;42709901&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brief-subcutaneous-lecanemab-leqembi-iqlik-initial-treatment-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brief-subcutaneous-lecanemab-leqembi-iqlik-initial-treatment-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Piano-Stool Ru (II) Complexes as Modulators of Human Prion Protein PrP106-126 Aggregation.</title>
 <link>https://www.alzforum.org/papers/piano-stool-ru-ii-complexes-modulators-human-prion-protein-prp106-126-aggregation</link>
 <description>ChemMedChem. 2026 Sep 14;21(17):e70480. &lt;br&gt;Authors: Chauhan R, Kumawat H, Saini S, Panwar A, Kukreti P, Medda N, Roy P, Ghosh K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715489&quot;&gt;42715489&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/piano-stool-ru-ii-complexes-modulators-human-prion-protein-prp106-126-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/piano-stool-ru-ii-complexes-modulators-human-prion-protein-prp106-126-aggregation#comments</comments>
</item>
<item>
 <title>Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products.</title>
 <link>https://www.alzforum.org/papers/innovative-therapies-under-clinical-development-als-treatment-part-2-biologics-and-natural</link>
 <description>Expert Opin Investig Drugs. 2026 Sep 12;:1-19.  Epub 2026 Sep 12&lt;br&gt;Authors: Huang CS, Sanchez-Santos C, Martinez-Gonzalez L, Gil C, Martinez A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720979&quot;&gt;42720979&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/innovative-therapies-under-clinical-development-als-treatment-part-2-biologics-and-natural#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/innovative-therapies-under-clinical-development-als-treatment-part-2-biologics-and-natural#comments</comments>
</item>
<item>
 <title>The role of overdose folic acid in promoting neuroinflammation, oxidative stress, and apoptosis in SOD1-G93A mice.</title>
 <link>https://www.alzforum.org/papers/role-overdose-folic-acid-promoting-neuroinflammation-oxidative-stress-and-apoptosis-sod1-g93a</link>
 <description>Free Radic Res. 2026 Sep 10;:1-12.  Epub 2026 Sep 10&lt;br&gt;Authors: Zhu Y, Zhang Y, Yan T, Li Y, Du H, Zhang S, Zhang T, Zhou W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701881&quot;&gt;42701881&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/role-overdose-folic-acid-promoting-neuroinflammation-oxidative-stress-and-apoptosis-sod1-g93a#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/role-overdose-folic-acid-promoting-neuroinflammation-oxidative-stress-and-apoptosis-sod1-g93a#comments</comments>
</item>
<item>
 <title>A comparative evaluation of p-tau217 stability in serum and plasma using two validated assays.</title>
 <link>https://www.alzforum.org/papers/comparative-evaluation-p-tau217-stability-serum-and-plasma-using-two-validated-assays</link>
 <description>Clin Chem Lab Med. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Guthknecht A, Steinacker P, Abu-Rumeileh S, Otto M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42713737&quot;&gt;42713737&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-evaluation-p-tau217-stability-serum-and-plasma-using-two-validated-assays#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-evaluation-p-tau217-stability-serum-and-plasma-using-two-validated-assays#comments</comments>
</item>
<item>
 <title>Comparative analysis of striatal subregions in behavioral variant frontotemporal dementia and late-life schizophrenia: A multimodal MRI study.</title>
 <link>https://www.alzforum.org/papers/comparative-analysis-striatal-subregions-behavioral-variant-frontotemporal-dementia-and-late</link>
 <description>Int Psychogeriatr. 2026 Sep 10;:100273.  Epub 2026 Sep 10&lt;br&gt;Authors: Li H, Zhang X, Yao M, Li T, Pan G, Wang H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722600&quot;&gt;42722600&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-analysis-striatal-subregions-behavioral-variant-frontotemporal-dementia-and-late#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-analysis-striatal-subregions-behavioral-variant-frontotemporal-dementia-and-late#comments</comments>
</item>
<item>
 <title>Mild cognitive impairment: Brain imaging and neuropsychological findings.</title>
 <link>https://www.alzforum.org/papers/mild-cognitive-impairment-brain-imaging-and-neuropsychological-findings</link>
 <description>Int Psychogeriatr. 2026 Sep 10;:100274.  Epub 2026 Sep 10&lt;br&gt;Authors: Flint AJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722599&quot;&gt;42722599&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mild-cognitive-impairment-brain-imaging-and-neuropsychological-findings#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mild-cognitive-impairment-brain-imaging-and-neuropsychological-findings#comments</comments>
</item>
<item>
 <title>Comparison of Expert Reads Versus Local Clinical Reads of Amyloid PET Scans in the IDEAS Study.</title>
 <link>https://www.alzforum.org/papers/comparison-expert-reads-versus-local-clinical-reads-amyloid-pet-scans-ideas-study</link>
 <description>J Nucl Med. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Chiotis K, Windon CC, Siegel BA, Apgar C, Carrillo M, Gareen I, Hanna L, March A, Romanoff J, Gatsonis C, Rabinovici GD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722444&quot;&gt;42722444&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparison-expert-reads-versus-local-clinical-reads-amyloid-pet-scans-ideas-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparison-expert-reads-versus-local-clinical-reads-amyloid-pet-scans-ideas-study#comments</comments>
</item>
<item>
 <title>Spatiotemporal Atrophy Subtypes in Alzheimer&#039;s Disease: Neurodegenerative-Vascular Associations and Potential Prognostic Value.</title>
 <link>https://www.alzforum.org/papers/spatiotemporal-atrophy-subtypes-alzheimers-disease-neurodegenerative-vascular-associations</link>
 <description>Neuroimage. 2026 Sep 10;:122215.  Epub 2026 Sep 10&lt;br&gt;Authors: Mao C, Qiu Y, Li B, Jiang Y, Bao J, You Y, Wang T, Li Y, Chu S, Jin W, Wang W, Fan P, Hou B, Huang X, Wu M, Wang Y, Sha L, Xu Q, Qiu L, Huo L, Feng F, Dong L, Gao J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722309&quot;&gt;42722309&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spatiotemporal-atrophy-subtypes-alzheimers-disease-neurodegenerative-vascular-associations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spatiotemporal-atrophy-subtypes-alzheimers-disease-neurodegenerative-vascular-associations#comments</comments>
</item>
<item>
 <title>Sociodemographic and clinical characteristics of participants in blood p-tau217 studies for Alzheimer&#039;s disease: A systematic review.</title>
 <link>https://www.alzforum.org/papers/sociodemographic-and-clinical-characteristics-participants-blood-p-tau217-studies-alzheimers</link>
 <description>Ageing Res Rev. 2026 Sep 10;122:103366.  Epub 2026 Sep 10&lt;br&gt;Authors: Toccaceli Blasi M, Buscarnera S, Salzillo M, Suárez-Calvet M, Iaccarino G, Grande G, Valletta M, Nielsen TR, Simonsen AH, Nuti F, Bruno G, Kjaergaard D, Canevelli M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722299&quot;&gt;42722299&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sociodemographic-and-clinical-characteristics-participants-blood-p-tau217-studies-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sociodemographic-and-clinical-characteristics-participants-blood-p-tau217-studies-alzheimers#comments</comments>
</item>
<item>
 <title>Associations of cognitive reserve with IGF-1 and global cognition differ by early-life conditions and APOE genotype.</title>
 <link>https://www.alzforum.org/papers/associations-cognitive-reserve-igf-1-and-global-cognition-differ-early-life-conditions-and</link>
 <description>Exp Gerontol. 2026 Sep 10;224:113315.  Epub 2026 Sep 10&lt;br&gt;Authors: da Silva SP, Lampraki C, Cullati S, Dos Santos Rêgo T, Ghisletta P, Kliegel M, Maurer J, Studer M, Gouveia ÉR, de Maio Nascimento M, Ihle A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722213&quot;&gt;42722213&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-cognitive-reserve-igf-1-and-global-cognition-differ-early-life-conditions-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-cognitive-reserve-igf-1-and-global-cognition-differ-early-life-conditions-and#comments</comments>
</item>
<item>
 <title>Alcohol-induced dysregulation of tau and acetylation pathways in the pathogenesis of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/alcohol-induced-dysregulation-tau-and-acetylation-pathways-pathogenesis-alzheimers-disease</link>
 <description>Neuroscience. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Basavaraju KC, Harshitha DK, Priyadarshini P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722128&quot;&gt;42722128&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alcohol-induced-dysregulation-tau-and-acetylation-pathways-pathogenesis-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alcohol-induced-dysregulation-tau-and-acetylation-pathways-pathogenesis-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Astrocyte-derived extracellular vesicle phosphorylated TDP-43 as a blood-based biomarker for amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/astrocyte-derived-extracellular-vesicle-phosphorylated-tdp-43-blood-based-biomarker</link>
 <description>Neurobiol Dis. 2026 Sep 10;:107601.  Epub 2026 Sep 10&lt;br&gt;Authors: Butt TH, Strait M, Marcinczyk L, Katz G, Kalia V, Jaafar C, Saxena R, Divjan A, Saglimbeni B, Munoz Umanes ME, Tipps E, Han M, Mehta P, Lee I, Mitsumoto H, Factor-Litvak P, Shneider NA, Kioumourtzoglou MA, Re DB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722112&quot;&gt;42722112&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/astrocyte-derived-extracellular-vesicle-phosphorylated-tdp-43-blood-based-biomarker#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/astrocyte-derived-extracellular-vesicle-phosphorylated-tdp-43-blood-based-biomarker#comments</comments>
</item>
<item>
 <title>Betulin supplementation reduces oxidative stress in Alzheimer&#039;s disease via the activation of KEAP1/NRF2 pathway.</title>
 <link>https://www.alzforum.org/papers/betulin-supplementation-reduces-oxidative-stress-alzheimers-disease-activation-keap1nrf2</link>
 <description>J Nutr Biochem. 2026 Sep 10;:110504.  Epub 2026 Sep 10&lt;br&gt;Authors: Dai C, Yang Y, Lin X, Xiang K, Zhuo L, Fang Z, Liu J, Sun J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722093&quot;&gt;42722093&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/betulin-supplementation-reduces-oxidative-stress-alzheimers-disease-activation-keap1nrf2#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/betulin-supplementation-reduces-oxidative-stress-alzheimers-disease-activation-keap1nrf2#comments</comments>
</item>
<item>
 <title>Exploring nonylphenol as a potential environmental contributor to Alzheimer&#039;s disease: A hypothesis-generating study integrating computational analyses and experimental evidence.</title>
 <link>https://www.alzforum.org/papers/exploring-nonylphenol-potential-environmental-contributor-alzheimers-disease-hypothesis</link>
 <description>Neurotoxicology. 2026 Sep 10;117:103573.  Epub 2026 Sep 10&lt;br&gt;Authors: Wang X, Liu T, Li S, Yao D, Ding R, Cai B, Wang D, Xu Y, Wang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722075&quot;&gt;42722075&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-nonylphenol-potential-environmental-contributor-alzheimers-disease-hypothesis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-nonylphenol-potential-environmental-contributor-alzheimers-disease-hypothesis#comments</comments>
</item>
<item>
 <title>The Time Is Now for an Upstream Palliative Approach to Alzheimer&#039;s Disease and Related Disorders.</title>
 <link>https://www.alzforum.org/papers/time-now-upstream-palliative-approach-alzheimers-disease-and-related-disorders</link>
 <description>J Pain Symptom Manage. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Morgan B, Brody A, Fleisher J, Chodosh J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722041&quot;&gt;42722041&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/time-now-upstream-palliative-approach-alzheimers-disease-and-related-disorders#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/time-now-upstream-palliative-approach-alzheimers-disease-and-related-disorders#comments</comments>
</item>
<item>
 <title>Anti-LAG-3 antibody treatment initiated after symptom onset extends survival in ALS model mice.</title>
 <link>https://www.alzforum.org/papers/anti-lag-3-antibody-treatment-initiated-after-symptom-onset-extends-survival-als-model-mice</link>
 <description>Neurosci Res. 2026 Sep 10;231:105119.  Epub 2026 Sep 10&lt;br&gt;Authors: Morisaki Y, Nomura N, Matsuda M, Ohshima M, Fukuda R, Komine O, Okuda T, Yamanaka K, Misawa H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722039&quot;&gt;42722039&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/anti-lag-3-antibody-treatment-initiated-after-symptom-onset-extends-survival-als-model-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/anti-lag-3-antibody-treatment-initiated-after-symptom-onset-extends-survival-als-model-mice#comments</comments>
</item>
<item>
 <title>Psilocybin Restores Spatial Memory but Not Fronto-Hippocampal Synchrony in a Rat Model of Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/psilocybin-restores-spatial-memory-not-fronto-hippocampal-synchrony-rat-model-alzheimers</link>
 <description>Neurosci Res. 2026 Sep 10;:105117.  Epub 2026 Sep 10&lt;br&gt;Authors: Shamsedin M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42722038&quot;&gt;42722038&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/psilocybin-restores-spatial-memory-not-fronto-hippocampal-synchrony-rat-model-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/psilocybin-restores-spatial-memory-not-fronto-hippocampal-synchrony-rat-model-alzheimers#comments</comments>
</item>
<item>
 <title>EEG markers of cholinergic dysfunction in Lewy body diseases: A review.</title>
 <link>https://www.alzforum.org/papers/eeg-markers-cholinergic-dysfunction-lewy-body-diseases-review</link>
 <description>Neurosci Biobehav Rev. 2026 Sep 10;191:106961.  Epub 2026 Sep 10&lt;br&gt;Authors: Hasoon J, Leung YK, Donaghy PC, Yarnall AJ, Taylor JP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721727&quot;&gt;42721727&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/eeg-markers-cholinergic-dysfunction-lewy-body-diseases-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/eeg-markers-cholinergic-dysfunction-lewy-body-diseases-review#comments</comments>
</item>
<item>
 <title>Utilizing intraindividual cognitive variability to predict progression in stage 2 neuronal synuclein disease.</title>
 <link>https://www.alzforum.org/papers/utilizing-intraindividual-cognitive-variability-predict-progression-stage-2-neuronal</link>
 <description>Neuropsychology. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Combs HL, Kurth R, Nair A, York MK, Weintraub D, Lafontant DE, Caspell-Garcia C, Parkinson’s Progression Markers Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721347&quot;&gt;42721347&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/utilizing-intraindividual-cognitive-variability-predict-progression-stage-2-neuronal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/utilizing-intraindividual-cognitive-variability-predict-progression-stage-2-neuronal#comments</comments>
</item>
<item>
 <title>Does the serial position effect identify those at risk for dementia? Findings from the Canadian Longitudinal Study on Aging.</title>
 <link>https://www.alzforum.org/papers/does-serial-position-effect-identify-those-risk-dementia-findings-canadian-longitudinal-study</link>
 <description>Neuropsychology. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Marinou S, Mick P, Phillips NA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721346&quot;&gt;42721346&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/does-serial-position-effect-identify-those-risk-dementia-findings-canadian-longitudinal-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/does-serial-position-effect-identify-those-risk-dementia-findings-canadian-longitudinal-study#comments</comments>
</item>
<item>
 <title>Clues to immune havoc in the brain.</title>
 <link>https://www.alzforum.org/papers/clues-immune-havoc-brain</link>
 <description>Science. 2026 Sep 10;393(6816):1070-1071.  Epub 2026 Sep 10&lt;br&gt;Authors: Smith JE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721244&quot;&gt;42721244&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clues-immune-havoc-brain#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clues-immune-havoc-brain#comments</comments>
</item>
<item>
 <title>Non-invasive brain stimulation in amyotrophic lateral sclerosis: a systematic review and meta-analysis of transcranial direct current stimulation and transcranial magnetic stimulation.</title>
 <link>https://www.alzforum.org/papers/non-invasive-brain-stimulation-amyotrophic-lateral-sclerosis-systematic-review-and-meta</link>
 <description>Neurodegener Dis Manag. 2026 Sep 10;:1-13.  Epub 2026 Sep 10&lt;br&gt;Authors: Alrabadi B, Matar HI, Bandak N, Yaseen S, Badwan A, Alomari O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721110&quot;&gt;42721110&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/non-invasive-brain-stimulation-amyotrophic-lateral-sclerosis-systematic-review-and-meta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/non-invasive-brain-stimulation-amyotrophic-lateral-sclerosis-systematic-review-and-meta#comments</comments>
</item>
<item>
 <title>Amyloid-β PET Radioligands in Alzheimer&#039;s Disease: From Plaque Detection to Biomarker-Guided Patient Stratification and Therapeutic Monitoring.</title>
 <link>https://www.alzforum.org/papers/amyloid-v-pet-radioligands-alzheimers-disease-plaque-detection-biomarker-guided-patient</link>
 <description>Mol Diagn Ther. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Lista S, Filippi L, Emanuele E, López-Ortiz S, Cisale GY, Minoretti P, Garaci F, Santos-Lozano A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720909&quot;&gt;42720909&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-v-pet-radioligands-alzheimers-disease-plaque-detection-biomarker-guided-patient#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-v-pet-radioligands-alzheimers-disease-plaque-detection-biomarker-guided-patient#comments</comments>
</item>
<item>
 <title>Brain-derived neurotrophic factor via TRPM2 inhibition reduces amyloid-beta-mediated increases of apoptosis and mitochondrial oxidative neurotoxicity in neuronal cells.</title>
 <link>https://www.alzforum.org/papers/brain-derived-neurotrophic-factor-trpm2-inhibition-reduces-amyloid-beta-mediated-increases</link>
 <description>Metab Brain Dis. 2026 Sep 10;41(1)&lt;br&gt;Authors: Demirdaş A, Nazıroğlu M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720842&quot;&gt;42720842&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-derived-neurotrophic-factor-trpm2-inhibition-reduces-amyloid-beta-mediated-increases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-derived-neurotrophic-factor-trpm2-inhibition-reduces-amyloid-beta-mediated-increases#comments</comments>
</item>
<item>
 <title>Mesenchymal Stem Cell-Derived Exosomes for Alzheimer&#039;s Disease: Mechanisms, Preclinical Evidence, and Translational Challenges.</title>
 <link>https://www.alzforum.org/papers/mesenchymal-stem-cell-derived-exosomes-alzheimers-disease-mechanisms-preclinical-evidence-and</link>
 <description>Mol Neurobiol. 2026 Sep 10;63(1)&lt;br&gt;Authors: Bach DH, Hoang VT, Nguyen TL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720824&quot;&gt;42720824&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mesenchymal-stem-cell-derived-exosomes-alzheimers-disease-mechanisms-preclinical-evidence-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mesenchymal-stem-cell-derived-exosomes-alzheimers-disease-mechanisms-preclinical-evidence-and#comments</comments>
</item>
<item>
 <title>GLP-1 receptor agonism in Alzheimer&#039;s disease after EVOKE: From single hypothesis to stratified program.</title>
 <link>https://www.alzforum.org/papers/glp-1-receptor-agonism-alzheimers-disease-after-evoke-single-hypothesis-stratified-program</link>
 <description>J Alzheimers Dis. 2026 Sep 10;:13872877261485580.  Epub 2026 Sep 10&lt;br&gt;Authors: Pereira Da Silva AM, Haddad Santos D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720565&quot;&gt;42720565&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glp-1-receptor-agonism-alzheimers-disease-after-evoke-single-hypothesis-stratified-program#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glp-1-receptor-agonism-alzheimers-disease-after-evoke-single-hypothesis-stratified-program#comments</comments>
</item>
<item>
 <title>Periventricular and Perivascular-Space Diffusion MRI Measures, Amyloid Abnormality, and Executive Decline in the Alzheimer&#039;s Disease Continuum: A Longitudinal Study.</title>
 <link>https://www.alzforum.org/papers/periventricular-and-perivascular-space-diffusion-mri-measures-amyloid-abnormality-and</link>
 <description>J Magn Reson Imaging. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Chen C, Gu J, Hu Q, Alzheimer&amp;#039;s Disease Neuroimaging Initiative, Zhang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720233&quot;&gt;42720233&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/periventricular-and-perivascular-space-diffusion-mri-measures-amyloid-abnormality-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/periventricular-and-perivascular-space-diffusion-mri-measures-amyloid-abnormality-and#comments</comments>
</item>
<item>
 <title>Preliminary development of a multidomain behavioral intervention for primary prevention of dementia in midlife: a qualitative study of focus group discussions.</title>
 <link>https://www.alzforum.org/papers/preliminary-development-multidomain-behavioral-intervention-primary-prevention-dementia</link>
 <description>Aging Ment Health. 2026 Sep 10;:1-12.  Epub 2026 Sep 10&lt;br&gt;Authors: Korthauer LE, Rosen RK, Arias I, Tremont G, Davis JD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720108&quot;&gt;42720108&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/preliminary-development-multidomain-behavioral-intervention-primary-prevention-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/preliminary-development-multidomain-behavioral-intervention-primary-prevention-dementia#comments</comments>
</item>
<item>
 <title>Conceptualizing cognition and behaviour across amyotrophic lateral sclerosis and frontotemporal dementia.</title>
 <link>https://www.alzforum.org/papers/conceptualizing-cognition-and-behaviour-across-amyotrophic-lateral-sclerosis-and</link>
 <description>Brain. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Benatar M, Huey ED, Onyike CU, McHutchison C, Tartaglia MC, Barker MS, Abrahams S, De Vocht J, Rhodes E, Pijnenburg YA, Turner MR, van Damme P, Lee EB, Wuu J, Benussi A, Boeve BF, McMillan CT, Strong MJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720086&quot;&gt;42720086&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/conceptualizing-cognition-and-behaviour-across-amyotrophic-lateral-sclerosis-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/conceptualizing-cognition-and-behaviour-across-amyotrophic-lateral-sclerosis-and#comments</comments>
</item>
<item>
 <title>Do periventricular white matter lesions indicate cholinergic or network vulnerability in Parkinson&#039;s disease?</title>
 <link>https://www.alzforum.org/papers/do-periventricular-white-matter-lesions-indicate-cholinergic-or-network-vulnerability</link>
 <description>Brain. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Liu S, Han D, Li J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720077&quot;&gt;42720077&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/do-periventricular-white-matter-lesions-indicate-cholinergic-or-network-vulnerability#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/do-periventricular-white-matter-lesions-indicate-cholinergic-or-network-vulnerability#comments</comments>
</item>
<item>
 <title>Reply: Do periventricular white matter lesions indicate cholinergic or network vulnerability in Parkinson&#039;s disease?</title>
 <link>https://www.alzforum.org/papers/reply-do-periventricular-white-matter-lesions-indicate-cholinergic-or-network-vulnerability</link>
 <description>Brain. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Carli G, Bohnen NI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720071&quot;&gt;42720071&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reply-do-periventricular-white-matter-lesions-indicate-cholinergic-or-network-vulnerability#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reply-do-periventricular-white-matter-lesions-indicate-cholinergic-or-network-vulnerability#comments</comments>
</item>
<item>
 <title>Dysregulated microRNA-mRNA networks in SOD1G93A mouse skeletal muscle reveal metabolic impairments in ALS.</title>
 <link>https://www.alzforum.org/papers/dysregulated-microrna-mrna-networks-sod1g93a-mouse-skeletal-muscle-reveal-metabolic</link>
 <description>Dis Model Mech. 2026 Sep 10; Epub 2026 Sep 10&lt;br&gt;Authors: Moody L, Christoforidou E, Joilin G, Dilley A, Hafezparast M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42717683&quot;&gt;42717683&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dysregulated-microrna-mrna-networks-sod1g93a-mouse-skeletal-muscle-reveal-metabolic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dysregulated-microrna-mrna-networks-sod1g93a-mouse-skeletal-muscle-reveal-metabolic#comments</comments>
</item>
<item>
 <title>Parkinson&#039;s and smoking: Exposure to carbon monoxide is linked to lower risk of disease.</title>
 <link>https://www.alzforum.org/papers/parkinsons-and-smoking-exposure-carbon-monoxide-linked-lower-risk-disease</link>
 <description>BMJ. 2026 Sep 9;394:e100810. &lt;br&gt;Authors: Wise J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716551&quot;&gt;42716551&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/parkinsons-and-smoking-exposure-carbon-monoxide-linked-lower-risk-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/parkinsons-and-smoking-exposure-carbon-monoxide-linked-lower-risk-disease#comments</comments>
</item>
<item>
 <title>Does Reported Sex Modifies the Association between Ambient Air Pollution exposure and Alzheimer&#039;s Disease and Related Dementia? A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/does-reported-sex-modifies-association-between-ambient-air-pollution-exposure-and-alzheimers</link>
 <description>Environ Pollut. 2026 Sep 9;:129138.  Epub 2026 Sep 9&lt;br&gt;Authors: Dehghani Firouzabadi D, Dadvand P, Aliabadi SF, Ashkalooei SS, Jacquemin B, Zare Sakhvidi MJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716371&quot;&gt;42716371&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/does-reported-sex-modifies-association-between-ambient-air-pollution-exposure-and-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/does-reported-sex-modifies-association-between-ambient-air-pollution-exposure-and-alzheimers#comments</comments>
</item>
<item>
 <title>Music intervention as a therapeutic approach to cognitive impairments in APP/PS1 mice.</title>
 <link>https://www.alzforum.org/papers/music-intervention-therapeutic-approach-cognitive-impairments-appps1-mice</link>
 <description>Brain Res Bull. 2026 Sep 9;245:112113.  Epub 2026 Sep 9&lt;br&gt;Authors: Bu X, Yuan Y, Song W, Wang W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716318&quot;&gt;42716318&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/music-intervention-therapeutic-approach-cognitive-impairments-appps1-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/music-intervention-therapeutic-approach-cognitive-impairments-appps1-mice#comments</comments>
</item>
<item>
 <title>Subchronic diethyl phthalate exposure aggravates Alzheimer-like phenotypes in 5XFAD mice: Partial attenuation by Akt activation.</title>
 <link>https://www.alzforum.org/papers/subchronic-diethyl-phthalate-exposure-aggravates-alzheimer-phenotypes-5xfad-mice-partial</link>
 <description>Brain Res Bull. 2026 Sep 9;245:112116.  Epub 2026 Sep 9&lt;br&gt;Authors: Zhao J, Zhang S, Gao D, Xie L, Wang Y, Peng D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716316&quot;&gt;42716316&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/subchronic-diethyl-phthalate-exposure-aggravates-alzheimer-phenotypes-5xfad-mice-partial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/subchronic-diethyl-phthalate-exposure-aggravates-alzheimer-phenotypes-5xfad-mice-partial#comments</comments>
</item>
<item>
 <title>Neuroinflammation and vascular pathology in Alzheimer&#039;s Disease: The NRF2/HO-1 axis as a modulator of microglial phenotypes.</title>
 <link>https://www.alzforum.org/papers/neuroinflammation-and-vascular-pathology-alzheimers-disease-nrf2ho-1-axis-modulator</link>
 <description>Neurochem Int. 2026 Sep 9;200:106258.  Epub 2026 Sep 9&lt;br&gt;Authors: Olazabal-Chias M, Kratochvil M, Rojo AI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716186&quot;&gt;42716186&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroinflammation-and-vascular-pathology-alzheimers-disease-nrf2ho-1-axis-modulator#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroinflammation-and-vascular-pathology-alzheimers-disease-nrf2ho-1-axis-modulator#comments</comments>
</item>
<item>
 <title>Sigma-1 receptor involvement in the paradigm-dependent anti-amnesic effects of multimodal HBK-10 under NMDA receptor hypofunction, with accompanying hippocampal ERK1/2 and BDNF modulation.</title>
 <link>https://www.alzforum.org/papers/sigma-1-receptor-involvement-paradigm-dependent-anti-amnesic-effects-multimodal-hbk-10-under</link>
 <description>Biochem Pharmacol. 2026 Sep 9;:118454.  Epub 2026 Sep 9&lt;br&gt;Authors: Lustyk K, Jagielska A, Sałaciak K, Dudzik P, Soren A, Konwar J, Żelaszczyk D, Marona H, Crouzier L, Meunier J, Maurice T, Sapa J, Pytka K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716138&quot;&gt;42716138&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sigma-1-receptor-involvement-paradigm-dependent-anti-amnesic-effects-multimodal-hbk-10-under#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sigma-1-receptor-involvement-paradigm-dependent-anti-amnesic-effects-multimodal-hbk-10-under#comments</comments>
</item>
<item>
 <title>Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies.</title>
 <link>https://www.alzforum.org/papers/plasma-phosphorylated-tau-217-concentrations-apoe-genotype-and-timing-cognitive-impairment</link>
 <description>Lancet Neurol. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Xu Y, Gunasekaran TI, Gu Y, Reyes-Dumeyer D, Piriz A, Sanchez D, Mejia DR, Medrano M, Lantigua RA, Alzheimer&amp;#039;s Disease Neuroimaging Initiative, Honig L, Wilson R, Reyes RE, Manly JJ, Brickman AM, Engelman CD, Johnson S, Asthana S, Bennett DA, Petersen M, O&amp;#039;Bryant S, Vardarajan BN, Mayeux R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716078&quot;&gt;42716078&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-phosphorylated-tau-217-concentrations-apoe-genotype-and-timing-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-phosphorylated-tau-217-concentrations-apoe-genotype-and-timing-cognitive-impairment#comments</comments>
</item>
<item>
 <title>Effects of Konjac glucosylceramides on cognitive function in cognitively unimpaired older adults with subjective cognitive concerns: a randomized, double-blind, controlled pilot study.</title>
 <link>https://www.alzforum.org/papers/effects-konjac-glucosylceramides-cognitive-function-cognitively-unimpaired-older-adults</link>
 <description>J Nutr Health Aging. 2026 Sep 9;30(11):100975.  Epub 2026 Sep 9&lt;br&gt;Authors: Yuyama K, Sun H, Eguchi K, Oe K, Ukawa Y, Otsuki M, Nakai H, Isono J, Sekine T, Imada T, Tanaka A, Kagami-Katsuyama H, Honma N, Nishihara J, Monde K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715913&quot;&gt;42715913&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-konjac-glucosylceramides-cognitive-function-cognitively-unimpaired-older-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-konjac-glucosylceramides-cognitive-function-cognitively-unimpaired-older-adults#comments</comments>
</item>
<item>
 <title>JNJ-42153605, a mGluR2 PAM, potentiates levetiracetam treatments of TBI to mitigate subsequent tau aggregation in a larval zebrafish model.</title>
 <link>https://www.alzforum.org/papers/jnj-42153605-mglur2-pam-potentiates-levetiracetam-treatments-tbi-mitigate-subsequent-tau</link>
 <description>Exp Neurol. 2026 Sep 9;407:116014.  Epub 2026 Sep 9&lt;br&gt;Authors: Locskai LF, Ghassemi S, Tan SA, Kinley MJ, Allison WT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715893&quot;&gt;42715893&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/jnj-42153605-mglur2-pam-potentiates-levetiracetam-treatments-tbi-mitigate-subsequent-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/jnj-42153605-mglur2-pam-potentiates-levetiracetam-treatments-tbi-mitigate-subsequent-tau#comments</comments>
</item>
<item>
 <title>Integrative transcriptomic analysis reveals KLHL2 downregulation as a potential driver of microglial inflammation in Alzheimer&#039;s disease via the WNK3/JNK/c-Jun axis.</title>
 <link>https://www.alzforum.org/papers/integrative-transcriptomic-analysis-reveals-klhl2-downregulation-potential-driver-microglial</link>
 <description>Neurotherapeutics. 2026 Sep 9;23(5):e01069.  Epub 2026 Sep 9&lt;br&gt;Authors: Yang Y, Dai C, Xu Z, Zhuo L, Xiang K, Lin X, Sun J, Liu J, Tong Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715818&quot;&gt;42715818&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrative-transcriptomic-analysis-reveals-klhl2-downregulation-potential-driver-microglial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrative-transcriptomic-analysis-reveals-klhl2-downregulation-potential-driver-microglial#comments</comments>
</item>
<item>
 <title>From molecular aggregates to neurodegenerative networks: Integrating electron and X-ray imaging across scale.</title>
 <link>https://www.alzforum.org/papers/molecular-aggregates-neurodegenerative-networks-integrating-electron-and-x-ray-imaging-across</link>
 <description>Curr Opin Struct Biol. 2026 Sep 9;101:103383.  Epub 2026 Sep 9&lt;br&gt;Authors: Mohammed I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715791&quot;&gt;42715791&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/molecular-aggregates-neurodegenerative-networks-integrating-electron-and-x-ray-imaging-across#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/molecular-aggregates-neurodegenerative-networks-integrating-electron-and-x-ray-imaging-across#comments</comments>
</item>
<item>
 <title>Telephone-based Hopkins Verbal Learning Test-Revised as a pre-screening tool for identifying SuperAgers.</title>
 <link>https://www.alzforum.org/papers/telephone-based-hopkins-verbal-learning-test-revised-pre-screening-tool-identifying</link>
 <description>Arch Clin Neuropsychol. 2026 Sep 9;41(7)&lt;br&gt;Authors: Piszczor J, Goicoechea EB, Schafer R, Peirce H, Hearns K, Capuano AW, Cook Maher A, Rogalski E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715377&quot;&gt;42715377&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/telephone-based-hopkins-verbal-learning-test-revised-pre-screening-tool-identifying#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/telephone-based-hopkins-verbal-learning-test-revised-pre-screening-tool-identifying#comments</comments>
</item>
<item>
 <title>Nitric oxide in the central nervous system: An emerging biomarker for neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/nitric-oxide-central-nervous-system-emerging-biomarker-neurodegeneration</link>
 <description>Med Gas Res. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Jávega-Cometto M, Hereñú CB, Crespo R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714877&quot;&gt;42714877&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nitric-oxide-central-nervous-system-emerging-biomarker-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nitric-oxide-central-nervous-system-emerging-biomarker-neurodegeneration#comments</comments>
</item>
<item>
 <title>Gut microbiota as a modulator of HDAC: insights into Alzheimer&#039;s disease treatment.</title>
 <link>https://www.alzforum.org/papers/gut-microbiota-modulator-hdac-insights-alzheimers-disease-treatment</link>
 <description>Pharmacol Rep. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Verma E, Mishra S, Chellammal HS, Khandige PS, Gasmi A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714783&quot;&gt;42714783&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/gut-microbiota-modulator-hdac-insights-alzheimers-disease-treatment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/gut-microbiota-modulator-hdac-insights-alzheimers-disease-treatment#comments</comments>
</item>
<item>
 <title>Hyperpolarized NMR study of the impact of alzheimer&#039;s disease on diabetes using a novel rat model.</title>
 <link>https://www.alzforum.org/papers/hyperpolarized-nmr-study-impact-alzheimers-disease-diabetes-using-novel-rat-model</link>
 <description>J Physiol Biochem. 2026 Sep 9;82(1)&lt;br&gt;Authors: Rehman U, Datta K, Liu SC, Park JM, Sriram R, Hong D, Chen Q, Mori H, Trinh V, Berman R, Hurd R, Spielman D, Jue T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714771&quot;&gt;42714771&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hyperpolarized-nmr-study-impact-alzheimers-disease-diabetes-using-novel-rat-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hyperpolarized-nmr-study-impact-alzheimers-disease-diabetes-using-novel-rat-model#comments</comments>
</item>
<item>
 <title>Atorvastatin Shows Limited Disease-Modifying Effects in an A53T α-Synuclein Mouse Model of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/atorvastatin-shows-limited-disease-modifying-effects-a53t-synuclein-mouse-model-parkinsons</link>
 <description>Neurotox Res. 2026 Sep 9;44(5)&lt;br&gt;Authors: Wei L, Hua J, Tang S, Lei J, Li G, Wei L, Mo M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714756&quot;&gt;42714756&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/atorvastatin-shows-limited-disease-modifying-effects-a53t-synuclein-mouse-model-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/atorvastatin-shows-limited-disease-modifying-effects-a53t-synuclein-mouse-model-parkinsons#comments</comments>
</item>
<item>
 <title>Discriminating behavioral variant frontotemporal dementia from Alzheimer&#039;s disease via the Frontal Assessment Battery.</title>
 <link>https://www.alzforum.org/papers/discriminating-behavioral-variant-frontotemporal-dementia-alzheimers-disease-frontal</link>
 <description>J Neurol. 2026 Sep 9;273(10)&lt;br&gt;Authors: Aiello EN, Canu E, Castelnovo V, Frisco F, Curti B, Moreschi A, De Luca G, Sibilla E, Freri F, Tripodi C, Bianchi A, Lamorgese B, Gilioli A, Spinelli EG, Cecchetti G, Ratti A, Maranzano A, Patisso V, Caroppo P, Prioni S, Villa C, Tremolizzo L, Appollonio I, Verde F, Silani V, Ticozzi N, Filippi M, Agosta F, Poletti B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714664&quot;&gt;42714664&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/discriminating-behavioral-variant-frontotemporal-dementia-alzheimers-disease-frontal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/discriminating-behavioral-variant-frontotemporal-dementia-alzheimers-disease-frontal#comments</comments>
</item>
<item>
 <title>Therapeutics candidates and repurposing strategies to target parkinson&#039;s disease pathology: current evidence and future directions.</title>
 <link>https://www.alzforum.org/papers/therapeutics-candidates-and-repurposing-strategies-target-parkinsons-disease-pathology</link>
 <description>Metab Brain Dis. 2026 Sep 9;41(1)&lt;br&gt;Authors: Dhanush Y, Nizamuddin ND, Neelima S, Kalpana S, Arla KK, Ganesh VS, Sree PC, Rohitha C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714656&quot;&gt;42714656&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutics-candidates-and-repurposing-strategies-target-parkinsons-disease-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutics-candidates-and-repurposing-strategies-target-parkinsons-disease-pathology#comments</comments>
</item>
<item>
 <title>[Antibody therapy in Alzheimer&#039;s disease].</title>
 <link>https://www.alzforum.org/papers/antibody-therapy-alzheimers-disease-1</link>
 <description>Z Gerontol Geriatr. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Schnieder M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714614&quot;&gt;42714614&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/antibody-therapy-alzheimers-disease-1#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/antibody-therapy-alzheimers-disease-1#comments</comments>
</item>
<item>
 <title>APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer&#039;s disease spectrum: A retrospective observational study.</title>
 <link>https://www.alzforum.org/papers/apoe4-dependent-cholinergicdopaminergic-contributions-clinical-symptoms-across-alzheimers</link>
 <description>Eur J Nucl Med Mol Imaging. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Kang S, Jeon S, Lee D, Lee H, Jeon SH, Choi M, Lee YG, Shin NY, Yun M, Ye BS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714593&quot;&gt;42714593&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe4-dependent-cholinergicdopaminergic-contributions-clinical-symptoms-across-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe4-dependent-cholinergicdopaminergic-contributions-clinical-symptoms-across-alzheimers#comments</comments>
</item>
<item>
 <title>Distinguishing early cognitive impairment in older adults with CogniScan: a nine-item composite derived from the Mini-Mental State Examination and Clock Drawing Test.</title>
 <link>https://www.alzforum.org/papers/distinguishing-early-cognitive-impairment-older-adults-cogniscan-nine-item-composite-derived</link>
 <description>Epidemiol Psychiatr Sci. 2026 Sep 9;35:e50. &lt;br&gt;Authors: Cacho-Gutiérrez J, García García-Patino R, García-García R, Cuevas-Pérez Y, Vicente-Villardón JL, Perea-Bartolomé MV, Benito-León J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42713682&quot;&gt;42713682&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/distinguishing-early-cognitive-impairment-older-adults-cogniscan-nine-item-composite-derived#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/distinguishing-early-cognitive-impairment-older-adults-cogniscan-nine-item-composite-derived#comments</comments>
</item>
<item>
 <title>Dissociable Handwriting Domains in Parkinson&#039;s Disease?</title>
 <link>https://www.alzforum.org/papers/dissociable-handwriting-domains-parkinsons-disease</link>
 <description>Mov Disord Clin Pract. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Cetin BN, Comoglu S, Ulker AC, Onder H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712204&quot;&gt;42712204&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dissociable-handwriting-domains-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dissociable-handwriting-domains-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Human amniotic mesenchymal stromal cell-derived extracellular vesicles reprogram microglia and prevent neurodegeneration in experimental models of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/human-amniotic-mesenchymal-stromal-cell-derived-extracellular-vesicles-reprogram-microglia</link>
 <description>Transl Neurodegener. 2026 Sep 9;15(1)&lt;br&gt;Authors: Papait A, Natale F, Silini AR, Nifo Sarrapochiello I, Orecchini E, Sollazzo R, Rinaudo M, Farigu S, Garofalo N, Mantini G, Giuffrè GM, Romele P, Ragozzino E, Dellaria A, Giacò L, Marra C, Ripoli C, Grassi C, Parolini O, Fusco S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711740&quot;&gt;42711740&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/human-amniotic-mesenchymal-stromal-cell-derived-extracellular-vesicles-reprogram-microglia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/human-amniotic-mesenchymal-stromal-cell-derived-extracellular-vesicles-reprogram-microglia#comments</comments>
</item>
<item>
 <title>Preliminary Development of a Hybrid Aptamer and Antibody Fluorescent Lateral Flow Assay for Ultrasensitive Detection of Tau441 Protein in Serum: Toward Point-of-Care Diagnostics for Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/preliminary-development-hybrid-aptamer-and-antibody-fluorescent-lateral-flow-assay</link>
 <description>J Fluoresc. 2026 Sep 9; Epub 2026 Sep 9&lt;br&gt;Authors: Mahrat R, Chen Y, Bruno JG, Nasaev S, Ufaev D, Kudryashova N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711626&quot;&gt;42711626&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/preliminary-development-hybrid-aptamer-and-antibody-fluorescent-lateral-flow-assay#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/preliminary-development-hybrid-aptamer-and-antibody-fluorescent-lateral-flow-assay#comments</comments>
</item>
<item>
 <title>Expert opinion on Alzheimer&#039;s disease diagnostics and management in Central Eastern European countries representing 88 million population.</title>
 <link>https://www.alzforum.org/papers/expert-opinion-alzheimers-disease-diagnostics-and-management-central-eastern-european</link>
 <description>Neurol Sci. 2026 Sep 9;47(10)&lt;br&gt;Authors: Mimica N, Dumitrescu L, Gregorič Kramberger M, Hort J, Kovács T, Popadić K, Popescu BO, Rakuša M, Rejdak K, Turčáni P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711466&quot;&gt;42711466&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/expert-opinion-alzheimers-disease-diagnostics-and-management-central-eastern-european#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/expert-opinion-alzheimers-disease-diagnostics-and-management-central-eastern-european#comments</comments>
</item>
<item>
 <title>Affinity peptide-based microfluidic electrochemical system for ultrasensitive detection of amyloid-β peptides.</title>
 <link>https://www.alzforum.org/papers/affinity-peptide-based-microfluidic-electrochemical-system-ultrasensitive-detection-amyloid-v</link>
 <description>Biosens Bioelectron. 2026 Sep 9;315:119216.  Epub 2026 Sep 9&lt;br&gt;Authors: Shang A, Zhang Z, Zhao J, Zhang H, Yuan H, Liu B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721512&quot;&gt;42721512&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/affinity-peptide-based-microfluidic-electrochemical-system-ultrasensitive-detection-amyloid-v#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/affinity-peptide-based-microfluidic-electrochemical-system-ultrasensitive-detection-amyloid-v#comments</comments>
</item>
<item>
 <title>Early Spatial and Contextual Coding Deficits in Hippocampal CA1 Precede Performance Decline in an Alzheimer&#039;s Disease Model.</title>
 <link>https://www.alzforum.org/papers/early-spatial-and-contextual-coding-deficits-hippocampal-ca1-precede-performance-decline</link>
 <description>Adv Sci (Weinh). 2026 Sep 9;:e77419.  Epub 2026 Sep 9&lt;br&gt;Authors: Li Y, Go MA, Zhang H, Aleksynas R, Kim J, Gao M, Prado S, Sastre M, Schultz SR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42717515&quot;&gt;42717515&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/early-spatial-and-contextual-coding-deficits-hippocampal-ca1-precede-performance-decline#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/early-spatial-and-contextual-coding-deficits-hippocampal-ca1-precede-performance-decline#comments</comments>
</item>
<item>
 <title>EXPRESS: Preclinical in-vivo cerebrovascular imaging in rodent models: Methods and applications in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/express-preclinical-vivo-cerebrovascular-imaging-rodent-models-methods-and-applications</link>
 <description>J Cereb Blood Flow Metab. 2026 Sep 9;:271678X261490246.  Epub 2026 Sep 9&lt;br&gt;Authors: Patalwala D, Ohene Y, Dickie BR, Rosenow T, Thomas-Bland I, Nesbit M, Takechi R, Parizel PM, Mamo JC, Lam V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42717406&quot;&gt;42717406&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/express-preclinical-vivo-cerebrovascular-imaging-rodent-models-methods-and-applications#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/express-preclinical-vivo-cerebrovascular-imaging-rodent-models-methods-and-applications#comments</comments>
</item>
<item>
 <title>RNA dysregulation as a determinant of aging and neurodegenerative vulnerability.</title>
 <link>https://www.alzforum.org/papers/rna-dysregulation-determinant-aging-and-neurodegenerative-vulnerability</link>
 <description>Trends Cell Biol. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Randles S, Yeo GW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711219&quot;&gt;42711219&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rna-dysregulation-determinant-aging-and-neurodegenerative-vulnerability#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rna-dysregulation-determinant-aging-and-neurodegenerative-vulnerability#comments</comments>
</item>
<item>
 <title>Basal Ganglia Perivascular Space Enlargement Is Associated with Sustained Amyloid-β Accumulation in the Alzheimer&#039;s Disease Continuum: A Longitudinal Study.</title>
 <link>https://www.alzforum.org/papers/basal-ganglia-perivascular-space-enlargement-associated-sustained-amyloid-v-accumulation</link>
 <description>Acad Radiol. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Liu L, Zeng Q, Luo X, Hong H, Xie L, Zhang Y, Lin M, Wang S, Li K, Liu X, Zhang R, Liu P, Yang Y, Huang P, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711180&quot;&gt;42711180&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/basal-ganglia-perivascular-space-enlargement-associated-sustained-amyloid-v-accumulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/basal-ganglia-perivascular-space-enlargement-associated-sustained-amyloid-v-accumulation#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;Let-7d-5p improves mouse cognitive function by targeting bach1 in Alzheimer&#039;s disease&quot; [Exp. Neurol. 406 (2026) 115957; https://doi.org/10.1016/j.expneurol.2026.115957].</title>
 <link>https://www.alzforum.org/papers/corrigendum-let-7d-5p-improves-mouse-cognitive-function-targeting-bach1-alzheimers-disease</link>
 <description>Exp Neurol. 2026 Sep 8;:116016.  Epub 2026 Sep 8&lt;br&gt;Authors: Liu Y, Peng L, Li M, Yan W, Xiang Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711162&quot;&gt;42711162&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-let-7d-5p-improves-mouse-cognitive-function-targeting-bach1-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-let-7d-5p-improves-mouse-cognitive-function-targeting-bach1-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Phosphorylation of α-synuclein directs trafficking of the v-SNARE synaptobrevin-2.</title>
 <link>https://www.alzforum.org/papers/phosphorylation-synuclein-directs-trafficking-v-snare-synaptobrevin-2</link>
 <description>J Neurosci. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Arvell EH, Carroll JP, Melland H, Engholm-Keller K, Hatters D, Graham ME, Gordon SL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711125&quot;&gt;42711125&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/phosphorylation-synuclein-directs-trafficking-v-snare-synaptobrevin-2#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/phosphorylation-synuclein-directs-trafficking-v-snare-synaptobrevin-2#comments</comments>
</item>
<item>
 <title>Passive Digital Marker-enabled identification and engagement for Alzheimer&#039;s disease and related dementias care in primary care: the INCLUDE study protocol.</title>
 <link>https://www.alzforum.org/papers/passive-digital-marker-enabled-identification-and-engagement-alzheimers-disease-and-related</link>
 <description>BMJ Open. 2026 Sep 8;16(9):e116755. &lt;br&gt;Authors: Summanwar D, Lee L, Willis DR, Ben Miled Z, Baucco C, Webber EC, Perkins AJ, Powell AY, Fowler NR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711082&quot;&gt;42711082&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/passive-digital-marker-enabled-identification-and-engagement-alzheimers-disease-and-related#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/passive-digital-marker-enabled-identification-and-engagement-alzheimers-disease-and-related#comments</comments>
</item>
<item>
 <title>Bayesian reweighting of α-synuclein ensembles reveals local-global discrepancies between chemical shifts and chain dimensions.</title>
 <link>https://www.alzforum.org/papers/bayesian-reweighting-synuclein-ensembles-reveals-local-global-discrepancies-between-chemical</link>
 <description>Int J Biol Macromol. 2026 Sep 8;382(Pt 1):154363.  Epub 2026 Sep 8&lt;br&gt;Authors: Akkum FI, Ozbas CE, Uversky VN, Coskuner-Weber O&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710762&quot;&gt;42710762&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/bayesian-reweighting-synuclein-ensembles-reveals-local-global-discrepancies-between-chemical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/bayesian-reweighting-synuclein-ensembles-reveals-local-global-discrepancies-between-chemical#comments</comments>
</item>
<item>
 <title>Adult primary whole-brain cultures from Thy1-aSyn mice (Line 61) retain Parkinson&#039;s disease-relevant phenotypes.</title>
 <link>https://www.alzforum.org/papers/adult-primary-whole-brain-cultures-thy1-asyn-mice-line-61-retain-parkinsons-disease-relevant</link>
 <description>Neuroscience. 2026 Sep 8;615:393-405.  Epub 2026 Sep 8&lt;br&gt;Authors: Zalpanow D, Merten A, Stelz S, Ofner A, Weiß S, Richter F, Lau K, Kotzur R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710736&quot;&gt;42710736&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/adult-primary-whole-brain-cultures-thy1-asyn-mice-line-61-retain-parkinsons-disease-relevant#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/adult-primary-whole-brain-cultures-thy1-asyn-mice-line-61-retain-parkinsons-disease-relevant#comments</comments>
</item>
<item>
 <title>Monomeric C-Reactive Protein Potentiates Microglia-Mediated Neuroinflammation in Alzheimer&#039;s Disease via the PLC-PKC-MAPK-NF-κB Pathway.</title>
 <link>https://www.alzforum.org/papers/monomeric-c-reactive-protein-potentiates-microglia-mediated-neuroinflammation-alzheimers</link>
 <description>J Biol Chem. 2026 Sep 8;:113527.  Epub 2026 Sep 8&lt;br&gt;Authors: Zhang J, Zhu Y, Zhang Q, Dai Y, Liu H, Shi J, Jiang Y, Chen Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710667&quot;&gt;42710667&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/monomeric-c-reactive-protein-potentiates-microglia-mediated-neuroinflammation-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/monomeric-c-reactive-protein-potentiates-microglia-mediated-neuroinflammation-alzheimers#comments</comments>
</item>
<item>
 <title>Du-Shu-Wan alleviates Tau protein phosphorylation in Alzheimer&#039;s disease by regulating MAPK/JNK signaling pathway.</title>
 <link>https://www.alzforum.org/papers/du-shu-wan-alleviates-tau-protein-phosphorylation-alzheimers-disease-regulating-mapkjnk</link>
 <description>J Ethnopharmacol. 2026 Sep 8;374(Pt 1):122380.  Epub 2026 Sep 8&lt;br&gt;Authors: Liu S, Ren L, Liu L, Chen LL, Zhang Y, Wang P, Xie GJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710608&quot;&gt;42710608&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/du-shu-wan-alleviates-tau-protein-phosphorylation-alzheimers-disease-regulating-mapkjnk#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/du-shu-wan-alleviates-tau-protein-phosphorylation-alzheimers-disease-regulating-mapkjnk#comments</comments>
</item>
<item>
 <title>Subregion-specific input organization of prefrontal-projecting basal forebrain cholinergic neurons and weakened striatal-NBM inhibitory transmission in 5xFAD mice.</title>
 <link>https://www.alzforum.org/papers/subregion-specific-input-organization-prefrontal-projecting-basal-forebrain-cholinergic-0</link>
 <description>Neurobiol Dis. 2026 Sep 8;229:107600.  Epub 2026 Sep 8&lt;br&gt;Authors: Huang Y, Xie X, Fernaine M, Li Z, Wang X, Wang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710552&quot;&gt;42710552&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/subregion-specific-input-organization-prefrontal-projecting-basal-forebrain-cholinergic-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/subregion-specific-input-organization-prefrontal-projecting-basal-forebrain-cholinergic-0#comments</comments>
</item>
<item>
 <title>Effect of tau silencing on tau pathology propagation, a treatment efficient at the earliest stages of the disease?</title>
 <link>https://www.alzforum.org/papers/effect-tau-silencing-tau-pathology-propagation-treatment-efficient-earliest-stages-disease</link>
 <description>Neurobiol Dis. 2026 Sep 8;229:107598.  Epub 2026 Sep 8&lt;br&gt;Authors: Kosa AC, Lopez-Gutierrez L, Ando K, Doeraene E, Aydin E, Lasri H, Wathelet-Depauw A, Pieters K, Van Morckhoven D, Dubois C, Hupkens E, Jespers P, Dewachter L, Stamatopoulos B, Brion JP, Leroy K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710551&quot;&gt;42710551&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effect-tau-silencing-tau-pathology-propagation-treatment-efficient-earliest-stages-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effect-tau-silencing-tau-pathology-propagation-treatment-efficient-earliest-stages-disease#comments</comments>
</item>
<item>
 <title>Protein Synthesis Dysregulation in Neurodegeneration: Mechanisms, Consequences, and Therapeutic Modulation.</title>
 <link>https://www.alzforum.org/papers/protein-synthesis-dysregulation-neurodegeneration-mechanisms-consequences-and-therapeutic</link>
 <description>Annu Rev Pharmacol Toxicol. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Brar KK, Butcher AJ, Mallucci GR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710072&quot;&gt;42710072&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/protein-synthesis-dysregulation-neurodegeneration-mechanisms-consequences-and-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/protein-synthesis-dysregulation-neurodegeneration-mechanisms-consequences-and-therapeutic#comments</comments>
</item>
<item>
 <title>Divergent biological consequences of APOE isoforms across industrialized and non-industrial environments.</title>
 <link>https://www.alzforum.org/papers/divergent-biological-consequences-apoe-isoforms-across-industrialized-and-non-industrial-0</link>
 <description>PLoS Genet. 2026 Sep 8;22(9):e1012285.  Epub 2026 Sep 8&lt;br&gt;Authors: Watowich MM, Petersen RM, Brassington L, Arner AM, Rodenberg G, Tan Boon Huat TB, Tam KL, Schellenberg E, Bin Mohd Sayed I, John E, Kahumbu JC, Muhoya B, Gurven M, Trumble BC, Njeru SN, Martins D, Ayroles JF, Lim YA, Venkataraman VV, Wallace IJ, Kraft TS, Lea AJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709892&quot;&gt;42709892&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/divergent-biological-consequences-apoe-isoforms-across-industrialized-and-non-industrial-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/divergent-biological-consequences-apoe-isoforms-across-industrialized-and-non-industrial-0#comments</comments>
</item>
<item>
 <title>Sample size determination for a prospective bridging study to harmonize retrospective data from multiple studies-Application to a biofluid biomarker study of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/sample-size-determination-prospective-bridging-study-harmonize-retrospective-data-multiple</link>
 <description>Stat Methods Med Res. 2026 Sep 8;:9622802261468023.  Epub 2026 Sep 8&lt;br&gt;Authors: Xiong C, Nie Y, Luo J, Lu R, Wolk D, Shaw LM, Gleason CE, Johnson SC, Agboola F, Morris JC, Schindler SE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709841&quot;&gt;42709841&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sample-size-determination-prospective-bridging-study-harmonize-retrospective-data-multiple#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sample-size-determination-prospective-bridging-study-harmonize-retrospective-data-multiple#comments</comments>
</item>
<item>
 <title>Rhinitis, sinusitis, and risk of dementia: A systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/rhinitis-sinusitis-and-risk-dementia-systematic-review-and-meta-analysis</link>
 <description>Neuroepidemiology. 2026 Sep 8;:1.  Epub 2026 Sep 8&lt;br&gt;Authors: Jung J, Lee H, Park S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709657&quot;&gt;42709657&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rhinitis-sinusitis-and-risk-dementia-systematic-review-and-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rhinitis-sinusitis-and-risk-dementia-systematic-review-and-meta-analysis#comments</comments>
</item>
<item>
 <title>Decoding the drivers of Alzheimer&#039;s disease and other dementias mortality in Asia, 1990-2023: a Global Burden of Diseases Study 2023.</title>
 <link>https://www.alzforum.org/papers/decoding-drivers-alzheimers-disease-and-other-dementias-mortality-asia-1990-2023-global</link>
 <description>Neuroepidemiology. 2026 Sep 8;:1.  Epub 2026 Sep 8&lt;br&gt;Authors: Kim DY, Yoon J, Kim S, Park J, Kim JH, Yoo H, Kim J, Kim K, Woo HG, Woo S, Yon DK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709642&quot;&gt;42709642&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/decoding-drivers-alzheimers-disease-and-other-dementias-mortality-asia-1990-2023-global#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/decoding-drivers-alzheimers-disease-and-other-dementias-mortality-asia-1990-2023-global#comments</comments>
</item>
<item>
 <title>Stage-dependent associations of glial fibrillary acidic protein and chitinase-3-like protein 1 with white matter network integrity in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/stage-dependent-associations-glial-fibrillary-acidic-protein-and-chitinase-3-protein-1-white</link>
 <description>J Alzheimers Dis. 2026 Sep 8;:13872877261485599.  Epub 2026 Sep 8&lt;br&gt;Authors: Li OY, Turnbull A, Vankee-Lin F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709512&quot;&gt;42709512&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/stage-dependent-associations-glial-fibrillary-acidic-protein-and-chitinase-3-protein-1-white#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/stage-dependent-associations-glial-fibrillary-acidic-protein-and-chitinase-3-protein-1-white#comments</comments>
</item>
<item>
 <title>Motor sequence learning and learning to learn across the Alzheimer&#039;s disease continuum: Associations with biomarkers.</title>
 <link>https://www.alzforum.org/papers/motor-sequence-learning-and-learning-learn-across-alzheimers-disease-continuum-associations</link>
 <description>J Alzheimers Dis. 2026 Sep 8;:13872877261485584.  Epub 2026 Sep 8&lt;br&gt;Authors: Ruitenberg MF, Carmona Osorio PD, King JB, Hoffman JM, Duff K, Koppelmans V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709508&quot;&gt;42709508&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/motor-sequence-learning-and-learning-learn-across-alzheimers-disease-continuum-associations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/motor-sequence-learning-and-learning-learn-across-alzheimers-disease-continuum-associations#comments</comments>
</item>
<item>
 <title>Cellular modifiers of TDP-43 phase transition and cytoplasmic aggregation.</title>
 <link>https://www.alzforum.org/papers/cellular-modifiers-tdp-43-phase-transition-and-cytoplasmic-aggregation</link>
 <description>Elife. 2026 Sep 8;15&lt;br&gt;Authors: Chin N, Zhang Q, Zou J, Cheng KC, Zheng W, Ye Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709471&quot;&gt;42709471&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cellular-modifiers-tdp-43-phase-transition-and-cytoplasmic-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cellular-modifiers-tdp-43-phase-transition-and-cytoplasmic-aggregation#comments</comments>
</item>
<item>
 <title>Exhaled Carbon Monoxide Levels May Offer Clues on the Etiology of Parkinson Disease.</title>
 <link>https://www.alzforum.org/papers/exhaled-carbon-monoxide-levels-may-offer-clues-etiology-parkinson-disease</link>
 <description>JAMA Neurol. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Darweesh SK, Remz MA, Goldman SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709453&quot;&gt;42709453&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exhaled-carbon-monoxide-levels-may-offer-clues-etiology-parkinson-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exhaled-carbon-monoxide-levels-may-offer-clues-etiology-parkinson-disease#comments</comments>
</item>
<item>
 <title>Common MC1R Variants and Parkinson Disease Progression.</title>
 <link>https://www.alzforum.org/papers/common-mc1r-variants-and-parkinson-disease-progression</link>
 <description>JAMA Neurol. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Schumacher JG, Zhang X, Wang J, Dijkstra JM, Watanabe H, Gao X, Cortese M, Macklin EA, Schwarzschild MA, Chen X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709445&quot;&gt;42709445&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/common-mc1r-variants-and-parkinson-disease-progression#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/common-mc1r-variants-and-parkinson-disease-progression#comments</comments>
</item>
<item>
 <title>MC1R Variants and Parkinson Disease Progression Genetics.</title>
 <link>https://www.alzforum.org/papers/mc1r-variants-and-parkinson-disease-progression-genetics</link>
 <description>JAMA Neurol. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Klein C, Bruggemann N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709428&quot;&gt;42709428&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mc1r-variants-and-parkinson-disease-progression-genetics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mc1r-variants-and-parkinson-disease-progression-genetics#comments</comments>
</item>
<item>
 <title>From Glycation to Toxicity: α-Synuclein Oligomers, Oxidative Stress, and Multi-Targeted Protection by Trans-Ferulic Acid.</title>
 <link>https://www.alzforum.org/papers/glycation-toxicity-synuclein-oligomers-oxidative-stress-and-multi-targeted-protection-trans</link>
 <description>Cell Biochem Biophys. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Hussain M, Hassan MN, Ahmad R, Zehra GE, Kaur A, Baliyavi UK, Aziz T, Khan RH, Siddiqui WA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709392&quot;&gt;42709392&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glycation-toxicity-synuclein-oligomers-oxidative-stress-and-multi-targeted-protection-trans#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glycation-toxicity-synuclein-oligomers-oxidative-stress-and-multi-targeted-protection-trans#comments</comments>
</item>
<item>
 <title>The Great Transatlantic Divide: The Case of Experimental Neuropharmacology.</title>
 <link>https://www.alzforum.org/papers/great-transatlantic-divide-case-experimental-neuropharmacology</link>
 <description>Clin Drug Investig. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Colosimo C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709336&quot;&gt;42709336&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/great-transatlantic-divide-case-experimental-neuropharmacology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/great-transatlantic-divide-case-experimental-neuropharmacology#comments</comments>
</item>
<item>
 <title>Cross-disease protein aggregate interactions in neurodegeneration: from molecular mechanisms to therapeutic strategies.</title>
 <link>https://www.alzforum.org/papers/cross-disease-protein-aggregate-interactions-neurodegeneration-molecular-mechanisms</link>
 <description>Neurol Sci. 2026 Sep 8;47(10)&lt;br&gt;Authors: Yang W, Lu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709250&quot;&gt;42709250&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cross-disease-protein-aggregate-interactions-neurodegeneration-molecular-mechanisms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cross-disease-protein-aggregate-interactions-neurodegeneration-molecular-mechanisms#comments</comments>
</item>
<item>
 <title>Sublingual apomorphine for Parkinsonian tremor: a post-hoc analysis of pivotal trial data.</title>
 <link>https://www.alzforum.org/papers/sublingual-apomorphine-parkinsonian-tremor-post-hoc-analysis-pivotal-trial-data</link>
 <description>J Neural Transm (Vienna). 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Dafsari HS, Reis J, Strauß K, Brigas HC, Denecke Muhr C, Jiménez IP, Holenz J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709169&quot;&gt;42709169&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sublingual-apomorphine-parkinsonian-tremor-post-hoc-analysis-pivotal-trial-data#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sublingual-apomorphine-parkinsonian-tremor-post-hoc-analysis-pivotal-trial-data#comments</comments>
</item>
<item>
 <title>Efficacy and safety of memantine in adults with amyotrophic lateral sclerosis: a systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/efficacy-and-safety-memantine-adults-amyotrophic-lateral-sclerosis-systematic-review-and-meta</link>
 <description>J Neural Transm (Vienna). 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Hamzeh LH, Seyed E, Elgendy MA, Heib D, Sadek BI, Mohammed CO, El Refaei K, Soliman YF, Eldmrdash N, Abdelgalil MS, Elsayed MM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709165&quot;&gt;42709165&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-and-safety-memantine-adults-amyotrophic-lateral-sclerosis-systematic-review-and-meta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-and-safety-memantine-adults-amyotrophic-lateral-sclerosis-systematic-review-and-meta#comments</comments>
</item>
<item>
 <title>Membrane Phase, Charge, and Curvature Regulate α-Synuclein Binding Dynamics.</title>
 <link>https://www.alzforum.org/papers/membrane-phase-charge-and-curvature-regulate-synuclein-binding-dynamics-0</link>
 <description>Langmuir. 2026 Sep 8;42(35):25681-25696. &lt;br&gt;Authors: Kou OH, Sakurai CM, Ramirez SY, Kim BH, Johnson DH, Zhang Z, Lee CT, Zeno WF&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42709078&quot;&gt;42709078&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/membrane-phase-charge-and-curvature-regulate-synuclein-binding-dynamics-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/membrane-phase-charge-and-curvature-regulate-synuclein-binding-dynamics-0#comments</comments>
</item>
<item>
 <title>Cross-sectional relationships between memory scores and neurodegeneration biomarkers in patients with suspected cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/cross-sectional-relationships-between-memory-scores-and-neurodegeneration-biomarkers-patients</link>
 <description>J Clin Exp Neuropsychol. 2026 Sep 8;:1-14.  Epub 2026 Sep 8&lt;br&gt;Authors: Sahhar L, Albrecht M, Pahl J, Häger A, Reetz K, Costa AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708793&quot;&gt;42708793&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cross-sectional-relationships-between-memory-scores-and-neurodegeneration-biomarkers-patients#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cross-sectional-relationships-between-memory-scores-and-neurodegeneration-biomarkers-patients#comments</comments>
</item>
<item>
 <title>When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/when-pathologies-collide-intersection-tau-and-alpha-synuclein-neurodegenerative-diseases</link>
 <description>Mol Neurobiol. 2026 Sep 8;63(1)&lt;br&gt;Authors: Hunt JN, Kortagere S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706463&quot;&gt;42706463&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/when-pathologies-collide-intersection-tau-and-alpha-synuclein-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/when-pathologies-collide-intersection-tau-and-alpha-synuclein-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Exploring cerebral small vessel disease signatures in familial Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/exploring-cerebral-small-vessel-disease-signatures-familial-parkinsons-disease</link>
 <description>Sci Rep. 2026 Sep 8;16(1)&lt;br&gt;Authors: Mahat B, Malla B, Foddis M, Beule D, Bras J, Guerreiro R, Kola V, Schmitt HM, Endres M, Sassi C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706363&quot;&gt;42706363&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-cerebral-small-vessel-disease-signatures-familial-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-cerebral-small-vessel-disease-signatures-familial-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Effects of Qi-fu-yin on Improving Cognitive Impairment and Reducing Cellular Senescence in the Brains of 5xFAD Mice.</title>
 <link>https://www.alzforum.org/papers/effects-qi-fu-yin-improving-cognitive-impairment-and-reducing-cellular-senescence-brains</link>
 <description>J Vis Exp. 2026 Sep 8;(235)&lt;br&gt;Authors: Li Y, Ye T, Lu H, Wang S, Yu T, Li H, Cheng X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42714032&quot;&gt;42714032&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-qi-fu-yin-improving-cognitive-impairment-and-reducing-cellular-senescence-brains#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-qi-fu-yin-improving-cognitive-impairment-and-reducing-cellular-senescence-brains#comments</comments>
</item>
<item>
 <title>Engineering mRNA-LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases.</title>
 <link>https://www.alzforum.org/papers/engineering-mrna-lnp-medicines-ageing-brain-opportunities-and-challenges-neurodegenerative</link>
 <description>Exploration (Beijing). 2026 Sep 8;:70223.  Epub 2026 Sep 8&lt;br&gt;Authors: Belaidi AA, Furtado DL, Alves F, Nisbet RM, Ayton S, Bush AI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42713005&quot;&gt;42713005&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/engineering-mrna-lnp-medicines-ageing-brain-opportunities-and-challenges-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/engineering-mrna-lnp-medicines-ageing-brain-opportunities-and-challenges-neurodegenerative#comments</comments>
</item>
<item>
 <title>Rapid plaque clearance with anti-amyloid therapy for Alzheimer&#039;s disease: in consideration of donanemab treatment duration from real-world cases.</title>
 <link>https://www.alzforum.org/papers/rapid-plaque-clearance-anti-amyloid-therapy-alzheimers-disease-consideration-donanemab</link>
 <description>Neurocase. 2026 Sep 8;:1-4.  Epub 2026 Sep 8&lt;br&gt;Authors: Hwang J, Pietras A, Naasan G, Elahi FM, Gandy S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711950&quot;&gt;42711950&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rapid-plaque-clearance-anti-amyloid-therapy-alzheimers-disease-consideration-donanemab#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rapid-plaque-clearance-anti-amyloid-therapy-alzheimers-disease-consideration-donanemab#comments</comments>
</item>
<item>
 <title>Plasma neuroimmune pathway signatures are associated with clinical impairment and lower MRI-derived hippocampal volume across the Alzheimer&#039;s disease continuum.</title>
 <link>https://www.alzforum.org/papers/plasma-neuroimmune-pathway-signatures-are-associated-clinical-impairment-and-lower-mri</link>
 <description>Eur Geriatr Med. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Alruwaili M, Alanazi MF, Almohaimeed HM, Alharbi SS, Alruwais N, Elkordy EA, Alshuhri MS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711543&quot;&gt;42711543&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-neuroimmune-pathway-signatures-are-associated-clinical-impairment-and-lower-mri#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-neuroimmune-pathway-signatures-are-associated-clinical-impairment-and-lower-mri#comments</comments>
</item>
<item>
 <title>The associations between ATN biomarkers and episodic memory diminish as age increases.</title>
 <link>https://www.alzforum.org/papers/associations-between-atn-biomarkers-and-episodic-memory-diminish-age-increases</link>
 <description>Eur Geriatr Med. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Ekman U, Gyllenhammar M, Almkvist O, Ocklind A, Hallerstam L, Ferreira D, Eriksdotter M, Wahlund LO, Rennie A, Westman E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711542&quot;&gt;42711542&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-between-atn-biomarkers-and-episodic-memory-diminish-age-increases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-between-atn-biomarkers-and-episodic-memory-diminish-age-increases#comments</comments>
</item>
<item>
 <title>The hidden role of the bone marrow in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/hidden-role-bone-marrow-alzheimers-disease</link>
 <description>Nat Neurosci. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: &lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711431&quot;&gt;42711431&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hidden-role-bone-marrow-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hidden-role-bone-marrow-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Mapping the dual functional organization of the substantia nigra.</title>
 <link>https://www.alzforum.org/papers/mapping-dual-functional-organization-substantia-nigra</link>
 <description>Mol Psychiatry. 2026 Sep 8; Epub 2026 Sep 8&lt;br&gt;Authors: Veréb D, Zufiria-Gerbolés B, Passaretti M, Mijalkov M, Veronese M, Pereira JB, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711409&quot;&gt;42711409&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mapping-dual-functional-organization-substantia-nigra#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mapping-dual-functional-organization-substantia-nigra#comments</comments>
</item>
<item>
 <title>Dysfunction of the blood-brain barrier and neurovascular unit in amyotrophic lateral sclerosis - From advanced human models to treatments.</title>
 <link>https://www.alzforum.org/papers/dysfunction-blood-brain-barrier-and-neurovascular-unit-amyotrophic-lateral-sclerosis-advanced</link>
 <description>J Neurol Sci. 2026 Sep 8;490:126168.  Epub 2026 Sep 8&lt;br&gt;Authors: Viljoen S, Chaves JC, Peall I, White AR, Oikari LE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721706&quot;&gt;42721706&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dysfunction-blood-brain-barrier-and-neurovascular-unit-amyotrophic-lateral-sclerosis-advanced#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dysfunction-blood-brain-barrier-and-neurovascular-unit-amyotrophic-lateral-sclerosis-advanced#comments</comments>
</item>
<item>
 <title>Biologically-synthesized zinc oxide nanoparticle-based α-synuclein nanoformulation mitigates Parkinson&#039;s disease progression in Drosophila melanogaster.</title>
 <link>https://www.alzforum.org/papers/biologically-synthesized-zinc-oxide-nanoparticle-based-synuclein-nanoformulation-mitigates</link>
 <description>Int J Biol Macromol. 2026 Sep 7;382(Pt 1):154365.  Epub 2026 Sep 7&lt;br&gt;Authors: Jena S, Subham K, Kalra H, Naik S, Sahu DD, Mishra M, Jha S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42705562&quot;&gt;42705562&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biologically-synthesized-zinc-oxide-nanoparticle-based-synuclein-nanoformulation-mitigates#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biologically-synthesized-zinc-oxide-nanoparticle-based-synuclein-nanoformulation-mitigates#comments</comments>
</item>
<item>
 <title>Missense mutations in the SNCA gene: Molecular mechanisms and clinical implications.</title>
 <link>https://www.alzforum.org/papers/missense-mutations-snca-gene-molecular-mechanisms-and-clinical-implications</link>
 <description>Mol Cell Neurosci. 2026 Sep 7;139:104116.  Epub 2026 Sep 7&lt;br&gt;Authors: Gade P, Patel N, Rissardo JP, Patino J, Fornari-Caprara AL, Walker IM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42705428&quot;&gt;42705428&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/missense-mutations-snca-gene-molecular-mechanisms-and-clinical-implications#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/missense-mutations-snca-gene-molecular-mechanisms-and-clinical-implications#comments</comments>
</item>
<item>
 <title>Pattern of Audio Telehealth Among Medicare Beneficiaries With Alzheimer&#039;s Disease and Related Dementias.</title>
 <link>https://www.alzforum.org/papers/pattern-audio-telehealth-among-medicare-beneficiaries-alzheimers-disease-and-related</link>
 <description>J Am Med Dir Assoc. 2026 Sep 7;27(11):106471.  Epub 2026 Sep 7&lt;br&gt;Authors: Yang MT, Temkin-Greener H, Cai S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42705121&quot;&gt;42705121&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pattern-audio-telehealth-among-medicare-beneficiaries-alzheimers-disease-and-related#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pattern-audio-telehealth-among-medicare-beneficiaries-alzheimers-disease-and-related#comments</comments>
</item>
<item>
 <title>NDIB-Sim: A Multimodal Bidirectional PINN Model for Simulating Brain Dynamics.</title>
 <link>https://www.alzforum.org/papers/ndib-sim-multimodal-bidirectional-pinn-model-simulating-brain-dynamics</link>
 <description>IEEE Trans Neural Netw Learn Syst. 2026 Sep 7;PP Epub 2026 Sep 7&lt;br&gt;Authors: Yang L, Cui X, Li T, Zhang X, Chang R, Lu J, Li D, Wang B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42704803&quot;&gt;42704803&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ndib-sim-multimodal-bidirectional-pinn-model-simulating-brain-dynamics#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ndib-sim-multimodal-bidirectional-pinn-model-simulating-brain-dynamics#comments</comments>
</item>
<item>
 <title>UPS-mediated P-glycoprotein regulation in Alzheimer&#039;s disease: pharmacological implications for the amyloid pathology.</title>
 <link>https://www.alzforum.org/papers/ups-mediated-p-glycoprotein-regulation-alzheimers-disease-pharmacological-implications</link>
 <description>Mol Biol Rep. 2026 Sep 7;53(1)&lt;br&gt;Authors: Joshi A, Salunkhe J, Ugale V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42704522&quot;&gt;42704522&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ups-mediated-p-glycoprotein-regulation-alzheimers-disease-pharmacological-implications#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ups-mediated-p-glycoprotein-regulation-alzheimers-disease-pharmacological-implications#comments</comments>
</item>
<item>
 <title>Efficacy and safety of cannabinoid-based interventions for behavioral and cognitive symptoms in dementia: systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/efficacy-and-safety-cannabinoid-based-interventions-behavioral-and-cognitive-symptoms</link>
 <description>Neurol Sci. 2026 Sep 7;47(10)&lt;br&gt;Authors: Tudella GC, Klostermann AU, Menegucci G, Fernandes JV, Pacheco JP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42704497&quot;&gt;42704497&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-and-safety-cannabinoid-based-interventions-behavioral-and-cognitive-symptoms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-and-safety-cannabinoid-based-interventions-behavioral-and-cognitive-symptoms#comments</comments>
</item>
<item>
 <title>Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian α-synucleinopathies: a systematic review.</title>
 <link>https://www.alzforum.org/papers/synaptic-vesicle-glycoprotein-2a-pet-imaging-parkinsonian-synucleinopathies-systematic-review</link>
 <description>J Neurol. 2026 Sep 7;273(10)&lt;br&gt;Authors: Garrou F, Leva L, Sacchetti GM, De Natale ER, Tondo G, Comi C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42704496&quot;&gt;42704496&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synaptic-vesicle-glycoprotein-2a-pet-imaging-parkinsonian-synucleinopathies-systematic-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synaptic-vesicle-glycoprotein-2a-pet-imaging-parkinsonian-synucleinopathies-systematic-review#comments</comments>
</item>
<item>
 <title>Disease-specific hypometabolic epicenters in dementia: Neural networks and clinical correlations.</title>
 <link>https://www.alzforum.org/papers/disease-specific-hypometabolic-epicenters-dementia-neural-networks-and-clinical-correlations</link>
 <description>J Alzheimers Dis. 2026 Sep 7;:13872877261481091.  Epub 2026 Sep 7&lt;br&gt;Authors: Fu X, Cui M, Yue A, He Q, Nan H, Ye H, Rosa-Neto P, Wu L, Nie B, Chu M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42704090&quot;&gt;42704090&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disease-specific-hypometabolic-epicenters-dementia-neural-networks-and-clinical-correlations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disease-specific-hypometabolic-epicenters-dementia-neural-networks-and-clinical-correlations#comments</comments>
</item>
<item>
 <title>Mild behavioral impairment and risk of incident dementia: A systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/mild-behavioral-impairment-and-risk-incident-dementia-systematic-review-and-meta-analysis</link>
 <description>J Alzheimers Dis. 2026 Sep 7;:13872877261480315.  Epub 2026 Sep 7&lt;br&gt;Authors: Sassi KL, Thomson A, Young VM, Rocha NP, Teixeira AL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42704084&quot;&gt;42704084&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mild-behavioral-impairment-and-risk-incident-dementia-systematic-review-and-meta-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mild-behavioral-impairment-and-risk-incident-dementia-systematic-review-and-meta-analysis#comments</comments>
</item>
<item>
 <title>Tracking Socio-emotional Brain Changes in Premanifest C9orf72 Repeat Expansion Carriers: A Structural and Functional 2-Year Longitudinal Magnetic Resonance Imaging Study.</title>
 <link>https://www.alzforum.org/papers/tracking-socio-emotional-brain-changes-premanifest-c9orf72-repeat-expansion-carriers</link>
 <description>Ann Neurol. 2026 Sep 7; Epub 2026 Sep 7&lt;br&gt;Authors: Sun J, Vocht J, Laroy M, Stam D, Lien CH, Lamaire N, D&amp;#039;Hondt A, Peeters R, Sunaert S, Van Damme P, Vandenbulcke M, Van den Stock J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42703939&quot;&gt;42703939&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tracking-socio-emotional-brain-changes-premanifest-c9orf72-repeat-expansion-carriers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tracking-socio-emotional-brain-changes-premanifest-c9orf72-repeat-expansion-carriers#comments</comments>
</item>
<item>
 <title>High-Performance Screen-Printed OECT-Inspired with Encased Cassette Based on PEDOT:GO for Sensitive and Specific Electrochemical Aptasensing of Aβ-42 in Management of Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/high-performance-screen-printed-oect-inspired-encased-cassette-based-pedotgo-sensitive-and</link>
 <description>ACS Appl Bio Mater. 2026 Sep 7;9(17):7945-7960. &lt;br&gt;Authors: Singh S, Naithani D, Raj G, Narang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702988&quot;&gt;42702988&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/high-performance-screen-printed-oect-inspired-encased-cassette-based-pedotgo-sensitive-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/high-performance-screen-printed-oect-inspired-encased-cassette-based-pedotgo-sensitive-and#comments</comments>
</item>
<item>
 <title>Prion disease mimicking rapidly progressive Alzheimer disease: case series and systematic review.</title>
 <link>https://www.alzforum.org/papers/prion-disease-mimicking-rapidly-progressive-alzheimer-disease-case-series-and-systematic</link>
 <description>J Neurol. 2026 Sep 7;273(10)&lt;br&gt;Authors: Elgenidi A, Shir D, Piura YD, Sokol LL, Duara R, Lachner C, Day GS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702666&quot;&gt;42702666&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prion-disease-mimicking-rapidly-progressive-alzheimer-disease-case-series-and-systematic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prion-disease-mimicking-rapidly-progressive-alzheimer-disease-case-series-and-systematic#comments</comments>
</item>
<item>
 <title>Association between p-tau181 in cerebrospinal fluid and shunt response in patients with normal-pressure hydrocephalus.</title>
 <link>https://www.alzforum.org/papers/association-between-p-tau181-cerebrospinal-fluid-and-shunt-response-patients-normal-pressure</link>
 <description>Neurol Sci. 2026 Sep 7;47(10)&lt;br&gt;Authors: Bergner A, Musaeus CS, Simonsen AH, Munch TN, Carlsen JF, Hasselbalch SG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702643&quot;&gt;42702643&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-between-p-tau181-cerebrospinal-fluid-and-shunt-response-patients-normal-pressure#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-between-p-tau181-cerebrospinal-fluid-and-shunt-response-patients-normal-pressure#comments</comments>
</item>
<item>
 <title>Intersecting pathologies in atypical Alzheimer&#039;s disease: a case of logopenic PPA with cerebral amyloid angiopathy.</title>
 <link>https://www.alzforum.org/papers/intersecting-pathologies-atypical-alzheimers-disease-case-logopenic-ppa-cerebral-amyloid</link>
 <description>Neurol Sci. 2026 Sep 7;47(10)&lt;br&gt;Authors: Sfikas E, Constantinides V, Koros C, Smaragdaki E, Angelopoulou G, Toulas P, Stefanis L, Papageorgiou S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702638&quot;&gt;42702638&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/intersecting-pathologies-atypical-alzheimers-disease-case-logopenic-ppa-cerebral-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/intersecting-pathologies-atypical-alzheimers-disease-case-logopenic-ppa-cerebral-amyloid#comments</comments>
</item>
<item>
 <title>Validity of the T-MoCA for Screening MCI and Dementia and Its Equivalence to the K-MoCA-22.</title>
 <link>https://www.alzforum.org/papers/validity-t-moca-screening-mci-and-dementia-and-its-equivalence-k-moca-22</link>
 <description>J Korean Med Sci. 2026 Sep 7;41(35):e238. &lt;br&gt;Authors: Kim H, Jeong Y, Ji H, Park JS, Song IU, Sohn JH, Chin J, Kang Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708484&quot;&gt;42708484&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/validity-t-moca-screening-mci-and-dementia-and-its-equivalence-k-moca-22#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/validity-t-moca-screening-mci-and-dementia-and-its-equivalence-k-moca-22#comments</comments>
</item>
<item>
 <title>A blood DNA methylation marker of cognitive ability is associated with six-year cognitive performance independent of blood Alzheimer&#039;s disease biomarkers.</title>
 <link>https://www.alzforum.org/papers/blood-dna-methylation-marker-cognitive-ability-associated-six-year-cognitive-performance</link>
 <description>J Gerontol A Biol Sci Med Sci. 2026 Sep 7; Epub 2026 Sep 7&lt;br&gt;Authors: O&amp;#039;Shea DM, Wang L, Lukacsovich D, Zhang W, Galvin JE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706996&quot;&gt;42706996&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-dna-methylation-marker-cognitive-ability-associated-six-year-cognitive-performance#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-dna-methylation-marker-cognitive-ability-associated-six-year-cognitive-performance#comments</comments>
</item>
<item>
 <title>Rare-Variant Burden in Mitochondrial Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/rare-variant-burden-mitochondrial-parkinsons-disease</link>
 <description>Mov Disord. 2026 Sep 7; Epub 2026 Sep 7&lt;br&gt;Authors: Rakusa M, Bergant G, Peterlin B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706699&quot;&gt;42706699&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rare-variant-burden-mitochondrial-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rare-variant-burden-mitochondrial-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Co- and multipathologies need serious consideration for understanding Parkinson&#039;s disease pathogenesis and designing novel experimental therapeutic strategies.</title>
 <link>https://www.alzforum.org/papers/co-and-multipathologies-need-serious-consideration-understanding-parkinsons-disease</link>
 <description>J Parkinsons Dis. 2026 Sep 7;:1877718X261486172.  Epub 2026 Sep 7&lt;br&gt;Authors: Boehringer A, Kalia LV, Bloem BR, Kordower JH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706618&quot;&gt;42706618&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/co-and-multipathologies-need-serious-consideration-understanding-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/co-and-multipathologies-need-serious-consideration-understanding-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Detection of α-synuclein seeding activity in tear fluid as a candidate biomarker for Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/detection-synuclein-seeding-activity-tear-fluid-candidate-biomarker-parkinsons-disease</link>
 <description>J Parkinsons Dis. 2026 Sep 7;:1877718X261486736.  Epub 2026 Sep 7&lt;br&gt;Authors: Kakimoto A, Satoh K, Tsukahara-Kawamura T, Tsuboi Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706613&quot;&gt;42706613&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/detection-synuclein-seeding-activity-tear-fluid-candidate-biomarker-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/detection-synuclein-seeding-activity-tear-fluid-candidate-biomarker-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Thyroid dysfunction: Another piece in the complex puzzle of Alzheimer&#039;s disease?</title>
 <link>https://www.alzforum.org/papers/thyroid-dysfunction-another-piece-complex-puzzle-alzheimers-disease</link>
 <description>J Alzheimers Dis. 2026 Sep 7;:13872877261485579.  Epub 2026 Sep 7&lt;br&gt;Authors: Ilardi A, Ilardi CR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706510&quot;&gt;42706510&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/thyroid-dysfunction-another-piece-complex-puzzle-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/thyroid-dysfunction-another-piece-complex-puzzle-alzheimers-disease#comments</comments>
</item>
<item>
 <title>From target engagement to translational disconnect: A systematic review and narrative synthesis of direct tau-targeted clinical trials in Alzheimer&#039;s disease and primary tauopathies.</title>
 <link>https://www.alzforum.org/papers/target-engagement-translational-disconnect-systematic-review-and-narrative-synthesis-direct</link>
 <description>Pharmacol Res. 2026 Sep 6;232:108439.  Epub 2026 Sep 6&lt;br&gt;Authors: Yin L, Ren R, Leo C, Lu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702342&quot;&gt;42702342&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/target-engagement-translational-disconnect-systematic-review-and-narrative-synthesis-direct#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/target-engagement-translational-disconnect-systematic-review-and-narrative-synthesis-direct#comments</comments>
</item>
<item>
 <title>HIF-1 plays a dual regulatory role in hippocampal neuronal PANoptosis in Alzheimer&#039;s disease via the HK2/VDAC1/NLRP3 axis and RIPK3 signaling.</title>
 <link>https://www.alzforum.org/papers/hif-1-plays-dual-regulatory-role-hippocampal-neuronal-panoptosis-alzheimers-disease</link>
 <description>Pharmacol Res. 2026 Sep 6;232:108440.  Epub 2026 Sep 6&lt;br&gt;Authors: Wang S, Luo L, Jiang X, Hai J, Liu W, Zhou X, Li Y, Yang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702341&quot;&gt;42702341&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hif-1-plays-dual-regulatory-role-hippocampal-neuronal-panoptosis-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hif-1-plays-dual-regulatory-role-hippocampal-neuronal-panoptosis-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Convergent vulnerability and divergent outcomes of the dopaminergic system in Parkinson&#039;s and Alzheimer&#039;s diseases.</title>
 <link>https://www.alzforum.org/papers/convergent-vulnerability-and-divergent-outcomes-dopaminergic-system-parkinsons-and-alzheimers</link>
 <description>Ageing Res Rev. 2026 Sep 6;122:103358.  Epub 2026 Sep 6&lt;br&gt;Authors: Xi YT, Jia CX, Wang HD, Liu PY, Li P, Niu Q, Yin YL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702294&quot;&gt;42702294&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/convergent-vulnerability-and-divergent-outcomes-dopaminergic-system-parkinsons-and-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/convergent-vulnerability-and-divergent-outcomes-dopaminergic-system-parkinsons-and-alzheimers#comments</comments>
</item>
<item>
 <title>Associations of peripheral inflammation with hippocampal atrophy in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/associations-peripheral-inflammation-hippocampal-atrophy-alzheimers-disease</link>
 <description>Prog Neuropsychopharmacol Biol Psychiatry. 2026 Sep 6;150:111917.  Epub 2026 Sep 6&lt;br&gt;Authors: Xie H, Li Y, Gan R, Zhao Z, Alzheimer&amp;#039;s Disease Neuroimaging Initiative, Chen Q, Jia Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702232&quot;&gt;42702232&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/associations-peripheral-inflammation-hippocampal-atrophy-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/associations-peripheral-inflammation-hippocampal-atrophy-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Comment on, &quot;Glaucoma and Neurodegenerative Disease Risk: A 10-Year Assessment of Real-World Global Data&quot;.</title>
 <link>https://www.alzforum.org/papers/comment-glaucoma-and-neurodegenerative-disease-risk-10-year-assessment-real-world-global-data</link>
 <description>Am J Ophthalmol. 2026 Sep 6; Epub 2026 Sep 6&lt;br&gt;Authors: Ansari DM, Zou D, Jarrar Z, Ansari AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702228&quot;&gt;42702228&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comment-glaucoma-and-neurodegenerative-disease-risk-10-year-assessment-real-world-global-data#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comment-glaucoma-and-neurodegenerative-disease-risk-10-year-assessment-real-world-global-data#comments</comments>
</item>
<item>
 <title>Reply to Comment on, &quot;Glaucoma and Neurodegenerative Disease Risk: A 10-Year Assessment of Real-World Global Data&quot;.</title>
 <link>https://www.alzforum.org/papers/reply-comment-glaucoma-and-neurodegenerative-disease-risk-10-year-assessment-real-world</link>
 <description>Am J Ophthalmol. 2026 Sep 6; Epub 2026 Sep 6&lt;br&gt;Authors: Chen HY, Wong MS, Wang J, Lin YH, Wu CW, Lu KC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702227&quot;&gt;42702227&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/reply-comment-glaucoma-and-neurodegenerative-disease-risk-10-year-assessment-real-world#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/reply-comment-glaucoma-and-neurodegenerative-disease-risk-10-year-assessment-real-world#comments</comments>
</item>
<item>
 <title>Corrigendum to &quot;Distinct associations between body mass index and polyunsaturated fatty acids in dementia with Lewy Bodies and Alzheimer&#039;s disease&quot; [J Nutr Health Aging, 30 (2026) 100810].</title>
 <link>https://www.alzforum.org/papers/corrigendum-distinct-associations-between-body-mass-index-and-polyunsaturated-fatty-acids</link>
 <description>J Nutr Health Aging. 2026 Sep 6;30(10):100974.  Epub 2026 Sep 6&lt;br&gt;Authors: Castellanos-Perilla N, Borda MG, Chong JR, Tovar-Rios DA, Jaramillo-Jimenez A, Berge RK, Barreto GE, Aarsland D, Vik-Mo AO&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702172&quot;&gt;42702172&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-distinct-associations-between-body-mass-index-and-polyunsaturated-fatty-acids#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-distinct-associations-between-body-mass-index-and-polyunsaturated-fatty-acids#comments</comments>
</item>
<item>
 <title>Mitochondria-endoplasmic reticulum contact sites (MERCS/MAM): Multi-layered upstream regulators of microglial senescence in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/mitochondria-endoplasmic-reticulum-contact-sites-mercsmam-multi-layered-upstream-regulators</link>
 <description>Ageing Res Rev. 2026 Sep 6;122:103352.  Epub 2026 Sep 6&lt;br&gt;Authors: Liu A, Xing L, Li J, Gao W, Yao M, Song J, Li H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700866&quot;&gt;42700866&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mitochondria-endoplasmic-reticulum-contact-sites-mercsmam-multi-layered-upstream-regulators#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mitochondria-endoplasmic-reticulum-contact-sites-mercsmam-multi-layered-upstream-regulators#comments</comments>
</item>
<item>
 <title>The clinical implications of anosognosia in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/clinical-implications-anosognosia-alzheimers-disease</link>
 <description>Expert Rev Neurother. 2026 Sep 6;:1-13.  Epub 2026 Sep 6&lt;br&gt;Authors: Moro V, Vianello G, Gambina G, Gobbetto V, Gasparini M, Beccherle M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702949&quot;&gt;42702949&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-implications-anosognosia-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-implications-anosognosia-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Longitudinal Iron Changes in the Substantia Nigra of Early-Stage Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/longitudinal-iron-changes-substantia-nigra-early-stage-parkinsons-disease</link>
 <description>Mov Disord. 2026 Sep 5; Epub 2026 Sep 5&lt;br&gt;Authors: Du G, Sica C, de Jesus S, Kong L, Mailman RB, Huang X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698345&quot;&gt;42698345&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/longitudinal-iron-changes-substantia-nigra-early-stage-parkinsons-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/longitudinal-iron-changes-substantia-nigra-early-stage-parkinsons-disease#comments</comments>
</item>
<item>
 <title>Progress towards a biotypic biomarker profile for amyotrophic lateral sclerosis-frontotemporal spectrum disorders.</title>
 <link>https://www.alzforum.org/papers/progress-towards-biotypic-biomarker-profile-amyotrophic-lateral-sclerosis-frontotemporal</link>
 <description>Brain. 2026 Sep 5; Epub 2026 Sep 5&lt;br&gt;Authors: Strong MJ, Donison N, Al-Chalabi A, Boeve B, Finger EC, Holstege H, Huey ED, Lee EB, Marzi SJ, McHutchison C, McMillan CT, Otto M, Petrucelli L, Prudencio M, Simuni T, Tartaglia MC, Turner MR, Van Damme P, Wolk DA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698276&quot;&gt;42698276&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/progress-towards-biotypic-biomarker-profile-amyotrophic-lateral-sclerosis-frontotemporal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/progress-towards-biotypic-biomarker-profile-amyotrophic-lateral-sclerosis-frontotemporal#comments</comments>
</item>
<item>
 <title>Spatial navigation and the basal forebrain in Alzheimer&#039;s disease and other neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/spatial-navigation-and-basal-forebrain-alzheimers-disease-and-other-neurodegenerative</link>
 <description>Trends Neurosci. 2026 Sep 5; Epub 2026 Sep 5&lt;br&gt;Authors: Laczó M, Lerch O, Nedelska Z, Laczó J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701059&quot;&gt;42701059&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spatial-navigation-and-basal-forebrain-alzheimers-disease-and-other-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spatial-navigation-and-basal-forebrain-alzheimers-disease-and-other-neurodegenerative#comments</comments>
</item>
<item>
 <title>Activity-dependent DNA methylation and demethylation: epigenetic regulators of learning and memory.</title>
 <link>https://www.alzforum.org/papers/activity-dependent-dna-methylation-and-demethylation-epigenetic-regulators-learning-and</link>
 <description>Neurobiol Dis. 2026 Sep 5;229:107596.  Epub 2026 Sep 5&lt;br&gt;Authors: Li Z, Xu Z, Li X, Ren H, Zhang Y, Sun Z, Xu H, Zeng F, Liu Z, Chen J, Shi J, Wei W, Li X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700779&quot;&gt;42700779&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/activity-dependent-dna-methylation-and-demethylation-epigenetic-regulators-learning-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/activity-dependent-dna-methylation-and-demethylation-epigenetic-regulators-learning-and#comments</comments>
</item>
<item>
 <title>Allele-specific expression modulates the immunological and cis-regulatory landscape of Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/allele-specific-expression-modulates-immunological-and-cis-regulatory-landscape-parkinsons</link>
 <description>Comput Biol Med. 2026 Sep 5;215:111920.  Epub 2026 Sep 5&lt;br&gt;Authors: Piergiorge RM, Silva AT, Francisco R Jr, Vasconcelos AT, Santos-Rebouças CB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700515&quot;&gt;42700515&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/allele-specific-expression-modulates-immunological-and-cis-regulatory-landscape-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/allele-specific-expression-modulates-immunological-and-cis-regulatory-landscape-parkinsons#comments</comments>
</item>
<item>
 <title>Envisioning the self: self-defining future projections in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/envisioning-self-self-defining-future-projections-alzheimers-disease</link>
 <description>Geriatr Nurs. 2026 Sep 5;74(Pt A):104344.  Epub 2026 Sep 5&lt;br&gt;Authors: Cuervo-Lombard C, El Haj M, Hallit S, Chapelet G, Bulteau S, Voltzenlogel V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700507&quot;&gt;42700507&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/envisioning-self-self-defining-future-projections-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/envisioning-self-self-defining-future-projections-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Amyloid beta plaque pathology induces chemosensory deficits and increases apnoeas in the 5XFAD mouse model of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/amyloid-beta-plaque-pathology-induces-chemosensory-deficits-and-increases-apnoeas-5xfad-mouse</link>
 <description>J Physiol. 2026 Sep 5; Epub 2026 Sep 5&lt;br&gt;Authors: Sprenger RJ, Ewald AC, Romero PZ, Marino KM, Gumnit MG, McCann EC, Radcliff AB, Ulland TK, Watters JJ, Baker TL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700451&quot;&gt;42700451&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/amyloid-beta-plaque-pathology-induces-chemosensory-deficits-and-increases-apnoeas-5xfad-mouse#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/amyloid-beta-plaque-pathology-induces-chemosensory-deficits-and-increases-apnoeas-5xfad-mouse#comments</comments>
</item>
<item>
 <title>Initial Psychometric Evaluation of the Riga Cognitive Screening Task (RiTa) in Older Adults with Varying Levels of Cognitive Functioning.</title>
 <link>https://www.alzforum.org/papers/initial-psychometric-evaluation-riga-cognitive-screening-task-rita-older-adults-varying</link>
 <description>Dement Geriatr Cogn Disord. 2026 Sep 5;:1.  Epub 2026 Sep 5&lt;br&gt;Authors: Sneidere-Pitersa K, Litauniece ZA, Ušacka A, Gulbe AI, Freibergs Z, Zdanovskis N, Stepens A, Martinsone K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700431&quot;&gt;42700431&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/initial-psychometric-evaluation-riga-cognitive-screening-task-rita-older-adults-varying#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/initial-psychometric-evaluation-riga-cognitive-screening-task-rita-older-adults-varying#comments</comments>
</item>
<item>
 <title>Prevalent Stroke, Fatigue, and Incident Dementia Risk in the UK Biobank.</title>
 <link>https://www.alzforum.org/papers/prevalent-stroke-fatigue-and-incident-dementia-risk-uk-biobank</link>
 <description>Cerebrovasc Dis. 2026 Sep 5;:1.  Epub 2026 Sep 5&lt;br&gt;Authors: Bian K, Zhao X, Yuan X, Feng X, Yang Z, Sun W, Xu G, Jin H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700426&quot;&gt;42700426&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prevalent-stroke-fatigue-and-incident-dementia-risk-uk-biobank#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prevalent-stroke-fatigue-and-incident-dementia-risk-uk-biobank#comments</comments>
</item>
<item>
 <title>Entorhinal cortex astrocytes in early Alzheimer disease: Human evidence, cross-species circuit rationale, and translational boundaries.</title>
 <link>https://www.alzforum.org/papers/entorhinal-cortex-astrocytes-early-alzheimer-disease-human-evidence-cross-species-circuit</link>
 <description>J Neuropathol Exp Neurol. 2026 Sep 5; Epub 2026 Sep 5&lt;br&gt;Authors: Wu F, Wang M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700370&quot;&gt;42700370&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/entorhinal-cortex-astrocytes-early-alzheimer-disease-human-evidence-cross-species-circuit#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/entorhinal-cortex-astrocytes-early-alzheimer-disease-human-evidence-cross-species-circuit#comments</comments>
</item>
<item>
 <title>Therapeutic potential of apigenin in neurodegenerative diseases and brain health.</title>
 <link>https://www.alzforum.org/papers/therapeutic-potential-apigenin-neurodegenerative-diseases-and-brain-health</link>
 <description>Mol Biol Rep. 2026 Sep 5;53(1)&lt;br&gt;Authors: Aldiqs M, Aliev M, Gajjar TB, Senapati JN, Alhasso B, Urazbaeva D, Aminqulov S, Mishra MK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700326&quot;&gt;42700326&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutic-potential-apigenin-neurodegenerative-diseases-and-brain-health#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutic-potential-apigenin-neurodegenerative-diseases-and-brain-health#comments</comments>
</item>
<item>
 <title>No evidence of major integrative brain clearance impairment in an Alzheimer´s disease model of transgenic APPswe/PS1dE9 mice.</title>
 <link>https://www.alzforum.org/papers/no-evidence-major-integrative-brain-clearance-impairment-alzheimers-disease-model-transgenic</link>
 <description>Fluids Barriers CNS. 2026 Sep 5;23(1)&lt;br&gt;Authors: Müller L, Köhler C, Lindner T, Polei S, Vollmar B, Weber MA, Krause BJ, Kirschstein T, Porath K, Engel N, Teipel S, Radbruch A, Deike K, Kuhla A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706570&quot;&gt;42706570&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/no-evidence-major-integrative-brain-clearance-impairment-alzheimers-disease-model-transgenic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/no-evidence-major-integrative-brain-clearance-impairment-alzheimers-disease-model-transgenic#comments</comments>
</item>
<item>
 <title>Dioxaborinine-styrylquinoline hybrids as multitarget small-molecule theranostic compounds against Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/dioxaborinine-styrylquinoline-hybrids-multitarget-small-molecule-theranostic-compounds</link>
 <description>Bioorg Chem. 2026 Sep 5;182:110475.  Epub 2026 Sep 5&lt;br&gt;Authors: Sarabia-Vallejo Á, Fuente-Tovar M, Clerigué J, López-Alvarado P, Ran C, Martín MA, Menéndez JC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721523&quot;&gt;42721523&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dioxaborinine-styrylquinoline-hybrids-multitarget-small-molecule-theranostic-compounds#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dioxaborinine-styrylquinoline-hybrids-multitarget-small-molecule-theranostic-compounds#comments</comments>
</item>
<item>
 <title>Lower serum serotonin is associated with greater cardiovascular risk burden and poorer cognitive outcomes in mild cognitive impairment and amyloid-positive participants.</title>
 <link>https://www.alzforum.org/papers/lower-serum-serotonin-associated-greater-cardiovascular-risk-burden-and-poorer-cognitive</link>
 <description>Neuroscience. 2026 Sep 4;615:334-350.  Epub 2026 Sep 4&lt;br&gt;Authors: Alreshidi NF, Al-Qahtani SA, Almasoudi KS, Mirza IM, Abdulhag MM, Alsaidan AA, Jumah JB, Alzheimer’s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697521&quot;&gt;42697521&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/lower-serum-serotonin-associated-greater-cardiovascular-risk-burden-and-poorer-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/lower-serum-serotonin-associated-greater-cardiovascular-risk-burden-and-poorer-cognitive#comments</comments>
</item>
<item>
 <title>Microbiota-derived metabolite-GPCR signalling in neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/microbiota-derived-metabolite-gpcr-signalling-neurodegeneration</link>
 <description>Neuroscience. 2026 Sep 4;615:312-333.  Epub 2026 Sep 4&lt;br&gt;Authors: Sharma A, Jatana N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697520&quot;&gt;42697520&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microbiota-derived-metabolite-gpcr-signalling-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microbiota-derived-metabolite-gpcr-signalling-neurodegeneration#comments</comments>
</item>
<item>
 <title>Breaking the autophagy-oxidative stress vicious cycle in Alzheimer&#039;s disease: Lactiflorin unlocks P62 dual phosphorylation via ULK1 targeting.</title>
 <link>https://www.alzforum.org/papers/breaking-autophagy-oxidative-stress-vicious-cycle-alzheimers-disease-lactiflorin-unlocks-p62</link>
 <description>J Ethnopharmacol. 2026 Sep 4;374(Pt 1):122367.  Epub 2026 Sep 4&lt;br&gt;Authors: Zhang J, Chen X, Hu Z, Zhang J, Wu T, Zhou J, Song B, Xu Y, Yang H, Zhu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697496&quot;&gt;42697496&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/breaking-autophagy-oxidative-stress-vicious-cycle-alzheimers-disease-lactiflorin-unlocks-p62#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/breaking-autophagy-oxidative-stress-vicious-cycle-alzheimers-disease-lactiflorin-unlocks-p62#comments</comments>
</item>
<item>
 <title>Therapeutic targeting of tauopathies: From druggable biology to precision intervention.</title>
 <link>https://www.alzforum.org/papers/therapeutic-targeting-tauopathies-druggable-biology-precision-intervention</link>
 <description>Pharmacol Res. 2026 Sep 4;232:108432.  Epub 2026 Sep 4&lt;br&gt;Authors: Zhang C, Ma J, Wu X, Wang X, Huang X, Zheng H, Zhao Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697418&quot;&gt;42697418&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/therapeutic-targeting-tauopathies-druggable-biology-precision-intervention#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/therapeutic-targeting-tauopathies-druggable-biology-precision-intervention#comments</comments>
</item>
<item>
 <title>Introduction to the special issue: central metabolic regulation in aging, obesity, and neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/introduction-special-issue-central-metabolic-regulation-aging-obesity-and-neurodegeneration</link>
 <description>Brain Res. 2026 Sep 4;:150539.  Epub 2026 Sep 4&lt;br&gt;Authors: Metzger M, Donato J Jr&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697397&quot;&gt;42697397&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/introduction-special-issue-central-metabolic-regulation-aging-obesity-and-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/introduction-special-issue-central-metabolic-regulation-aging-obesity-and-neurodegeneration#comments</comments>
</item>
<item>
 <title>Extracellular vesicles in neurodegenerative diseases: A new frontier in diagnosis and therapy.</title>
 <link>https://www.alzforum.org/papers/extracellular-vesicles-neurodegenerative-diseases-new-frontier-diagnosis-and-therapy</link>
 <description>Behav Brain Res. 2026 Sep 4;516:116455.  Epub 2026 Sep 4&lt;br&gt;Authors: Mohammad SI, Vasudevan A, Oriquat G, Gajjar TB, Hanumanthayya M, Shukla SK, Tailor NK, Baig MR, Fadaam O, Abdul AS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697379&quot;&gt;42697379&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/extracellular-vesicles-neurodegenerative-diseases-new-frontier-diagnosis-and-therapy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/extracellular-vesicles-neurodegenerative-diseases-new-frontier-diagnosis-and-therapy#comments</comments>
</item>
<item>
 <title>Artemether alleviates Aβ1-42-induced neuronal cell damage via PGC-1α-mediated mitochondrial homeostasis in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/artemether-alleviates-av1-42-induced-neuronal-cell-damage-pgc-1a-mediated-mitochondrial</link>
 <description>Cell Signal. 2026 Sep 4;149:112879.  Epub 2026 Sep 4&lt;br&gt;Authors: Cai J, Luo J, Cai Y, Xu Y, Ran R, Xiao M, Ye Q, Zheng W, Li S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697346&quot;&gt;42697346&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/artemether-alleviates-av1-42-induced-neuronal-cell-damage-pgc-1a-mediated-mitochondrial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/artemether-alleviates-av1-42-induced-neuronal-cell-damage-pgc-1a-mediated-mitochondrial#comments</comments>
</item>
<item>
 <title>Targeting the mitochondrial functional network: Decoding upstream pathological mechanisms and novel therapeutic paradigms for Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/targeting-mitochondrial-functional-network-decoding-upstream-pathological-mechanisms-and</link>
 <description>Ageing Res Rev. 2026 Sep 4;:103359.  Epub 2026 Sep 4&lt;br&gt;Authors: Li X, Wan R, Wu Y, Zhao Y, Chen X, Li Y, Yang R, Zhang D, Li Q, Luo C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697335&quot;&gt;42697335&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-mitochondrial-functional-network-decoding-upstream-pathological-mechanisms-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-mitochondrial-functional-network-decoding-upstream-pathological-mechanisms-and#comments</comments>
</item>
<item>
 <title>Integrating frailty into decision-making for disease-modifying therapies in Alzheimer&#039;s disease: a proposed expert-opinion based approach.</title>
 <link>https://www.alzforum.org/papers/integrating-frailty-decision-making-disease-modifying-therapies-alzheimers-disease-proposed</link>
 <description>J Prev Alzheimers Dis. 2026 Sep 4;13(9):100666.  Epub 2026 Sep 4&lt;br&gt;Authors: Bellelli G, Brignoli O, Canevelli M, Cherubini A, Clegg A, Dubois B, Ferrara MC, Fratiglioni L, Frisoni GB, Grande G, Jessen F, Kennelly SP, Magni A, Marelli M, Marengoni A, Velilla NM, Shenkin SD, Suárez-Calvet M, Timmons S, Padovani A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697176&quot;&gt;42697176&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrating-frailty-decision-making-disease-modifying-therapies-alzheimers-disease-proposed#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrating-frailty-decision-making-disease-modifying-therapies-alzheimers-disease-proposed#comments</comments>
</item>
<item>
 <title>Corrigendum to &#039;Nicotinamide riboside, pterostilbene and ibudilast protect motor neurons and extend survival in ALS mice&#039;.</title>
 <link>https://www.alzforum.org/papers/corrigendum-nicotinamide-riboside-pterostilbene-and-ibudilast-protect-motor-neurons-and</link>
 <description>Neurotherapeutics. 2026 Sep 4;23(5):e01070.  Epub 2026 Sep 4&lt;br&gt;Authors: Lo&amp;#039;pez-Blanch R, Salvador-Palmer R, Oriol-Caballo M, Moreno-Murciano P, Dellinger RW, Estrela JM, Obrador E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697153&quot;&gt;42697153&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/corrigendum-nicotinamide-riboside-pterostilbene-and-ibudilast-protect-motor-neurons-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/corrigendum-nicotinamide-riboside-pterostilbene-and-ibudilast-protect-motor-neurons-and#comments</comments>
</item>
<item>
 <title>Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1G93A mouse model of ALS.</title>
 <link>https://www.alzforum.org/papers/pharmacological-modulation-lxr-agonist-t0901317-attenuates-motor-pathology-sod1g93a-mouse</link>
 <description>Neurotherapeutics. 2026 Sep 4;23(5):e01062.  Epub 2026 Sep 4&lt;br&gt;Authors: Fernández-Beltrán LC, García-Toledo I, Javaloyes García K, Jiménez-Coca I, Jiménez-Rodríguez J, Fernández-Bernal A, Godoy-Corchuelo JM, Portero-Otín M, Corrochano S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697152&quot;&gt;42697152&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pharmacological-modulation-lxr-agonist-t0901317-attenuates-motor-pathology-sod1g93a-mouse#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pharmacological-modulation-lxr-agonist-t0901317-attenuates-motor-pathology-sod1g93a-mouse#comments</comments>
</item>
<item>
 <title>Discovering repurposable drugs for Alzheimer&#039;s disease and related dementias: target trial emulation using decentralised real-world data.</title>
 <link>https://www.alzforum.org/papers/discovering-repurposable-drugs-alzheimers-disease-and-related-dementias-target-trial</link>
 <description>EBioMedicine. 2026 Sep 4;132:106466.  Epub 2026 Sep 4&lt;br&gt;Authors: Wu Q, Li L, Lei Y, Zhou T, Tang H, Zhang B, Lu Y, Salvatore M, Zhang D, Tong J, Wang T, Chen S, Li H, Xu Z, Huang Y, Hu Y, Hong N, Zhou Y, Lin F, O&amp;#039;Brien KS, Chen Y, Li R, Xu H, Wang F, Bian J, Wolk DA, Chen Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697072&quot;&gt;42697072&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/discovering-repurposable-drugs-alzheimers-disease-and-related-dementias-target-trial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/discovering-repurposable-drugs-alzheimers-disease-and-related-dementias-target-trial#comments</comments>
</item>
<item>
 <title>From trial population to treated population: why EU-eligible subgroup analyses matter for anti-amyloid immunotherapy.</title>
 <link>https://www.alzforum.org/papers/trial-population-treated-population-why-eu-eligible-subgroup-analyses-matter-anti-amyloid</link>
 <description>J Prev Alzheimers Dis. 2026 Sep 4;13(8):100665.  Epub 2026 Sep 4&lt;br&gt;Authors: Grimmer T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697030&quot;&gt;42697030&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/trial-population-treated-population-why-eu-eligible-subgroup-analyses-matter-anti-amyloid#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/trial-population-treated-population-why-eu-eligible-subgroup-analyses-matter-anti-amyloid#comments</comments>
</item>
<item>
 <title>Linking behavioral and psychological symptoms to nutritional status in Alzheimer&#039;s disease: Clinical correlations and implications.</title>
 <link>https://www.alzforum.org/papers/linking-behavioral-and-psychological-symptoms-nutritional-status-alzheimers-disease-clinical</link>
 <description>Acta Psychol (Amst). 2026 Sep 4;270:107768.  Epub 2026 Sep 4&lt;br&gt;Authors: Nie W, Liang Z, Fu Q, Tan Y, Wang L, Wu W, Liang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696905&quot;&gt;42696905&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/linking-behavioral-and-psychological-symptoms-nutritional-status-alzheimers-disease-clinical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/linking-behavioral-and-psychological-symptoms-nutritional-status-alzheimers-disease-clinical#comments</comments>
</item>
<item>
 <title>Electroencephalography Functional Network Responses to Immersive Virtual Reality in Alzheimer Disease and Mild Cognitive Impairment: Exploratory Single-Session 3-Group Repeated-Measures Study.</title>
 <link>https://www.alzforum.org/papers/electroencephalography-functional-network-responses-immersive-virtual-reality-alzheimer</link>
 <description>JMIR Serious Games. 2026 Sep 4;14:e95160. &lt;br&gt;Authors: Yao YH, Xu S, Kim ES, Kim EA, Wang YX, Kim HS, Kim DH, Liang JG, Shin YK, Kim NY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696736&quot;&gt;42696736&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/electroencephalography-functional-network-responses-immersive-virtual-reality-alzheimer#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/electroencephalography-functional-network-responses-immersive-virtual-reality-alzheimer#comments</comments>
</item>
<item>
 <title>Mini-Mental State Examination Scores in Dementia and Capacity Assessment: A Narrative Review.</title>
 <link>https://www.alzforum.org/papers/mini-mental-state-examination-scores-dementia-and-capacity-assessment-narrative-review</link>
 <description>J Geriatr Psychiatry Neurol. 2026 Sep 4;:8919887261486064.  Epub 2026 Sep 4&lt;br&gt;Authors: Rosenberg N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696655&quot;&gt;42696655&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mini-mental-state-examination-scores-dementia-and-capacity-assessment-narrative-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mini-mental-state-examination-scores-dementia-and-capacity-assessment-narrative-review#comments</comments>
</item>
<item>
 <title>Protocol to quantify LRRK2-mediated Rab10 phosphorylation using high-content imaging.</title>
 <link>https://www.alzforum.org/papers/protocol-quantify-lrrk2-mediated-rab10-phosphorylation-using-high-content-imaging</link>
 <description>STAR Protoc. 2026 Sep 4;7(3):104819.  Epub 2026 Sep 4&lt;br&gt;Authors: Masotti B, Lorenzon P, Covello G, Greggio E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696457&quot;&gt;42696457&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/protocol-quantify-lrrk2-mediated-rab10-phosphorylation-using-high-content-imaging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/protocol-quantify-lrrk2-mediated-rab10-phosphorylation-using-high-content-imaging#comments</comments>
</item>
<item>
 <title>Nearly Half of Dementia Cases May Be Preventable-Here&#039;s What the Research Says So Far.</title>
 <link>https://www.alzforum.org/papers/nearly-half-dementia-cases-may-be-preventable-heres-what-research-says-so-far</link>
 <description>JAMA. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Rubin R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696296&quot;&gt;42696296&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nearly-half-dementia-cases-may-be-preventable-heres-what-research-says-so-far#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nearly-half-dementia-cases-may-be-preventable-heres-what-research-says-so-far#comments</comments>
</item>
<item>
 <title>Association of global gray matter volume and cortical thickness with cognitive function stratified by amyloid PET status.</title>
 <link>https://www.alzforum.org/papers/association-global-gray-matter-volume-and-cortical-thickness-cognitive-function-stratified</link>
 <description>Ann Nucl Med. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Nakaoka Y, Sohara K, Matsuda H, Mizumura S, Suda M, Imai S, Sekine T, Ando T, Tanaka A, Ishiwata A, Tateno A, Koeda M, Saito T, Suda S, Yamazaki A, Hayashi H, Kumita S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696260&quot;&gt;42696260&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/association-global-gray-matter-volume-and-cortical-thickness-cognitive-function-stratified#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/association-global-gray-matter-volume-and-cortical-thickness-cognitive-function-stratified#comments</comments>
</item>
<item>
 <title>Altered dynamic functional connectivity of the language network associated with electronegative L5 in patients with mild cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/altered-dynamic-functional-connectivity-language-network-associated-electronegative-l5</link>
 <description>Geroscience. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Chou PS, Chen SC, Chou MC, Hsu CY, Wu MN, Liu CK, Lai CL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696254&quot;&gt;42696254&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/altered-dynamic-functional-connectivity-language-network-associated-electronegative-l5#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/altered-dynamic-functional-connectivity-language-network-associated-electronegative-l5#comments</comments>
</item>
<item>
 <title>Microglia-derived extracellular vesicles uncover early alterations of inflammatory signaling in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/microglia-derived-extracellular-vesicles-uncover-early-alterations-inflammatory-signaling</link>
 <description>Geroscience. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Bianchessi C, Serpente M, Ferri E, Giudici G, Arcaro M, Borracci V, Visconte C, Buccellato F, Sacchi L, Pintus M, Arosio B, Arighi A, Fenoglio C, Galimberti D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696253&quot;&gt;42696253&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglia-derived-extracellular-vesicles-uncover-early-alterations-inflammatory-signaling#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglia-derived-extracellular-vesicles-uncover-early-alterations-inflammatory-signaling#comments</comments>
</item>
<item>
 <title>Targeting cytokine-driven neuroinflammation in Alzheimer&#039;s disease: mechanistic insights and pharmacological strategies.</title>
 <link>https://www.alzforum.org/papers/targeting-cytokine-driven-neuroinflammation-alzheimers-disease-mechanistic-insights-and</link>
 <description>Inflammopharmacology. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Wasim R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696209&quot;&gt;42696209&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/targeting-cytokine-driven-neuroinflammation-alzheimers-disease-mechanistic-insights-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/targeting-cytokine-driven-neuroinflammation-alzheimers-disease-mechanistic-insights-and#comments</comments>
</item>
<item>
 <title>Oligodendroglial somatic SNCA copy number gains are associated with inclusions and disease onset in multiple system atrophy.</title>
 <link>https://www.alzforum.org/papers/oligodendroglial-somatic-snca-copy-number-gains-are-associated-inclusions-and-disease-onset</link>
 <description>Acta Neuropathol. 2026 Sep 4;152(1)&lt;br&gt;Authors: Morley C, Kalef-Ezra E, Perez-Rodriguez D, Jaunmuktane Z, Proukakis C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696165&quot;&gt;42696165&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oligodendroglial-somatic-snca-copy-number-gains-are-associated-inclusions-and-disease-onset#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oligodendroglial-somatic-snca-copy-number-gains-are-associated-inclusions-and-disease-onset#comments</comments>
</item>
<item>
 <title>Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.</title>
 <link>https://www.alzforum.org/papers/spatiotemporal-tau-accumulation-and-its-clinical-impact-progressive-supranuclear-palsy</link>
 <description>Mov Disord. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Chishiki Y, Tagai K, Kataoka Y, Goto R, Osawa K, Oyama A, Matsumoto H, Ichihashi M, Momota Y, Kamada T, Seki C, Matsuoka K, Hirata K, Kurose S, Moriguchi S, Komatsu Y, Kato H, Yamamoto Y, Nakano Y, Hirano S, Shinotoh H, Shimada H, Tokuda T, Kawamura K, Zhang MR, Takahata K, Higuchi M, Endo H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696070&quot;&gt;42696070&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spatiotemporal-tau-accumulation-and-its-clinical-impact-progressive-supranuclear-palsy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spatiotemporal-tau-accumulation-and-its-clinical-impact-progressive-supranuclear-palsy#comments</comments>
</item>
<item>
 <title>Familial, neuropathological and cellular analysis identify ARPP21 as a major amyotrophic lateral sclerosis associated gene in French cohorts.</title>
 <link>https://www.alzforum.org/papers/familial-neuropathological-and-cellular-analysis-identify-arpp21-major-amyotrophic-lateral</link>
 <description>Acta Neuropathol. 2026 Sep 4;152(1)&lt;br&gt;Authors: de Bertier S, Amador MD, Guissart C, Miki T, Boillée S, Lobsiger CS, Bohl D, Fauret-Amsellem AL, Bohic A, Brainbank Neuro-CEB neuropathology network, Giguet-Valard AG, Bellance R, Beauvais K, Meininger V, Bruneteau G, Salachas F, Vial C, Camu W, Esselin F, de la Cruz E, Bernard E, Seilhean D, Millecamps S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42696048&quot;&gt;42696048&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/familial-neuropathological-and-cellular-analysis-identify-arpp21-major-amyotrophic-lateral#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/familial-neuropathological-and-cellular-analysis-identify-arpp21-major-amyotrophic-lateral#comments</comments>
</item>
<item>
 <title>Glycolytic Reprogramming in Parkinson&#039;s Disease: From Bioenergetic Crosstalk to Therapeutic Modulation.</title>
 <link>https://www.alzforum.org/papers/glycolytic-reprogramming-parkinsons-disease-bioenergetic-crosstalk-therapeutic-modulation</link>
 <description>Med Res Rev. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Yi Y, Chen C, He Y, Sun YZ, Cheng R, Liu MX, Liu ZG, Zhang XL&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42695230&quot;&gt;42695230&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glycolytic-reprogramming-parkinsons-disease-bioenergetic-crosstalk-therapeutic-modulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glycolytic-reprogramming-parkinsons-disease-bioenergetic-crosstalk-therapeutic-modulation#comments</comments>
</item>
<item>
 <title>MARK4 enhances stress granule formation under oxidative stress and increases tau accumulation.</title>
 <link>https://www.alzforum.org/papers/mark4-enhances-stress-granule-formation-under-oxidative-stress-and-increases-tau-accumulation</link>
 <description>FEBS Open Bio. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Nakajima S, Watanabe K, Sultanakhmetov G, Fukuchi A, Ito K, Shimizu S, Saito T, Asada A, Ando K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42695218&quot;&gt;42695218&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mark4-enhances-stress-granule-formation-under-oxidative-stress-and-increases-tau-accumulation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mark4-enhances-stress-granule-formation-under-oxidative-stress-and-increases-tau-accumulation#comments</comments>
</item>
<item>
 <title>Multilevel genomic, transcriptomic, and epidemiologic evidence linking diabetic retinopathy to Alzheimer disease.</title>
 <link>https://www.alzforum.org/papers/multilevel-genomic-transcriptomic-and-epidemiologic-evidence-linking-diabetic-retinopathy</link>
 <description>J Glob Health. 2026 Sep 4;16:04311. &lt;br&gt;Authors: Li J, Liu Q, Ma Q, Shen T, Xia J, Yang X, Liu K, Li N, Yan B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693903&quot;&gt;42693903&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multilevel-genomic-transcriptomic-and-epidemiologic-evidence-linking-diabetic-retinopathy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multilevel-genomic-transcriptomic-and-epidemiologic-evidence-linking-diabetic-retinopathy#comments</comments>
</item>
<item>
 <title>Serum Neurofilament Light Chain and GFAP in Amyotrophic Lateral Sclerosis on a Commercial ECLIA Platform.</title>
 <link>https://www.alzforum.org/papers/serum-neurofilament-light-chain-and-gfap-amyotrophic-lateral-sclerosis-commercial-eclia</link>
 <description>Muscle Nerve. 2026 Sep 4; Epub 2026 Sep 4&lt;br&gt;Authors: Streicher NS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698124&quot;&gt;42698124&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/serum-neurofilament-light-chain-and-gfap-amyotrophic-lateral-sclerosis-commercial-eclia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/serum-neurofilament-light-chain-and-gfap-amyotrophic-lateral-sclerosis-commercial-eclia#comments</comments>
</item>
<item>
 <title>Proteo-metabolomic integration identifies stage-specific candidate biomarkers for Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/proteo-metabolomic-integration-identifies-stage-specific-candidate-biomarkers-parkinsons</link>
 <description>NPJ Parkinsons Dis. 2026 Sep 4;12(1)&lt;br&gt;Authors: Galal A, Moustafa A, Salama M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697887&quot;&gt;42697887&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/proteo-metabolomic-integration-identifies-stage-specific-candidate-biomarkers-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/proteo-metabolomic-integration-identifies-stage-specific-candidate-biomarkers-parkinsons#comments</comments>
</item>
<item>
 <title>Glial fibrillary acidic protein in progressive supranuclear palsy: A systematic review and meta-analysis.</title>
 <link>https://www.alzforum.org/papers/glial-fibrillary-acidic-protein-progressive-supranuclear-palsy-systematic-review-and-meta</link>
 <description>J Neurol Sci. 2026 Sep 4;490:126162.  Epub 2026 Sep 4&lt;br&gt;Authors: Magro G, Laterza V, Mechelli A, Tosto F, Longo A, Camastra C, Quattrone A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702161&quot;&gt;42702161&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/glial-fibrillary-acidic-protein-progressive-supranuclear-palsy-systematic-review-and-meta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/glial-fibrillary-acidic-protein-progressive-supranuclear-palsy-systematic-review-and-meta#comments</comments>
</item>
<item>
 <title>Alzheimer disease and lichen planus: A Mendelian randomization analysis.</title>
 <link>https://www.alzforum.org/papers/alzheimer-disease-and-lichen-planus-mendelian-randomization-analysis</link>
 <description>Medicine (Baltimore). 2026 Sep 4;105(36):e50313. &lt;br&gt;Authors: Huang W, Xiao L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700087&quot;&gt;42700087&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alzheimer-disease-and-lichen-planus-mendelian-randomization-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alzheimer-disease-and-lichen-planus-mendelian-randomization-analysis#comments</comments>
</item>
<item>
 <title>A signal-locked clamped hybridization chain reaction nanoamplifier for rapid and highly sensitive analysis of Aβ42.</title>
 <link>https://www.alzforum.org/papers/signal-locked-clamped-hybridization-chain-reaction-nanoamplifier-rapid-and-highly-sensitive</link>
 <description>Talanta. 2026 Sep 4;312(Pt C):130596.  Epub 2026 Sep 4&lt;br&gt;Authors: Kong X, Jiang H, Hu B, Shu Q, Luo X, Pan F, Hu J, Wang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42705087&quot;&gt;42705087&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/signal-locked-clamped-hybridization-chain-reaction-nanoamplifier-rapid-and-highly-sensitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/signal-locked-clamped-hybridization-chain-reaction-nanoamplifier-rapid-and-highly-sensitive#comments</comments>
</item>
<item>
 <title>Is there a role for B cells in Alzheimer&#039;s disease?</title>
 <link>https://www.alzforum.org/papers/there-role-b-cells-alzheimers-disease</link>
 <description>Cell Immunol. 2026 Sep 4;428-429:105154.  Epub 2026 Sep 4&lt;br&gt;Authors: Charavner EL, Fillatreau S, El Behi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710414&quot;&gt;42710414&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/there-role-b-cells-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/there-role-b-cells-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Hyperphosphorylated tau pathology in patients with epilepsy and dementia - Neuropathological insights from a historical autopsy cohort.</title>
 <link>https://www.alzforum.org/papers/hyperphosphorylated-tau-pathology-patients-epilepsy-and-dementia-neuropathological-insights</link>
 <description>Epilepsy Res. 2026 Sep 4;228:107910.  Epub 2026 Sep 4&lt;br&gt;Authors: Laustsen SE, Petersen JK, Cornwall CD, Wirenfeldt M, Beier CP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715912&quot;&gt;42715912&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/hyperphosphorylated-tau-pathology-patients-epilepsy-and-dementia-neuropathological-insights#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/hyperphosphorylated-tau-pathology-patients-epilepsy-and-dementia-neuropathological-insights#comments</comments>
</item>
<item>
 <title>Quantitative Assessment of Cerebrospinal Fluid-Vascular Association in Alzheimer&#039;s Disease Using Phase-Contrast and 4D-Flow Magnetic Resonance Imaging.</title>
 <link>https://www.alzforum.org/papers/quantitative-assessment-cerebrospinal-fluid-vascular-association-alzheimers-disease-using</link>
 <description>J Vis Exp. 2026 Sep 3;(235)&lt;br&gt;Authors: Lu M, Zheng Y, Chen T, Wu Y, Li Z, Zheng T, Chen Q, Peng X, Shi L, Pan Y, Xu Y, Wei D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42695591&quot;&gt;42695591&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/quantitative-assessment-cerebrospinal-fluid-vascular-association-alzheimers-disease-using#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/quantitative-assessment-cerebrospinal-fluid-vascular-association-alzheimers-disease-using#comments</comments>
</item>
<item>
 <title>Distinct Spatiotemporal Patterns of Dopaminergic and Metabolic Imaging in De Novo Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/distinct-spatiotemporal-patterns-dopaminergic-and-metabolic-imaging-de-novo-parkinsons</link>
 <description>Mov Disord. 2026 Sep 3; Epub 2026 Sep 3&lt;br&gt;Authors: Lee JH, Na HK, Ahn SJ, Park M, Bio J, Lee JH, Ryu YH, Yoo HS, Lyoo CH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693703&quot;&gt;42693703&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/distinct-spatiotemporal-patterns-dopaminergic-and-metabolic-imaging-de-novo-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/distinct-spatiotemporal-patterns-dopaminergic-and-metabolic-imaging-de-novo-parkinsons#comments</comments>
</item>
<item>
 <title>From Volumetrics to 3D Tensors: A Multi-Cohort Evaluation of Machine Learning and Deep Learning for Alzheimer&#039;s Classification.</title>
 <link>https://www.alzforum.org/papers/volumetrics-3d-tensors-multi-cohort-evaluation-machine-learning-and-deep-learning-alzheimers</link>
 <description>J Imaging Inform Med. 2026 Sep 3; Epub 2026 Sep 3&lt;br&gt;Authors: Kamalov F, Ibrahim A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693331&quot;&gt;42693331&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/volumetrics-3d-tensors-multi-cohort-evaluation-machine-learning-and-deep-learning-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/volumetrics-3d-tensors-multi-cohort-evaluation-machine-learning-and-deep-learning-alzheimers#comments</comments>
</item>
<item>
 <title>Applying a systemic approach that extends beyond the brain to Alzheimer&#039;s disease pathogenesis.</title>
 <link>https://www.alzforum.org/papers/applying-systemic-approach-extends-beyond-brain-alzheimers-disease-pathogenesis</link>
 <description>Commun Med (Lond). 2026 Sep 3;6(1)&lt;br&gt;Authors: Barnaghi P, Fogel A, Walsh C, Nilforooshan R, Ricotti V, Voit T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693207&quot;&gt;42693207&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/applying-systemic-approach-extends-beyond-brain-alzheimers-disease-pathogenesis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/applying-systemic-approach-extends-beyond-brain-alzheimers-disease-pathogenesis#comments</comments>
</item>
<item>
 <title>DNA- and aptamer-based biosensors for Alzheimer&#039;s disease biomarkers toward clinical translation.</title>
 <link>https://www.alzforum.org/papers/dna-and-aptamer-based-biosensors-alzheimers-disease-biomarkers-toward-clinical-translation</link>
 <description>Talanta. 2026 Sep 3;312(Pt C):130583.  Epub 2026 Sep 3&lt;br&gt;Authors: Pahlavan Y, Nozari-Asbemarz M, Amani M, Hasani E, Aliakbari M, Khaleghinejad SH, Pahlavan F, Emami A, Imanzadeh H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715723&quot;&gt;42715723&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dna-and-aptamer-based-biosensors-alzheimers-disease-biomarkers-toward-clinical-translation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dna-and-aptamer-based-biosensors-alzheimers-disease-biomarkers-toward-clinical-translation#comments</comments>
</item>
<item>
 <title>Proteoform-Resolved Cross-Linking Reveals Environment-Dependent Structural Effects of α-Synuclein S129 Phosphorylation.</title>
 <link>https://www.alzforum.org/papers/proteoform-resolved-cross-linking-reveals-environment-dependent-structural-effects-synuclein</link>
 <description>J Am Chem Soc. 2026 Sep 2;148(34):37102-37109. &lt;br&gt;Authors: Dollar AN, Kelley DW, Webb IK&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701266&quot;&gt;42701266&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/proteoform-resolved-cross-linking-reveals-environment-dependent-structural-effects-synuclein#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/proteoform-resolved-cross-linking-reveals-environment-dependent-structural-effects-synuclein#comments</comments>
</item>
<item>
 <title>Biomolecular Condensates Dictate the Folding Landscape of Protein Alpha-Helices.</title>
 <link>https://www.alzforum.org/papers/biomolecular-condensates-dictate-folding-landscape-protein-alpha-helices</link>
 <description>J Am Chem Soc. 2026 Sep 2;148(34):36392-36413. &lt;br&gt;Authors: Hess N, Joseph JA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701255&quot;&gt;42701255&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/biomolecular-condensates-dictate-folding-landscape-protein-alpha-helices#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/biomolecular-condensates-dictate-folding-landscape-protein-alpha-helices#comments</comments>
</item>
<item>
 <title>Mass Spectrometric Footprinting and DFT Calculations Explain the Effect of Curcumin on the Aggregation of Amyloid β 42 (Aβ42).</title>
 <link>https://www.alzforum.org/papers/mass-spectrometric-footprinting-and-dft-calculations-explain-effect-curcumin-aggregation</link>
 <description>J Am Chem Soc. 2026 Sep 2;148(34):36365-36378. &lt;br&gt;Authors: Mathai G, Chemuru S, Moyle AB, Song JH, Rempel D, Giblin D, Gross ML&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701209&quot;&gt;42701209&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mass-spectrometric-footprinting-and-dft-calculations-explain-effect-curcumin-aggregation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mass-spectrometric-footprinting-and-dft-calculations-explain-effect-curcumin-aggregation#comments</comments>
</item>
<item>
 <title>A Site-Specific Organometallic Approach for Installing Tyrosine Phosphorylation Mimics to Decipher the Role of Phosphorylation in α-Synuclein Aggregation and Seeding.</title>
 <link>https://www.alzforum.org/papers/site-specific-organometallic-approach-installing-tyrosine-phosphorylation-mimics-decipher</link>
 <description>J Am Chem Soc. 2026 Sep 2;148(34):37286-37297. &lt;br&gt;Authors: Mandal S, Lin X, Gemelli AV, Singh M, Mahul-Mellier AL, Jasiqi Y, Bouri B, Jbara M, Lashuel HA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701208&quot;&gt;42701208&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/site-specific-organometallic-approach-installing-tyrosine-phosphorylation-mimics-decipher#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/site-specific-organometallic-approach-installing-tyrosine-phosphorylation-mimics-decipher#comments</comments>
</item>
<item>
 <title>Neurobiological mechanisms of 40-Hz stimulation in Alzheimer&#039;s disease: evidence, heterogeneity, and constraints.</title>
 <link>https://www.alzforum.org/papers/neurobiological-mechanisms-40-hz-stimulation-alzheimers-disease-evidence-heterogeneity-and</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71806. &lt;br&gt;Authors: Qi L, Wang W, Abdullah R, Zhao Y, Wang Z, Tang Y, Luo B, Peng G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693677&quot;&gt;42693677&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neurobiological-mechanisms-40-hz-stimulation-alzheimers-disease-evidence-heterogeneity-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neurobiological-mechanisms-40-hz-stimulation-alzheimers-disease-evidence-heterogeneity-and#comments</comments>
</item>
<item>
 <title>Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis.</title>
 <link>https://www.alzforum.org/papers/protein-biomarkers-risk-and-prognosis-amyotrophic-lateral-sclerosis</link>
 <description>Eur J Neurol. 2026 Sep;33(9):e70741. &lt;br&gt;Authors: Pan L, Hou C, Seitz C, Ingre C, Hedman ÅK, Laffita J, Vu TN, Pawitan Y, Ullgren A, Yazdani S, Andersson J, Joyce EE, Chourpiliadis C, Lovik A, Chen Y, Lewandowski SA, Fernandez-Capetillo O, Barz M, Samuelsson K, Press R, Piehl F, Graff C, Mälarstig A, Fang F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698373&quot;&gt;42698373&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/protein-biomarkers-risk-and-prognosis-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/protein-biomarkers-risk-and-prognosis-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Unveiling the Distinctive Brain Functional Dynamics Between Parkinson&#039;s Disease and Progressive Supranuclear Palsy.</title>
 <link>https://www.alzforum.org/papers/unveiling-distinctive-brain-functional-dynamics-between-parkinsons-disease-and-progressive</link>
 <description>CNS Neurosci Ther. 2026 Sep;32(9):e71147. &lt;br&gt;Authors: Ye C, Shi J, Fang J, Wu T, Chan P, Ma J, Ma T&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698292&quot;&gt;42698292&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/unveiling-distinctive-brain-functional-dynamics-between-parkinsons-disease-and-progressive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/unveiling-distinctive-brain-functional-dynamics-between-parkinsons-disease-and-progressive#comments</comments>
</item>
<item>
 <title>Large-scale single-molecule analysis of tau proteoforms.</title>
 <link>https://www.alzforum.org/papers/large-scale-single-molecule-analysis-tau-proteoforms</link>
 <description>Nat Methods. 2026 Sep;23(9):1786-1797.  Epub 2026 Sep 4&lt;br&gt;Authors: Joly J, Budamagunta V, Zhang Z, Nortman B, Jouzi M, Bhatnagar R, Egertson JD, Flaster ME, Grothe R, Guha S, Kaneshige K, McVey K, Nelson N, Perera RT, Tan SJ, Trinh T, Arnott D, Lipka J, Pandya NJ, Rougé L, Wendorff TJ, Kirkpatrick DS, Rohou A, Butler DC, Lotz S, Forton A, Sartori ER, Schwarz JE, Brereton PS, Chen K, Darcy MA, Golnabi HR, Hartley R, Indermuhl PF, Inman CE, Jin KM, Katsyuk S, Kota R, Lowry B, Menger JC, Miller DA, Newman MR, Ogunyemi A, Robinson JK, Steiner N, Sun J, Tabakman SM, Wang L, Wang Z, Wilcox SK, Nautilus Biotechnology, Kapp GT, Patel S, Temple S, Bertucci T, Blanchard J, Huhmer AF, Sankar SV, Juneau K, Mallick P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697987&quot;&gt;42697987&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/large-scale-single-molecule-analysis-tau-proteoforms#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/large-scale-single-molecule-analysis-tau-proteoforms#comments</comments>
</item>
<item>
 <title>Referral in Mild Cognitive Impairment: Subjectivity or Uncalibrated Prudence?</title>
 <link>https://www.alzforum.org/papers/referral-mild-cognitive-impairment-subjectivity-or-uncalibrated-prudence</link>
 <description>Acta Med Port. 2026 Sep 1;39(9):585-586.  Epub 2026 Sep 1&lt;br&gt;Authors: Acosta-Batista C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697873&quot;&gt;42697873&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/referral-mild-cognitive-impairment-subjectivity-or-uncalibrated-prudence#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/referral-mild-cognitive-impairment-subjectivity-or-uncalibrated-prudence#comments</comments>
</item>
<item>
 <title>&quot;S-Tau-Lled&quot; Lysosomes Disrupt Autophagic Processes in Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/s-tau-lled-lysosomes-disrupt-autophagic-processes-neurodegeneration</link>
 <description>Traffic. 2026 Sep;27(3):e70051. &lt;br&gt;Authors: Bécot A, Kabani M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702350&quot;&gt;42702350&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/s-tau-lled-lysosomes-disrupt-autophagic-processes-neurodegeneration#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/s-tau-lled-lysosomes-disrupt-autophagic-processes-neurodegeneration#comments</comments>
</item>
<item>
 <title>Age-Period-Cohort Analysis of Creutzfeldt-Jakob Disease in Israel (1985-2019).</title>
 <link>https://www.alzforum.org/papers/age-period-cohort-analysis-creutzfeldt-jakob-disease-israel-1985-2019</link>
 <description>Isr Med Assoc J. 2026 Sep;28(9):572-577. &lt;br&gt;Authors: Balash Y, Kahana E, Gilad R, Eilam A, Korczyn AD&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701842&quot;&gt;42701842&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/age-period-cohort-analysis-creutzfeldt-jakob-disease-israel-1985-2019#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/age-period-cohort-analysis-creutzfeldt-jakob-disease-israel-1985-2019#comments</comments>
</item>
<item>
 <title>A curriculum-guided unified framework for robust unsupervised domain adaptation on multi-cohort Parkinson&#039;s disease diagnosis.</title>
 <link>https://www.alzforum.org/papers/curriculum-guided-unified-framework-robust-unsupervised-domain-adaptation-multi-cohort</link>
 <description>Quant Imaging Med Surg. 2026 Sep 1;16(9):708.  Epub 2026 Aug 10&lt;br&gt;Authors: Shen Y, Hai J, Qiao K, Chen J, Li Y, Yan B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42701495&quot;&gt;42701495&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/curriculum-guided-unified-framework-robust-unsupervised-domain-adaptation-multi-cohort#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/curriculum-guided-unified-framework-robust-unsupervised-domain-adaptation-multi-cohort#comments</comments>
</item>
<item>
 <title>Efficacy and Durability of Repetitive Transcranial Magnetic Stimulation on Cognitive Function in Patients With Mild-to-Moderate Alzheimer&#039;s Disease: A Systematic Review and Meta-Analysis.</title>
 <link>https://www.alzforum.org/papers/efficacy-and-durability-repetitive-transcranial-magnetic-stimulation-cognitive-function</link>
 <description>Psychogeriatrics. 2026 Sep;26(5):e70199. &lt;br&gt;Authors: Zhou Q, Yang MX, Zhang QQ, Li YQ, Wang ZQ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42705844&quot;&gt;42705844&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/efficacy-and-durability-repetitive-transcranial-magnetic-stimulation-cognitive-function#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/efficacy-and-durability-repetitive-transcranial-magnetic-stimulation-cognitive-function#comments</comments>
</item>
<item>
 <title>Surgery Is Not Associated With Early Presentation of Alzheimer&#039;s Disease and Mild Cognitive Impairment or Increased Risk for Both.</title>
 <link>https://www.alzforum.org/papers/surgery-not-associated-early-presentation-alzheimers-disease-and-mild-cognitive-impairment-or</link>
 <description>CNS Neurosci Ther. 2026 Sep;32(9):e71149. &lt;br&gt;Authors: Zang W, Vithoulkas J, Zuo Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702948&quot;&gt;42702948&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/surgery-not-associated-early-presentation-alzheimers-disease-and-mild-cognitive-impairment-or#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/surgery-not-associated-early-presentation-alzheimers-disease-and-mild-cognitive-impairment-or#comments</comments>
</item>
<item>
 <title>Choroid Plexus Microstructural Alterations Link Glymphatic Dysfunction and White Matter Degeneration in Parkinson&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/choroid-plexus-microstructural-alterations-link-glymphatic-dysfunction-and-white-matter</link>
 <description>CNS Neurosci Ther. 2026 Sep;32(9):e71039. &lt;br&gt;Authors: Zhou S, Zhen Z, Lai C, Huang P, Sun Z, Yang T, Yu F, Chen W, Zuo Z, Chen W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42702933&quot;&gt;42702933&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/choroid-plexus-microstructural-alterations-link-glymphatic-dysfunction-and-white-matter#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/choroid-plexus-microstructural-alterations-link-glymphatic-dysfunction-and-white-matter#comments</comments>
</item>
<item>
 <title>Two consecutive double-blind phases for two-period disease-modifying therapy trials: A personal viewpoint methodological proposal.</title>
 <link>https://www.alzforum.org/papers/two-consecutive-double-blind-phases-two-period-disease-modifying-therapy-trials-personal</link>
 <description>Neurologia (Engl Ed). 2026 Sep;41(7):502010. &lt;br&gt;Authors: Santos-García D, Solleiro Á, Figueiras Vázquez TM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711044&quot;&gt;42711044&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/two-consecutive-double-blind-phases-two-period-disease-modifying-therapy-trials-personal#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/two-consecutive-double-blind-phases-two-period-disease-modifying-therapy-trials-personal#comments</comments>
</item>
<item>
 <title>MRI-guided versus OSEM Amyloid Brain PET Reconstruction for Reader Agreement, Visual Consistency, and Diagnostic Accuracy.</title>
 <link>https://www.alzforum.org/papers/mri-guided-versus-osem-amyloid-brain-pet-reconstruction-reader-agreement-visual-consistency</link>
 <description>Radiology. 2026 Sep;320(3):e260692. &lt;br&gt;Authors: Cai Y, Lin C, Jain M, Pooley R, Benson BL, Zhang J, Spangler-Bickell MG, Smith AK, Gupta V, Bullock KC, Middlebrooks EH, Soni N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708852&quot;&gt;42708852&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mri-guided-versus-osem-amyloid-brain-pet-reconstruction-reader-agreement-visual-consistency#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mri-guided-versus-osem-amyloid-brain-pet-reconstruction-reader-agreement-visual-consistency#comments</comments>
</item>
<item>
 <title>Are infraslow oscillations the missing link between sleep and Alzheimer&#039;s?</title>
 <link>https://www.alzforum.org/papers/are-infraslow-oscillations-missing-link-between-sleep-and-alzheimers</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71525. &lt;br&gt;Authors: Grollero D, Gabb V, Blackman J, Heslegrave A, de Vivo L, Coulthard E, Bellesi M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708477&quot;&gt;42708477&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/are-infraslow-oscillations-missing-link-between-sleep-and-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/are-infraslow-oscillations-missing-link-between-sleep-and-alzheimers#comments</comments>
</item>
<item>
 <title>Increased Amyloidogenic Neuronal Injury in HIV-1-infected APP-KI Alzheimer&#039;s disease mice.</title>
 <link>https://www.alzforum.org/papers/increased-amyloidogenic-neuronal-injury-hiv-1-infected-app-ki-alzheimers-disease-mice</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71807. &lt;br&gt;Authors: Bhattarai S, Foster EG, Kadry R, Lu Y, Kumar M, Qasim S, Mitra A, Pathak H, Poluektova LY, Gorantla S, Mosley RL, Yeapuri P, Gendelman HE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708464&quot;&gt;42708464&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/increased-amyloidogenic-neuronal-injury-hiv-1-infected-app-ki-alzheimers-disease-mice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/increased-amyloidogenic-neuronal-injury-hiv-1-infected-app-ki-alzheimers-disease-mice#comments</comments>
</item>
<item>
 <title>Routine Blood Indicators Combined With Sleep Questionnaires for the Identification of Cognitive Impairment in Parkinson&#039;s Disease: A Cross-Sectional Study With a Leakage-Free Nested Modeling Framework.</title>
 <link>https://www.alzforum.org/papers/routine-blood-indicators-combined-sleep-questionnaires-identification-cognitive-impairment</link>
 <description>Brain Behav. 2026 Sep;16(9):e71655. &lt;br&gt;Authors: Wang Z, Lam T, Zhang S, Song C, Pei X, Zhong J, Li B, Liu G, Cui Y, Wang S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706737&quot;&gt;42706737&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/routine-blood-indicators-combined-sleep-questionnaires-identification-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/routine-blood-indicators-combined-sleep-questionnaires-identification-cognitive-impairment#comments</comments>
</item>
<item>
 <title>The Cog-Aging: a 15-year cohort study of cognition in Brazilian older adults.</title>
 <link>https://www.alzforum.org/papers/cog-aging-15-year-cohort-study-cognition-brazilian-older-adults</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71780. &lt;br&gt;Authors: Engelmann GT, de Alvarenga JC, Moro GC, Bolaños Burgos IC, Miranda MF, Miranda MF, de Souza AS, Saldanha MF, Hansen EO, Dias NS, da Cunha Cintra FC, Dias BF, da Silva Souza AL, Carvalho AT, Martino-Adami PV, Cintra MT, Labanca L, Lanna IN, de Ávila RT, de Paula JJ, Costa-Silva L, Freitas Rosa DV, de Miranda DM, Romano-Silva MA, de Marco LA, Ramírez A, de Mattos Viana B, Camargos Bicalho MA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706593&quot;&gt;42706593&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cog-aging-15-year-cohort-study-cognition-brazilian-older-adults#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cog-aging-15-year-cohort-study-cognition-brazilian-older-adults#comments</comments>
</item>
<item>
 <title>Distinct ocular microvascular alterations in Alzheimer&#039;s disease and cerebral small vessel disease.</title>
 <link>https://www.alzforum.org/papers/distinct-ocular-microvascular-alterations-alzheimers-disease-and-cerebral-small-vessel</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71809. &lt;br&gt;Authors: Zhang Z, Cao L, Liu P, Yang S, Yan Y, Kwapong WR, He Y, Yang M, Wang H, Wang Y, Feng Z, Zhou J, Liu M, Lei P, Wu B, Zhang S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706564&quot;&gt;42706564&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/distinct-ocular-microvascular-alterations-alzheimers-disease-and-cerebral-small-vessel#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/distinct-ocular-microvascular-alterations-alzheimers-disease-and-cerebral-small-vessel#comments</comments>
</item>
<item>
 <title>A meta-refined human Alzheimer&#039;s disease-associated gene subset shows partial mouse-model pathway correspondence and limited cross-cohort machine-learning transportability.</title>
 <link>https://www.alzforum.org/papers/meta-refined-human-alzheimers-disease-associated-gene-subset-shows-partial-mouse-model</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71804. &lt;br&gt;Authors: Chai L, Huang Y, Ni J, Zuo S, Huang J, Lin B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706501&quot;&gt;42706501&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/meta-refined-human-alzheimers-disease-associated-gene-subset-shows-partial-mouse-model#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/meta-refined-human-alzheimers-disease-associated-gene-subset-shows-partial-mouse-model#comments</comments>
</item>
<item>
 <title>Does G-ALPS measure glymphatic function? Revisiting construct validity in diffusion-based glymphatic imaging.</title>
 <link>https://www.alzforum.org/papers/does-g-alps-measure-glymphatic-function-revisiting-construct-validity-diffusion-based</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71830. &lt;br&gt;Authors: Camargos EF, Olegário RL, Nóbrega OT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706497&quot;&gt;42706497&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/does-g-alps-measure-glymphatic-function-revisiting-construct-validity-diffusion-based#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/does-g-alps-measure-glymphatic-function-revisiting-construct-validity-diffusion-based#comments</comments>
</item>
<item>
 <title>Beyond Bulk: Cell-Type-Resolved Epigenomics as the Path Forward in Alzheimer&#039;s Disease Research.</title>
 <link>https://www.alzforum.org/papers/beyond-bulk-cell-type-resolved-epigenomics-path-forward-alzheimers-disease-research</link>
 <description>Eur J Neurosci. 2026 Sep;64(5):e70683. &lt;br&gt;Authors: Cañizares-Moscato L, Ruiz-Iglesias J, Isoler-Alcaraz J, Palomer E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42716912&quot;&gt;42716912&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/beyond-bulk-cell-type-resolved-epigenomics-path-forward-alzheimers-disease-research#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/beyond-bulk-cell-type-resolved-epigenomics-path-forward-alzheimers-disease-research#comments</comments>
</item>
<item>
 <title>More efficient screening for preclinical Alzheimer&#039;s clinical trials using mixture of experts.</title>
 <link>https://www.alzforum.org/papers/more-efficient-screening-preclinical-alzheimers-clinical-trials-using-mixture-experts</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71681. &lt;br&gt;Authors: Langford O, Raman R, Aisen P, Sperling R, Johnson K, Molina-Henry D, Sachdev P, Li D, Jimenez-Maggiora GA, Johnson SC, Braunstein JB, Birkenbihl C, Cuppels M, Buckley RF, Rissman RA, Donohue MC&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42713877&quot;&gt;42713877&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/more-efficient-screening-preclinical-alzheimers-clinical-trials-using-mixture-experts#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/more-efficient-screening-preclinical-alzheimers-clinical-trials-using-mixture-experts#comments</comments>
</item>
<item>
 <title>Neuroinflammatory and Motor Alterations in LRRK2*G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP-Induced Nigrostriatal Neurodegeneration.</title>
 <link>https://www.alzforum.org/papers/neuroinflammatory-and-motor-alterations-lrrk2g2019s-transgenic-mice-without-enhanced</link>
 <description>J Neurochem. 2026 Sep;170(9):e70547. &lt;br&gt;Authors: García-Swinburn R, Morón-Márquez L, Conde-Naranjo C, García-Roldán E, Espadas I, Rodríguez-Gil A, Ramírez-Lorca R, Villadiego J, Toledo-Aral JJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42713709&quot;&gt;42713709&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neuroinflammatory-and-motor-alterations-lrrk2g2019s-transgenic-mice-without-enhanced#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neuroinflammatory-and-motor-alterations-lrrk2g2019s-transgenic-mice-without-enhanced#comments</comments>
</item>
<item>
 <title>Multi-Omics Analysis Reveals That Aβ42- Me3 Co-Aggregation Induces Mitophagy Blockade in Early Stages of Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/multi-omics-analysis-reveals-av42-me3-co-aggregation-induces-mitophagy-blockade-early-stages</link>
 <description>MedComm (2020). 2026 Sep;7(9):e70984.  Epub 2026 Sep 8&lt;br&gt;Authors: Zhu W, Zhang Y, Li P, Zhong Y, Lin Y, Liu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712882&quot;&gt;42712882&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-omics-analysis-reveals-av42-me3-co-aggregation-induces-mitophagy-blockade-early-stages#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-omics-analysis-reveals-av42-me3-co-aggregation-induces-mitophagy-blockade-early-stages#comments</comments>
</item>
<item>
 <title>UHPLC-Q/TOF-MS Characterization of Danshen-Chuanxiong and Mechanistic Insights Into Its Protective Effects Against Aβ1-42-Induced Brain Endothelial Injury Through Metabolomics.</title>
 <link>https://www.alzforum.org/papers/uhplc-qtof-ms-characterization-danshen-chuanxiong-and-mechanistic-insights-its-protective</link>
 <description>J Sep Sci. 2026 Sep;49(9):e70527. &lt;br&gt;Authors: Wang H, Li L, He X, Shen S, Chao L, You P, Ji K, Liu Y, Hong Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712219&quot;&gt;42712219&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/uhplc-qtof-ms-characterization-danshen-chuanxiong-and-mechanistic-insights-its-protective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/uhplc-qtof-ms-characterization-danshen-chuanxiong-and-mechanistic-insights-its-protective#comments</comments>
</item>
<item>
 <title>Tau-associated neuronal loss in the intermediate nucleus of the human hypothalamus, a putative VLPO analog, in progressive supranuclear palsy and Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/tau-associated-neuronal-loss-intermediate-nucleus-human-hypothalamus-putative-vlpo-analog</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71808. &lt;br&gt;Authors: Rastegar-Pouyani S, Lew C, Pereira FL, Satpati A, Arnas AM, Paes V, Leite RE, Suemoto CK, Spina S, Son G, Heinsen H, Seeley WW, Walsh CM, Neylan TC, Grinberg LT&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712109&quot;&gt;42712109&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tau-associated-neuronal-loss-intermediate-nucleus-human-hypothalamus-putative-vlpo-analog#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tau-associated-neuronal-loss-intermediate-nucleus-human-hypothalamus-putative-vlpo-analog#comments</comments>
</item>
<item>
 <title>MCH-Guard: Multimodal machine learning framework for risk stratification of cerebral microhemorrhage risk in the Alzheimer&#039;s Disease Neuroimaging Initiative.</title>
 <link>https://www.alzforum.org/papers/mch-guard-multimodal-machine-learning-framework-risk-stratification-cerebral-0</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71818. &lt;br&gt;Authors: Gel A, Phillips E, Hausle I, Thropp P, Tosun D, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712106&quot;&gt;42712106&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mch-guard-multimodal-machine-learning-framework-risk-stratification-cerebral-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mch-guard-multimodal-machine-learning-framework-risk-stratification-cerebral-0#comments</comments>
</item>
<item>
 <title>Alterations of gut microbiota in Down syndrome and their association with Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/alterations-gut-microbiota-down-syndrome-and-their-association-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71815. &lt;br&gt;Authors: Pellegrini C, Ravaioli F, De Fanti S, Siliquini A, Sala C, Rochat M, Pollarini V, Polischi B, Pasti A, Grasso M, Rambaldi M, Cardoni F, Grotteschi N, Caraci F, Cortelli P, Provini F, Lodi R, Morandi L, Parchi P, Pirazzoli GL, Sambati L, Tonon C, Bacalini MG&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712102&quot;&gt;42712102&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alterations-gut-microbiota-down-syndrome-and-their-association-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alterations-gut-microbiota-down-syndrome-and-their-association-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Shared genetic architecture between DTI-ALPS traits and neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/shared-genetic-architecture-between-dti-alps-traits-and-neurodegenerative-diseases</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71820. &lt;br&gt;Authors: Zhou H, Deng J, Wu Q, Zeng Y, Wang T, Wu J, Duan X, Tang B, Wei X, He L, Liu F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712094&quot;&gt;42712094&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/shared-genetic-architecture-between-dti-alps-traits-and-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/shared-genetic-architecture-between-dti-alps-traits-and-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Psychological impacts of APOE genotype disclosure among Latinos in New York City: a randomized controlled trial.</title>
 <link>https://www.alzforum.org/papers/psychological-impacts-apoe-genotype-disclosure-among-latinos-new-york-city-randomized</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71796. &lt;br&gt;Authors: Ottman R, Wetmore JB, Leu CS, Uhlmann WR, Goldman J, Rodriguez S, Diaz Caro D, Cabán M, McCain S, Blasco D, Lantigua RA, Abraido-Lanza A, Chung WK, Roberts JS, Siegel K&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712082&quot;&gt;42712082&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/psychological-impacts-apoe-genotype-disclosure-among-latinos-new-york-city-randomized#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/psychological-impacts-apoe-genotype-disclosure-among-latinos-new-york-city-randomized#comments</comments>
</item>
<item>
 <title>Oligodendrocyte-Targeted SGK1.1 Inhibition Alleviates White Matter Injury and Cognitive Impairment in Alzheimer&#039;s Disease via Modulation of HDAC2 Phosphorylation.</title>
 <link>https://www.alzforum.org/papers/oligodendrocyte-targeted-sgk11-inhibition-alleviates-white-matter-injury-and-cognitive</link>
 <description>CNS Neurosci Ther. 2026 Sep;32(9):e71150. &lt;br&gt;Authors: Deng S, Gao S, Zhou C, Lan Z, Li H, Chen J, Xu Y, Li J, Liu P, Zhang S, Bao X, Wang T, Xu Y, Zhu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711949&quot;&gt;42711949&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/oligodendrocyte-targeted-sgk11-inhibition-alleviates-white-matter-injury-and-cognitive#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/oligodendrocyte-targeted-sgk11-inhibition-alleviates-white-matter-injury-and-cognitive#comments</comments>
</item>
<item>
 <title>Novel Therapeutic Insights Into Alzheimer&#039;s Disease: Glymphatic System and Meningeal Lymphatic Vessels.</title>
 <link>https://www.alzforum.org/papers/novel-therapeutic-insights-alzheimers-disease-glymphatic-system-and-meningeal-lymphatic</link>
 <description>Aging Cell. 2026 Sep;25(9):e70699. &lt;br&gt;Authors: Song B, Wang W, Liu S, Jin X, Qi Y, Li M, Yue D, Liu Y, Li X, Yin L, Feng L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720212&quot;&gt;42720212&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/novel-therapeutic-insights-alzheimers-disease-glymphatic-system-and-meningeal-lymphatic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/novel-therapeutic-insights-alzheimers-disease-glymphatic-system-and-meningeal-lymphatic#comments</comments>
</item>
<item>
 <title>TMEM106B is a selective modulator of TDP-43 pathology in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/tmem106b-selective-modulator-tdp-43-pathology-alzheimers-disease</link>
 <description>Alzheimers Dement. 2026 Sep;22(9):e71713. &lt;br&gt;Authors: Reeves MM, Calliari A, Todd TW, Maroto Cidfuentes C, Jansen-West K, Yue M, Song Y, Dunmore J, Rawlinson B, Engelberg-Cook E, DeTure M, Day GS, Graff-Radford NR, Boeve BF, Knopman DS, Petersen RC, Cook CN, Murray ME, Dickson DW, Josephs KA, Petrucelli L, Prudencio M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42720122&quot;&gt;42720122&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tmem106b-selective-modulator-tdp-43-pathology-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tmem106b-selective-modulator-tdp-43-pathology-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Investigating Translocation Mechanisms of TDP-43 Into the Endoplasmic Reticulum Using Budding Yeast Models.</title>
 <link>https://www.alzforum.org/papers/investigating-translocation-mechanisms-tdp-43-endoplasmic-reticulum-using-budding-yeast</link>
 <description>Traffic. 2026 Sep;27(3):e70054. &lt;br&gt;Authors: Saito M, Tsuzuki H, Hosomi A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719958&quot;&gt;42719958&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/investigating-translocation-mechanisms-tdp-43-endoplasmic-reticulum-using-budding-yeast#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/investigating-translocation-mechanisms-tdp-43-endoplasmic-reticulum-using-budding-yeast#comments</comments>
</item>
<item>
 <title>Traditional Chinese medicine ginseng regulates neurotrophic factors to improve neurodegenerative diseases: A potential strategy for Alzheimer&#039;s disease treatment.</title>
 <link>https://www.alzforum.org/papers/traditional-chinese-medicine-ginseng-regulates-neurotrophic-factors-improve-neurodegenerative</link>
 <description>J Ginseng Res. 2026 Sep;50(5):101078.  Epub 2026 Jun 19&lt;br&gt;Authors: Huang Q, Xie Y, Zhang X, Zuo Y, Wang L, Xu H, Yu M, Liu C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719334&quot;&gt;42719334&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/traditional-chinese-medicine-ginseng-regulates-neurotrophic-factors-improve-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/traditional-chinese-medicine-ginseng-regulates-neurotrophic-factors-improve-neurodegenerative#comments</comments>
</item>
<item>
 <title>Dopaminergic- and Cholinergic-Related Structural MRI Patterns Across Cognitive Subtypes of Parkinson&#039;s Disease With Mild Cognitive Impairment.</title>
 <link>https://www.alzforum.org/papers/dopaminergic-and-cholinergic-related-structural-mri-patterns-across-cognitive-subtypes</link>
 <description>Eur J Neurol. 2026 Sep;33(9):e70746. &lt;br&gt;Authors: Bai X, Chen H, Li Q, Zhang S, Chen S, Qian A, Zhou R, Cheng Y, Xie C, Wang Z, Yang Y, Wang M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42717472&quot;&gt;42717472&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dopaminergic-and-cholinergic-related-structural-mri-patterns-across-cognitive-subtypes#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dopaminergic-and-cholinergic-related-structural-mri-patterns-across-cognitive-subtypes#comments</comments>
</item>
<item>
 <title>High-Resolution Diffusion Tensor Imaging of the Hippocampus and Associations With Neuropsychiatric Symptoms in Lewy Body Diseases.</title>
 <link>https://www.alzforum.org/papers/high-resolution-diffusion-tensor-imaging-hippocampus-and-associations-neuropsychiatric</link>
 <description>Hippocampus. 2026 Sep;36(5):e70127. &lt;br&gt;Authors: Budd AS, Solar KG, Gee M, Nelles K, Mankasingh B, Ismail Z, Smith EE, Martyna M, Ba F, Kalra S, Beaulieu C, Camicioli R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42717433&quot;&gt;42717433&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/high-resolution-diffusion-tensor-imaging-hippocampus-and-associations-neuropsychiatric#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/high-resolution-diffusion-tensor-imaging-hippocampus-and-associations-neuropsychiatric#comments</comments>
</item>
<item>
 <title>Diagnosis-guided multimodal adversarial graph masked autoencoder network for association analysis between brain imaging and gene expression in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/diagnosis-guided-multimodal-adversarial-graph-masked-autoencoder-network-association-analysis</link>
 <description>Comput Methods Programs Biomed. 2026 Aug 31;287:109620.  Epub 2026 Aug 31&lt;br&gt;Authors: Li JN, Zhang SW, Zhang TH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42705154&quot;&gt;42705154&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/diagnosis-guided-multimodal-adversarial-graph-masked-autoencoder-network-association-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/diagnosis-guided-multimodal-adversarial-graph-masked-autoencoder-network-association-analysis#comments</comments>
</item>
<item>
 <title>Nested Continual Learning with Elastic Weight Consolidation for Progressive Alzheimer&#039;s Disease Classification from MRI.</title>
 <link>https://www.alzforum.org/papers/nested-continual-learning-elastic-weight-consolidation-progressive-alzheimers-disease</link>
 <description>Curr Med Imaging. 2026 Aug 31; Epub 2026 Aug 31&lt;br&gt;Authors: Akgündoğdu A, Çeli̇kbaş Ş&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708298&quot;&gt;42708298&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nested-continual-learning-elastic-weight-consolidation-progressive-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nested-continual-learning-elastic-weight-consolidation-progressive-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Decoding Frontotemporal Dementia: Genes, Proteins and Prospects for Precision Medicine.</title>
 <link>https://www.alzforum.org/papers/decoding-frontotemporal-dementia-genes-proteins-and-prospects-precision-medicine</link>
 <description>Curr Alzheimer Res. 2026 Aug 30; Epub 2026 Aug 30&lt;br&gt;Authors: Raj K, Kumari N, Bharti P, Kumar R, Kumar D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708260&quot;&gt;42708260&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/decoding-frontotemporal-dementia-genes-proteins-and-prospects-precision-medicine#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/decoding-frontotemporal-dementia-genes-proteins-and-prospects-precision-medicine#comments</comments>
</item>
<item>
 <title>Mesoporous silica-coated gold nanorods functionalized with the D3 peptide and loaded with epigallocatechin-3-gallate reduce β-amyloid toxicity in the presence of Zn(II) ions.</title>
 <link>https://www.alzforum.org/papers/mesoporous-silica-coated-gold-nanorods-functionalized-d3-peptide-and-loaded-epigallocatechin</link>
 <description>Biomater Adv. 2026 Aug 29;190:215149.  Epub 2026 Aug 29&lt;br&gt;Authors: Avendaño-Godoy J, Álamos C, Araya E, Olea-Azar C, Ortega-Campos J, Cattoën X, Valenzuela JM, Kogan MJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42700732&quot;&gt;42700732&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mesoporous-silica-coated-gold-nanorods-functionalized-d3-peptide-and-loaded-epigallocatechin#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mesoporous-silica-coated-gold-nanorods-functionalized-d3-peptide-and-loaded-epigallocatechin#comments</comments>
</item>
<item>
 <title>Circadian Rhythm Disruption in Alzheimer&#039;s Disease: Molecular Mechanisms, Clinical Implications, and Therapeutic Approaches.</title>
 <link>https://www.alzforum.org/papers/circadian-rhythm-disruption-alzheimers-disease-molecular-mechanisms-clinical-implications-and</link>
 <description>Curr Neurovasc Res. 2026 Aug 29; Epub 2026 Aug 29&lt;br&gt;Authors: Rajput R, Sharma A, Mittal V, Sharma D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708270&quot;&gt;42708270&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/circadian-rhythm-disruption-alzheimers-disease-molecular-mechanisms-clinical-implications-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/circadian-rhythm-disruption-alzheimers-disease-molecular-mechanisms-clinical-implications-and#comments</comments>
</item>
<item>
 <title>Late-onset unprovoked seizures and subsequent risk of dementia in older adults: A target trial emulation.</title>
 <link>https://www.alzforum.org/papers/late-onset-unprovoked-seizures-and-subsequent-risk-dementia-older-adults-target-trial</link>
 <description>Seizure. 2026 Aug 29;142:212-219.  Epub 2026 Aug 29&lt;br&gt;Authors: Pereira da Silva AM, Vicente de Siqueira Lima D Jr, Campos Cardoso LJ, Tudella GC, Mi Lee A, Martines da Costa M, Mella Cukiert C, Sousa Noleto G, Haddad Santos D, Perry G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721538&quot;&gt;42721538&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/late-onset-unprovoked-seizures-and-subsequent-risk-dementia-older-adults-target-trial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/late-onset-unprovoked-seizures-and-subsequent-risk-dementia-older-adults-target-trial#comments</comments>
</item>
<item>
 <title>Psychotropic Polypharmacy in Alzheimer&#039;s Disease: A Potentially Inappropriate Medication Perspective in Older Adults.</title>
 <link>https://www.alzforum.org/papers/psychotropic-polypharmacy-alzheimers-disease-potentially-inappropriate-medication-perspective</link>
 <description>Curr Alzheimer Res. 2026 Aug 28; Epub 2026 Aug 28&lt;br&gt;Authors: Gou KJ, Chen Y, Sheng Z, Yu W, Wang L, Lü Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706981&quot;&gt;42706981&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/psychotropic-polypharmacy-alzheimers-disease-potentially-inappropriate-medication-perspective#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/psychotropic-polypharmacy-alzheimers-disease-potentially-inappropriate-medication-perspective#comments</comments>
</item>
<item>
 <title>AI-Driven Precision Medicine in Alzheimer&#039;s Disease: Drug Repurposing, Digital Therapeutics and Clinical Decision Support.</title>
 <link>https://www.alzforum.org/papers/ai-driven-precision-medicine-alzheimers-disease-drug-repurposing-digital-therapeutics-and</link>
 <description>Curr Pharm Des. 2026 Aug 28; Epub 2026 Aug 28&lt;br&gt;Authors: Saxena B, Sisodiya N, Khabiya R, Pandit A, Rajput MS, Gupta R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706977&quot;&gt;42706977&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/ai-driven-precision-medicine-alzheimers-disease-drug-repurposing-digital-therapeutics-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/ai-driven-precision-medicine-alzheimers-disease-drug-repurposing-digital-therapeutics-and#comments</comments>
</item>
<item>
 <title>Scutellaria Barbata Flavonoids Mitigate Alzheimer&#039;s Disease-related Aβ25-35 Toxicity in N2a Cells through CREB Phosphorylation.</title>
 <link>https://www.alzforum.org/papers/scutellaria-barbata-flavonoids-mitigate-alzheimers-disease-related-av25-35-toxicity-n2a-cells</link>
 <description>Curr Med Chem. 2026 Aug 28; Epub 2026 Aug 28&lt;br&gt;Authors: Yu X, Yi Y, Liu X, Zhao C, Li C, Shang Y, He K, Zhai Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42706972&quot;&gt;42706972&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/scutellaria-barbata-flavonoids-mitigate-alzheimers-disease-related-av25-35-toxicity-n2a-cells#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/scutellaria-barbata-flavonoids-mitigate-alzheimers-disease-related-av25-35-toxicity-n2a-cells#comments</comments>
</item>
<item>
 <title>14-3-3/Tau molecular glues modulate in vitro tau condensation.</title>
 <link>https://www.alzforum.org/papers/14-3-3tau-molecular-glues-modulate-vitro-tau-condensation</link>
 <description>RSC Chem Biol. 2026 Aug 28; Epub 2026 Aug 28&lt;br&gt;Authors: van den Oetelaar MC, Ravatt L, Zelaya FM, Oberheide A, van de Wijngaart TR, van Boxtel FM, Pennings MA, Verhoef CJ, van Veldhuisen TW, Cossar PJ, Ottmann C, Wegmann S, Brunsveld L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712752&quot;&gt;42712752&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/14-3-3tau-molecular-glues-modulate-vitro-tau-condensation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/14-3-3tau-molecular-glues-modulate-vitro-tau-condensation#comments</comments>
</item>
<item>
 <title>Epilepsy and subsequent dementia in adults with down syndrome: a propensity score-matched cohort study using federated electronic health records.</title>
 <link>https://www.alzforum.org/papers/epilepsy-and-subsequent-dementia-adults-down-syndrome-propensity-score-matched-cohort-study</link>
 <description>Seizure. 2026 Aug 28;142:220-229.  Epub 2026 Aug 28&lt;br&gt;Authors: Pereira da Silva AM, Tudella GC, Lee AM, Santos DH, Cukiert CM, Perry G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721539&quot;&gt;42721539&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/epilepsy-and-subsequent-dementia-adults-down-syndrome-propensity-score-matched-cohort-study#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/epilepsy-and-subsequent-dementia-adults-down-syndrome-propensity-score-matched-cohort-study#comments</comments>
</item>
<item>
 <title>Arterial spin labeling-derived cerebral blood flow as a translational biomarker and candidate surrogate endpoint for cognitive impairment.</title>
 <link>https://www.alzforum.org/papers/arterial-spin-labeling-derived-cerebral-blood-flow-translational-biomarker-and-candidate</link>
 <description>Curr Opin Psychiatry. 2026 Aug 27; Epub 2026 Aug 27&lt;br&gt;Authors: Hosoki S, Sachdev PS, Ihara M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42708376&quot;&gt;42708376&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/arterial-spin-labeling-derived-cerebral-blood-flow-translational-biomarker-and-candidate#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/arterial-spin-labeling-derived-cerebral-blood-flow-translational-biomarker-and-candidate#comments</comments>
</item>
<item>
 <title>Nanoscale localisation of memantine governs structural modulation and loading in bicontinuous cubic phase systems.</title>
 <link>https://www.alzforum.org/papers/nanoscale-localisation-memantine-governs-structural-modulation-and-loading-bicontinuous-cubic</link>
 <description>J Colloid Interface Sci. 2026 Aug 26;726:141405.  Epub 2026 Aug 26&lt;br&gt;Authors: Guarneri L, Beh C, de Campo L, Whitten AE, Moir M, Hung A, Clulow AJ, Conn CE, van &amp;#039;t Hag L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42705162&quot;&gt;42705162&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/nanoscale-localisation-memantine-governs-structural-modulation-and-loading-bicontinuous-cubic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/nanoscale-localisation-memantine-governs-structural-modulation-and-loading-bicontinuous-cubic#comments</comments>
</item>
<item>
 <title>Cortisol Dysregulation as a Major Factor in the Development of Neurodegenerative Diseases, Drug Targets and Therapeutic Prospects: A Comprehensive Review.</title>
 <link>https://www.alzforum.org/papers/cortisol-dysregulation-major-factor-development-neurodegenerative-diseases-drug-targets-and</link>
 <description>CNS Neurol Disord Drug Targets. 2026 Aug 24; Epub 2026 Aug 24&lt;br&gt;Authors: Ardakani RH, Dashtaki M, Mohamadi-Zarch SM, Bagheri SM&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693862&quot;&gt;42693862&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cortisol-dysregulation-major-factor-development-neurodegenerative-diseases-drug-targets-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cortisol-dysregulation-major-factor-development-neurodegenerative-diseases-drug-targets-and#comments</comments>
</item>
<item>
 <title>Plant-Derived Exosomes in Neurodegenerative Disorders and Age-Related Brain Dysfunction: From Isolation to Clinical Potential.</title>
 <link>https://www.alzforum.org/papers/plant-derived-exosomes-neurodegenerative-disorders-and-age-related-brain-dysfunction</link>
 <description>Curr Neuropharmacol. 2026 Aug 24; Epub 2026 Aug 24&lt;br&gt;Authors: Aykora D, Uzun M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693839&quot;&gt;42693839&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plant-derived-exosomes-neurodegenerative-disorders-and-age-related-brain-dysfunction#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plant-derived-exosomes-neurodegenerative-disorders-and-age-related-brain-dysfunction#comments</comments>
</item>
<item>
 <title>A third-generation, high-affinity biparatopic anti-tau antibody inhibits intracellular tau aggregation seeded by Alzheimer&#039;s brain extracts.</title>
 <link>https://www.alzforum.org/papers/third-generation-high-affinity-biparatopic-anti-tau-antibody-inhibits-intracellular-tau</link>
 <description>Alzheimers Res Ther. 2026 Aug 22;18(1)&lt;br&gt;Authors: Hatterer E, Broyer L, Pecoraro S, Cusin F, Simsek N, Breve JJ, Clavel M, Batenburg KL, Klein B, Zuidweg T, Piché K, Bourguignon J, Bonnet-Gamard M, Malinge P, Gueneau F, Moine V, Anceriz N, Masternak K, Fischer N, Gjølberg TT, Telstad JS, Calamera G, Mester S, Scheper W, Van de Berg WD, Courade JP&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693483&quot;&gt;42693483&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/third-generation-high-affinity-biparatopic-anti-tau-antibody-inhibits-intracellular-tau#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/third-generation-high-affinity-biparatopic-anti-tau-antibody-inhibits-intracellular-tau#comments</comments>
</item>
<item>
 <title>ResSpikingNet: residual spiking neural network for early detection of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/resspikingnet-residual-spiking-neural-network-early-detection-alzheimers-disease</link>
 <description>Psychiatry Res Neuroimaging. 2026 Aug 22;364:112311.  Epub 2026 Aug 22&lt;br&gt;Authors: M S, Thanka MR, Edwin EB&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42715639&quot;&gt;42715639&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/resspikingnet-residual-spiking-neural-network-early-detection-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/resspikingnet-residual-spiking-neural-network-early-detection-alzheimers-disease#comments</comments>
</item>
<item>
 <title>DIPOG: A dynamic pooling graph neural network with spatial-temporal-frequency awareness for diagnosis of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/dipog-dynamic-pooling-graph-neural-network-spatial-temporal-frequency-awareness-diagnosis</link>
 <description>Med Image Anal. 2026 Aug 22;115:104280.  Epub 2026 Aug 22&lt;br&gt;Authors: Zhang S, Huang L, Wang M, Li Y, Guo Q, Wang Z, Lv H, Jiang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42721942&quot;&gt;42721942&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/dipog-dynamic-pooling-graph-neural-network-spatial-temporal-frequency-awareness-diagnosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/dipog-dynamic-pooling-graph-neural-network-spatial-temporal-frequency-awareness-diagnosis#comments</comments>
</item>
<item>
 <title>Effects of Escitalopram on Neuropsychiatric Symptoms in Alzheimer Disease: A Secondary Analysis From the S-CitAD Study.</title>
 <link>https://www.alzforum.org/papers/effects-escitalopram-neuropsychiatric-symptoms-alzheimer-disease-secondary-analysis-s-citad</link>
 <description>Am J Geriatr Psychiatry. 2026 Aug 12; Epub 2026 Aug 12&lt;br&gt;Authors: Clark ED, Perin J, Devanand DP, Padala PR, Shade DM, Lyketsos CG, Porsteinsson AP, S-CitAD Research Group&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42697812&quot;&gt;42697812&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-escitalopram-neuropsychiatric-symptoms-alzheimer-disease-secondary-analysis-s-citad#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-escitalopram-neuropsychiatric-symptoms-alzheimer-disease-secondary-analysis-s-citad#comments</comments>
</item>
<item>
 <title>TDP-43 controls RNA structure through high affinity lattice interactions.</title>
 <link>https://www.alzforum.org/papers/tdp-43-controls-rna-structure-through-high-affinity-lattice-interactions-0</link>
 <description>Nat Commun. 2026 Aug 12;17(1)&lt;br&gt;Authors: Vivek R, Kume T, Roschdi S, Record MT Jr, Hoskins AA, Butcher SE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42717208&quot;&gt;42717208&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tdp-43-controls-rna-structure-through-high-affinity-lattice-interactions-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tdp-43-controls-rna-structure-through-high-affinity-lattice-interactions-0#comments</comments>
</item>
<item>
 <title>Diagnostic performance of plasma pTau217 in genetically admixed South American populations.</title>
 <link>https://www.alzforum.org/papers/diagnostic-performance-plasma-ptau217-genetically-admixed-south-american-populations</link>
 <description>Nat Commun. 2026 Aug 6;17(1)&lt;br&gt;Authors: Martino-Adami PV, Coutinho de Alvarenga J, Freccero P, Huber H, Fernandez J, Bolaños Burgos IC, Postillone MB, Tomé Oliveira Engelmann G, Mintz I, Romano Silva MA, Medel N, de Oliveira Hansen E, Lisso J, Dias Silva N, Teixeira Carvalho A, Irureta N, de Miranda DM, Vallejo-Azar M, Cunha de Marco LA, Heilmann-Heimbach S, de Paula JJ, Kochen S, Teixeira de Ávila R, Solis P, Schneider A, Gonzalez P, de Mattos Viana B, Dalmasso MC, Camargos Bicalho MA, Ramírez A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42693124&quot;&gt;42693124&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/diagnostic-performance-plasma-ptau217-genetically-admixed-south-american-populations#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/diagnostic-performance-plasma-ptau217-genetically-admixed-south-american-populations#comments</comments>
</item>
<item>
 <title>A Practical Radiosynthesis of (S)-[11C]SMBT-1 for MAO-B PET Imaging.</title>
 <link>https://www.alzforum.org/papers/practical-radiosynthesis-s-11csmbt-1-mao-b-pet-imaging</link>
 <description>J Labelled Comp Radiopharm. 2026 Aug;69(10-11):e70037. &lt;br&gt;Authors: Akula HK, Pati S, Qu W, Slifstein M, Parsey R, Harada R, Furumoto S, Okamura N, Kim MJ, Hu B&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42710855&quot;&gt;42710855&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/practical-radiosynthesis-s-11csmbt-1-mao-b-pet-imaging#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/practical-radiosynthesis-s-11csmbt-1-mao-b-pet-imaging#comments</comments>
</item>
<item>
 <title>From a Pinched Nerve to a Fatal Prognosis: Sporadic Creutzfeldt-Jakob Disease Masquerading as Cervical Myelopathy.</title>
 <link>https://www.alzforum.org/papers/pinched-nerve-fatal-prognosis-sporadic-creutzfeldt-jakob-disease-masquerading-cervical</link>
 <description>Cureus. 2026 Aug;18(8):e114217.  Epub 2026 Aug 9&lt;br&gt;Authors: Bayati J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42713555&quot;&gt;42713555&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/pinched-nerve-fatal-prognosis-sporadic-creutzfeldt-jakob-disease-masquerading-cervical#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/pinched-nerve-fatal-prognosis-sporadic-creutzfeldt-jakob-disease-masquerading-cervical#comments</comments>
</item>
<item>
 <title>Single cell transcriptomic analysis by deep learning identifies novel microglial transcription regulations in Alzheimer&#039;s Disease.</title>
 <link>https://www.alzforum.org/papers/single-cell-transcriptomic-analysis-deep-learning-identifies-novel-microglial-transcription</link>
 <description>AI Neurosci. 2026 Jul 26; Epub 2026 Jul 26&lt;br&gt;Authors: Trivedi MR, Shah J, Su Y, Reiman EM, Wu T, Wang Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42699651&quot;&gt;42699651&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/single-cell-transcriptomic-analysis-deep-learning-identifies-novel-microglial-transcription#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/single-cell-transcriptomic-analysis-deep-learning-identifies-novel-microglial-transcription#comments</comments>
</item>
<item>
 <title>In the absence of Alzheimer&#039;s Disease pathology, PET-measured hippocampal tau is reduced in association with greater depressive symptoms: Could tau PET be sensitive to physiological tau involved in neurogenesis?</title>
 <link>https://www.alzforum.org/papers/absence-alzheimers-disease-pathology-pet-measured-hippocampal-tau-reduced-association-greater</link>
 <description>J Affect Disord Rep. 2026 Jul;25:101071.  Epub 2026 May 8&lt;br&gt;Authors: Hojjati SH, Wang XH, Zhou L, Keil S, Tanzi E, Maloney T, Feiz F, Shah S, Glodzik L, Li Y, Chiang GC, Butler TA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42713462&quot;&gt;42713462&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/absence-alzheimers-disease-pathology-pet-measured-hippocampal-tau-reduced-association-greater#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/absence-alzheimers-disease-pathology-pet-measured-hippocampal-tau-reduced-association-greater#comments</comments>
</item>
<item>
 <title>ALSGate: An Efficient Gated Mixture-of-Experts Model for Reliable ALS Detection Using EMG Signals.</title>
 <link>https://www.alzforum.org/papers/alsgate-efficient-gated-mixture-experts-model-reliable-als-detection-using-emg-signals</link>
 <description>Healthc Technol Lett. 2026;13(1):e70097.  Epub 2026 Sep 3&lt;br&gt;Authors: Chowdhury S, Pramanik S, Bhattacharjee S, Billah M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694829&quot;&gt;42694829&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/alsgate-efficient-gated-mixture-experts-model-reliable-als-detection-using-emg-signals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/alsgate-efficient-gated-mixture-experts-model-reliable-als-detection-using-emg-signals#comments</comments>
</item>
<item>
 <title>Retinoic acid-related orphan receptor alpha (RORα) as a candidate multi-pathway target in Alzheimer&#039;s disease: mechanisms and therapeutic prospects.</title>
 <link>https://www.alzforum.org/papers/retinoic-acid-related-orphan-receptor-alpha-rora-candidate-multi-pathway-target-alzheimers</link>
 <description>Front Neurosci. 2026;20:1912268.  Epub 2026 Aug 20&lt;br&gt;Authors: Chintalapally S, Rajanala K, Upadhyay A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694676&quot;&gt;42694676&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/retinoic-acid-related-orphan-receptor-alpha-rora-candidate-multi-pathway-target-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/retinoic-acid-related-orphan-receptor-alpha-rora-candidate-multi-pathway-target-alzheimers#comments</comments>
</item>
<item>
 <title>Herpes simplex virus infection and Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/herpes-simplex-virus-infection-and-alzheimers-disease</link>
 <description>Front Aging Neurosci. 2026;18:1858017.  Epub 2026 Aug 20&lt;br&gt;Authors: Hur JY&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694660&quot;&gt;42694660&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/herpes-simplex-virus-infection-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/herpes-simplex-virus-infection-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>TREM2 as a central hub of neuroimmune-metabolic crosstalk in central nervous system disorders: from microglial biology to therapeutic targeting.</title>
 <link>https://www.alzforum.org/papers/trem2-central-hub-neuroimmune-metabolic-crosstalk-central-nervous-system-disorders-microglial</link>
 <description>Front Immunol. 2026;17:1912989.  Epub 2026 Aug 20&lt;br&gt;Authors: Wu Y, Duan L, Zhang L, Wang S, Yan H, He M, Wang T, Li L, Gao Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694654&quot;&gt;42694654&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/trem2-central-hub-neuroimmune-metabolic-crosstalk-central-nervous-system-disorders-microglial#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/trem2-central-hub-neuroimmune-metabolic-crosstalk-central-nervous-system-disorders-microglial#comments</comments>
</item>
<item>
 <title>Synergistic Regulation of Alzheimer&#039;s Disease and Intestinal Microbiota Metabolism Mediated by the Gut-Brain Axis: A Comprehensive Analysis from a Multidisciplinary Perspective.</title>
 <link>https://www.alzforum.org/papers/synergistic-regulation-alzheimers-disease-and-intestinal-microbiota-metabolism-mediated-gut</link>
 <description>Int J Med Sci. 2026;23(9):2939-2962.  Epub 2026 Jul 30&lt;br&gt;Authors: Lu P, Liu M, Zhang L, Fan JJ, Sun Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694564&quot;&gt;42694564&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/synergistic-regulation-alzheimers-disease-and-intestinal-microbiota-metabolism-mediated-gut#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/synergistic-regulation-alzheimers-disease-and-intestinal-microbiota-metabolism-mediated-gut#comments</comments>
</item>
<item>
 <title>The APOE4-estrogen-microglia axis in perimenopausal cognitive changes: mechanisms and therapeutic implications.</title>
 <link>https://www.alzforum.org/papers/apoe4-estrogen-microglia-axis-perimenopausal-cognitive-changes-mechanisms-and-therapeutic</link>
 <description>Front Immunol. 2026;17:1925850.  Epub 2026 Aug 20&lt;br&gt;Authors: Shi L, Zhou C, Han H, Lu M, Li M, Miao J, Feng S, Zhou X, Chen H, Ren L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694561&quot;&gt;42694561&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/apoe4-estrogen-microglia-axis-perimenopausal-cognitive-changes-mechanisms-and-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/apoe4-estrogen-microglia-axis-perimenopausal-cognitive-changes-mechanisms-and-therapeutic#comments</comments>
</item>
<item>
 <title>Correction: Unraveling the neuroprotective mechanisms of elephant black garlic extract against beta amyloid peptide-induced neurotoxicity.</title>
 <link>https://www.alzforum.org/papers/correction-unraveling-neuroprotective-mechanisms-elephant-black-garlic-extract-against-beta</link>
 <description>Front Nutr. 2026;13:1960775.  Epub 2026 Aug 20&lt;br&gt;Authors: Gavilan J, Panes-Fernández J, Araya A, Pérez-Manríquez C, Becerra J, Varas P, Moraga-Cid G, Yévenes GE, Fuentealba J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694538&quot;&gt;42694538&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correction-unraveling-neuroprotective-mechanisms-elephant-black-garlic-extract-against-beta#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correction-unraveling-neuroprotective-mechanisms-elephant-black-garlic-extract-against-beta#comments</comments>
</item>
<item>
 <title>Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer&#039;s disease using integrated bioinformatics and machine learning.</title>
 <link>https://www.alzforum.org/papers/identification-interleukin-11-comorbid-risk-factor-prostate-cancer-and-alzheimers-disease</link>
 <description>Front Immunol. 2026;17:1911726.  Epub 2026 Aug 20&lt;br&gt;Authors: Wang M, Qian Y, Huang E, Chu C, Gao T, Chen S, Zhao N, Luo C, Liu Y, Zheng X, Hu H, Han B, Chen M, Mao W, Li W&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694488&quot;&gt;42694488&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/identification-interleukin-11-comorbid-risk-factor-prostate-cancer-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/identification-interleukin-11-comorbid-risk-factor-prostate-cancer-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>From metabolism to neurodegeneration: how microglial functional reprogramming drives neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/metabolism-neurodegeneration-how-microglial-functional-reprogramming-drives-neurodegenerative</link>
 <description>Front Mol Neurosci. 2026;19:1921079.  Epub 2026 Aug 20&lt;br&gt;Authors: Cui Q, Zheng K, Liu Q, Wang L, Liu Y, Bai R, Zhang W, Guo J, Chang X, Wang J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694478&quot;&gt;42694478&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/metabolism-neurodegeneration-how-microglial-functional-reprogramming-drives-neurodegenerative#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/metabolism-neurodegeneration-how-microglial-functional-reprogramming-drives-neurodegenerative#comments</comments>
</item>
<item>
 <title>Microglia-mediated neuroinflammation in Alzheimer&#039;s disease: mechanisms and emerging therapeutic targets.</title>
 <link>https://www.alzforum.org/papers/microglia-mediated-neuroinflammation-alzheimers-disease-mechanisms-and-emerging-therapeutic</link>
 <description>Front Cell Neurosci. 2026;20:1902577.  Epub 2026 Aug 20&lt;br&gt;Authors: Xu L, Zhang Y, Jiang L, Xing JF, Hu J, Lan T, Ta G&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694464&quot;&gt;42694464&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/microglia-mediated-neuroinflammation-alzheimers-disease-mechanisms-and-emerging-therapeutic#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/microglia-mediated-neuroinflammation-alzheimers-disease-mechanisms-and-emerging-therapeutic#comments</comments>
</item>
<item>
 <title>The effects of obesogenic diet on a Drosophila model of frontotemporal dementia.</title>
 <link>https://www.alzforum.org/papers/effects-obesogenic-diet-drosophila-model-frontotemporal-dementia</link>
 <description>MicroPubl Biol. 2026;2026 Epub 2026 Aug 19&lt;br&gt;Authors: Ake C, Cervantes E, Garcia C, Hammons H, Obawole L, Morton I, Pham L, Salas B, Stacks S, Villarreal L, York F, Biglari S, Yeragi E, Lillvis E, Moulton M, Keene A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694457&quot;&gt;42694457&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/effects-obesogenic-diet-drosophila-model-frontotemporal-dementia#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/effects-obesogenic-diet-drosophila-model-frontotemporal-dementia#comments</comments>
</item>
<item>
 <title>Liuwei Dihuang pills attenuates cognitive dysfunction in APP/PS1 mice through restoring mitochondrial homeostasis and activating the IRS/AKT/GSK3β insulin signaling pathway.</title>
 <link>https://www.alzforum.org/papers/liuwei-dihuang-pills-attenuates-cognitive-dysfunction-appps1-mice-through-restoring</link>
 <description>Front Pharmacol. 2026;17:1873606.  Epub 2026 Aug 20&lt;br&gt;Authors: Song J, Yuan Y, Wang M, Li J, Ding R, Jia Y, Wang Z, Xie Z, Li Z, Zhang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694370&quot;&gt;42694370&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/liuwei-dihuang-pills-attenuates-cognitive-dysfunction-appps1-mice-through-restoring#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/liuwei-dihuang-pills-attenuates-cognitive-dysfunction-appps1-mice-through-restoring#comments</comments>
</item>
<item>
 <title>Disrupted astrocyte-neuron metabolic coupling in amyotrophic lateral sclerosis.</title>
 <link>https://www.alzforum.org/papers/disrupted-astrocyte-neuron-metabolic-coupling-amyotrophic-lateral-sclerosis</link>
 <description>Front Cell Dev Biol. 2026;14:1899307.  Epub 2026 Aug 20&lt;br&gt;Authors: Heffernan ÁB, Do F, Carter E, Al-Tameemi F, Selvaraj BT, Stavrou M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694267&quot;&gt;42694267&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/disrupted-astrocyte-neuron-metabolic-coupling-amyotrophic-lateral-sclerosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/disrupted-astrocyte-neuron-metabolic-coupling-amyotrophic-lateral-sclerosis#comments</comments>
</item>
<item>
 <title>Matrix and intermembrane space-specific mitochondrial stress response in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/matrix-and-intermembrane-space-specific-mitochondrial-stress-response-alzheimers-disease</link>
 <description>NPJ Dement. 2026;2(1):83.  Epub 2026 Sep 2&lt;br&gt;Authors: Shukla S, Kolmetzky D, Goyani S, Samantaray K, Sinha A, Kramer PA, Tomar D, Jadiya P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694256&quot;&gt;42694256&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/matrix-and-intermembrane-space-specific-mitochondrial-stress-response-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/matrix-and-intermembrane-space-specific-mitochondrial-stress-response-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Blood-based biomarkers of Alzheimer&#039;s disease and neurodegeneration in an indigenous African cohort using both Simoa and NULISA platforms.</title>
 <link>https://www.alzforum.org/papers/blood-based-biomarkers-alzheimers-disease-and-neurodegeneration-indigenous-african-cohort-0</link>
 <description>NPJ Dement. 2026;2(1):80.  Epub 2026 Sep 2&lt;br&gt;Authors: Akinyemi T, Pola I, Tan K, Olalusi O, Yaria J, Ogunde G, Traichel W, Rahmouni N, Oguntiloye O, Fagbemi A, Cadmus E, Popoola F, Therriault J, Ogunronbi M, Olujobi D, Famuyiwa O, Akinyemi J, Pascoal T, Owolabi M, Rosa-Neto P, Udeh-Momoh CT, Ladokun O, Romero-Ortuno R, Ogunniyi A, Lawlor B, Kalaria R, Zetterberg H, Benedet AL, Akinyemi R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694243&quot;&gt;42694243&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/blood-based-biomarkers-alzheimers-disease-and-neurodegeneration-indigenous-african-cohort-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/blood-based-biomarkers-alzheimers-disease-and-neurodegeneration-indigenous-african-cohort-0#comments</comments>
</item>
<item>
 <title>Sleep and stress as modifiable drivers of Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/sleep-and-stress-modifiable-drivers-alzheimers-disease</link>
 <description>NPJ Dement. 2026;2(1):84.  Epub 2026 Sep 2&lt;br&gt;Authors: Wear D, Hussaini SA, Yu WH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42694129&quot;&gt;42694129&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/sleep-and-stress-modifiable-drivers-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/sleep-and-stress-modifiable-drivers-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Prion protein (PrP) profiles in blood and CSF: insights into pre-symptomatic and symptomatic prion disease.</title>
 <link>https://www.alzforum.org/papers/prion-protein-prp-profiles-blood-and-csf-insights-pre-symptomatic-and-symptomatic-prion</link>
 <description>Brain Commun. 2026;8(5):fcag321.  Epub 2026 Aug 22&lt;br&gt;Authors: Laginha I, Schmitz M, da Silva Correia Â, Saleem T, da Silva Correia S, Zafar S, Younas N, Canaslan S, Göbel S, Root E, Breitbarth M, Fischer AL, Dittmar K, Žakova D, Hermann P, Zerr I&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42699553&quot;&gt;42699553&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/prion-protein-prp-profiles-blood-and-csf-insights-pre-symptomatic-and-symptomatic-prion#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/prion-protein-prp-profiles-blood-and-csf-insights-pre-symptomatic-and-symptomatic-prion#comments</comments>
</item>
<item>
 <title>Coagulation factor XII deficiency alleviates vascular dysfunction and cognitive impairment in a mouse model of cerebral β-amyloidosis and cerebral amyloid angiopathy.</title>
 <link>https://www.alzforum.org/papers/coagulation-factor-xii-deficiency-alleviates-vascular-dysfunction-and-cognitive-impairment</link>
 <description>Aging Brain. 2026;10:100167.  Epub 2026 Aug 25&lt;br&gt;Authors: Rouault M, Kindler DR, Ni R, Liberale L, Seiler R, Ielacqua GD, Nitsch R, Pryce C, Camici GG, Kulic L, Klohs J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42699154&quot;&gt;42699154&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/coagulation-factor-xii-deficiency-alleviates-vascular-dysfunction-and-cognitive-impairment#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/coagulation-factor-xii-deficiency-alleviates-vascular-dysfunction-and-cognitive-impairment#comments</comments>
</item>
<item>
 <title>Spectrum of Dystonia in Progressive Supranuclear Palsy: A Prospective Observational Study and Review of Literature.</title>
 <link>https://www.alzforum.org/papers/spectrum-dystonia-progressive-supranuclear-palsy-prospective-observational-study-and-review</link>
 <description>Tremor Other Hyperkinet Mov (N Y). 2026;16:48.  Epub 2026 Aug 19&lt;br&gt;Authors: Gulati K, Pandey S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698924&quot;&gt;42698924&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/spectrum-dystonia-progressive-supranuclear-palsy-prospective-observational-study-and-review#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/spectrum-dystonia-progressive-supranuclear-palsy-prospective-observational-study-and-review#comments</comments>
</item>
<item>
 <title>Translating blood-based biomarkers into Alzheimer&#039;s disease clinical practice: screening, diagnosis, and longitudinal monitoring.</title>
 <link>https://www.alzforum.org/papers/translating-blood-based-biomarkers-alzheimers-disease-clinical-practice-screening-diagnosis</link>
 <description>Front Aging Neurosci. 2026;18:1852137.  Epub 2026 Aug 21&lt;br&gt;Authors: Xie B, Zhang W, Zhang Y, Liu L, You J, Li Q&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42698737&quot;&gt;42698737&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/translating-blood-based-biomarkers-alzheimers-disease-clinical-practice-screening-diagnosis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/translating-blood-based-biomarkers-alzheimers-disease-clinical-practice-screening-diagnosis#comments</comments>
</item>
<item>
 <title>Region-specific tau phosphorylation and microtubule pathology following α-synuclein exposure in the mouse brain: biochemical and ultrastructural evidence.</title>
 <link>https://www.alzforum.org/papers/region-specific-tau-phosphorylation-and-microtubule-pathology-following-synuclein-exposure</link>
 <description>Folia Neuropathol. 2026;64(2):125-141. &lt;br&gt;Authors: Gąssowska-Dobrowolska M, Olech-Kochańczyk G, Gewartowska M, Babiec L, Bielska E, Czapski G, Wilkaniec A, Gawinek E, Adamczyk A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42704860&quot;&gt;42704860&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/region-specific-tau-phosphorylation-and-microtubule-pathology-following-synuclein-exposure#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/region-specific-tau-phosphorylation-and-microtubule-pathology-following-synuclein-exposure#comments</comments>
</item>
<item>
 <title>Exposome influences: a multi-omics perspective on the combined toxic effects of pharmaceuticals and personal care products in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/exposome-influences-multi-omics-perspective-combined-toxic-effects-pharmaceuticals-and</link>
 <description>Front Toxicol. 2026;8:1871830.  Epub 2026 Aug 24&lt;br&gt;Authors: Boşgelmez Iİ, Mertaş B, Deliser H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42703487&quot;&gt;42703487&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exposome-influences-multi-omics-perspective-combined-toxic-effects-pharmaceuticals-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exposome-influences-multi-omics-perspective-combined-toxic-effects-pharmaceuticals-and#comments</comments>
</item>
<item>
 <title>Physical inactivity in preclinical Alzheimer&#039;s disease: Risk factor, early symptom, or both?</title>
 <link>https://www.alzforum.org/papers/physical-inactivity-preclinical-alzheimers-disease-risk-factor-early-symptom-or-both</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70316.  Epub 2026 Sep 5&lt;br&gt;Authors: Zhao J, Li X, Wu M, Zhang Z&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42703295&quot;&gt;42703295&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/physical-inactivity-preclinical-alzheimers-disease-risk-factor-early-symptom-or-both#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/physical-inactivity-preclinical-alzheimers-disease-risk-factor-early-symptom-or-both#comments</comments>
</item>
<item>
 <title>REM sleep behavior disorder and synucleinopathies.</title>
 <link>https://www.alzforum.org/papers/rem-sleep-behavior-disorder-and-synucleinopathies</link>
 <description>Prog Brain Res. 2026;300:93-127.  Epub 2026 Aug 6&lt;br&gt;Authors: Uzma N, Wajdi M, Alhashmi A, Qatanany B, Sharafkhaneh A, Kosagisharaf JR, Nami M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42711026&quot;&gt;42711026&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/rem-sleep-behavior-disorder-and-synucleinopathies#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/rem-sleep-behavior-disorder-and-synucleinopathies#comments</comments>
</item>
<item>
 <title>Complementary biomarkers or conflicting signals? DaT SPECT and synuclein skin biopsy in parkinsonian syndromes.</title>
 <link>https://www.alzforum.org/papers/complementary-biomarkers-or-conflicting-signals-dat-spect-and-synuclein-skin-biopsy</link>
 <description>BMJ Neurol Open. 2026;8(2):e001759.  Epub 2026 Sep 3&lt;br&gt;Authors: Martinez-Nunez AE, Walker-Pizarro N, Wagle Shukla A, Ramirez-Zamora A, McFarland NR&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707903&quot;&gt;42707903&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/complementary-biomarkers-or-conflicting-signals-dat-spect-and-synuclein-skin-biopsy#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/complementary-biomarkers-or-conflicting-signals-dat-spect-and-synuclein-skin-biopsy#comments</comments>
</item>
<item>
 <title>Update on sex-specific microglia contribution to early synaptic dysfunction in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/update-sex-specific-microglia-contribution-early-synaptic-dysfunction-alzheimers-disease</link>
 <description>Front Mol Neurosci. 2026;19:1905780.  Epub 2026 Aug 24&lt;br&gt;Authors: Roux CM, Krantic S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707818&quot;&gt;42707818&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/update-sex-specific-microglia-contribution-early-synaptic-dysfunction-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/update-sex-specific-microglia-contribution-early-synaptic-dysfunction-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Integrating brain organoids, meningeal immunity, and glymphatic dynamics: toward modeling neuroimmune clearance and crosstalk in disease.</title>
 <link>https://www.alzforum.org/papers/integrating-brain-organoids-meningeal-immunity-and-glymphatic-dynamics-toward-modeling</link>
 <description>Front Immunol. 2026;17:1931370.  Epub 2026 Aug 24&lt;br&gt;Authors: Wu X, Du B, Chen Q, Hang R, Cui C, Li M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707783&quot;&gt;42707783&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/integrating-brain-organoids-meningeal-immunity-and-glymphatic-dynamics-toward-modeling#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/integrating-brain-organoids-meningeal-immunity-and-glymphatic-dynamics-toward-modeling#comments</comments>
</item>
<item>
 <title>Neurotoxic mechanisms of cadmium in neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/neurotoxic-mechanisms-cadmium-neurodegenerative-diseases</link>
 <description>Front Cell Dev Biol. 2026;14:1899381.  Epub 2026 Aug 24&lt;br&gt;Authors: Zhang Z, Lu Y, Yang J, Li M, Yang M, Xu Y, Ullah MS, Wan Q, Bao B, Yu W, Liu X&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707600&quot;&gt;42707600&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/neurotoxic-mechanisms-cadmium-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/neurotoxic-mechanisms-cadmium-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Tracing melanin-concentrating hormone function: decades of memory research and emerging links to Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/tracing-melanin-concentrating-hormone-function-decades-memory-research-and-emerging-links</link>
 <description>Front Neurosci. 2026;20:1918594.  Epub 2026 Aug 24&lt;br&gt;Authors: Niño-Rivero S, Blanco E, Rodríguez-Canclini V, Morelli L, Lagos P, Galeano P&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707409&quot;&gt;42707409&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/tracing-melanin-concentrating-hormone-function-decades-memory-research-and-emerging-links#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/tracing-melanin-concentrating-hormone-function-decades-memory-research-and-emerging-links#comments</comments>
</item>
<item>
 <title>Target-level convergence of directional prefrontal connectivity across Alzheimer&#039;s disease stages: an fNIRS study.</title>
 <link>https://www.alzforum.org/papers/target-level-convergence-directional-prefrontal-connectivity-across-alzheimers-disease-stages</link>
 <description>Front Aging Neurosci. 2026;18:1834253.  Epub 2026 Aug 24&lt;br&gt;Authors: Mateen N, Kaleem Ullah RM, Baik J, Hong KS, Kang MK, Kim CS, Shin YI&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707257&quot;&gt;42707257&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/target-level-convergence-directional-prefrontal-connectivity-across-alzheimers-disease-stages#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/target-level-convergence-directional-prefrontal-connectivity-across-alzheimers-disease-stages#comments</comments>
</item>
<item>
 <title>Cerebrospinal fluid and plasma biomarkers in idiopathic normal pressure hydrocephalus: comparison with Alzheimer&#039;s and Parkinson&#039;s diseases.</title>
 <link>https://www.alzforum.org/papers/cerebrospinal-fluid-and-plasma-biomarkers-idiopathic-normal-pressure-hydrocephalus-comparison</link>
 <description>Front Aging Neurosci. 2026;18:1866009.  Epub 2026 Aug 24&lt;br&gt;Authors: Pappafava F, Gaetani L, Ottaviani MM, Fiorucci G, Nardi G, Salvadori N, Megaro A, Paolini Paoletti F, Parnetti L, Conti C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707243&quot;&gt;42707243&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cerebrospinal-fluid-and-plasma-biomarkers-idiopathic-normal-pressure-hydrocephalus-comparison#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cerebrospinal-fluid-and-plasma-biomarkers-idiopathic-normal-pressure-hydrocephalus-comparison#comments</comments>
</item>
<item>
 <title>Interpretable multimodal learning for integrating neuroimaging and genetic data in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/interpretable-multimodal-learning-integrating-neuroimaging-and-genetic-data-alzheimers</link>
 <description>Front Radiol. 2026;6:1912277.  Epub 2026 Aug 24&lt;br&gt;Authors: Zhao K, Dai S, Zhang Y, Liu G, Gu P, Lin C, Thompson PM, Leow A, Huang H, He L, Zhan L, Tang H&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707167&quot;&gt;42707167&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/interpretable-multimodal-learning-integrating-neuroimaging-and-genetic-data-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/interpretable-multimodal-learning-integrating-neuroimaging-and-genetic-data-alzheimers#comments</comments>
</item>
<item>
 <title>Mitochondrial resilience: a convergent framework for pathogenesis and neuroprotection in Parkinson&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/mitochondrial-resilience-convergent-framework-pathogenesis-and-neuroprotection-parkinsons</link>
 <description>Front Pharmacol. 2026;17:1886917.  Epub 2026 Aug 24&lt;br&gt;Authors: Arias-Carrión O, Guerra-Crespo M, Soto-Rojas LO, Valle Y, Ortega-Robles E, Ortuño-Sahagún D&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42707090&quot;&gt;42707090&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mitochondrial-resilience-convergent-framework-pathogenesis-and-neuroprotection-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mitochondrial-resilience-convergent-framework-pathogenesis-and-neuroprotection-parkinsons#comments</comments>
</item>
<item>
 <title>Cumulative incidence and risk factors of dementia in Parkinson&#039;s disease and parkinsonism: a population-based study.</title>
 <link>https://www.alzforum.org/papers/cumulative-incidence-and-risk-factors-dementia-parkinsons-disease-and-parkinsonism-population</link>
 <description>Brain Commun. 2026;8(5):fcag330.  Epub 2026 Aug 28&lt;br&gt;Authors: Malfer L, Mullan AF, Lynott E, Troxel C, Ali F, Benarroch EE, Boeve BF, Bower JH, Savica R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712997&quot;&gt;42712997&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/cumulative-incidence-and-risk-factors-dementia-parkinsons-disease-and-parkinsonism-population#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/cumulative-incidence-and-risk-factors-dementia-parkinsons-disease-and-parkinsonism-population#comments</comments>
</item>
<item>
 <title>Mapping and modulating brain dynamics in aging and neurodegeneration with electroencephalography and integrated neurotechnologies in primates.</title>
 <link>https://www.alzforum.org/papers/mapping-and-modulating-brain-dynamics-aging-and-neurodegeneration-electroencephalography-and</link>
 <description>Front Neurosci. 2026;20:1689222.  Epub 2026 Aug 25&lt;br&gt;Authors: Gupta A, Dembitskaya Y, Pushkarev A, Popov A&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712987&quot;&gt;42712987&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mapping-and-modulating-brain-dynamics-aging-and-neurodegeneration-electroencephalography-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mapping-and-modulating-brain-dynamics-aging-and-neurodegeneration-electroencephalography-and#comments</comments>
</item>
<item>
 <title>Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/baseline-plasma-c1q-and-c3-potential-biomarkers-lecanemab-efficacy-and-aria-risk-early</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70313.  Epub 2026 Sep 7&lt;br&gt;Authors: Byeon G, Lee JW, Kim S, Um YH, Wang SM, Ha S, Park SY, Shin I, Jang J, Lee CU, Lim HK, Kang DW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712875&quot;&gt;42712875&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/baseline-plasma-c1q-and-c3-potential-biomarkers-lecanemab-efficacy-and-aria-risk-early#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/baseline-plasma-c1q-and-c3-potential-biomarkers-lecanemab-efficacy-and-aria-risk-early#comments</comments>
</item>
<item>
 <title>Aquaporin-4 mis-localization decreases glymphatic clearance of α-synuclein in an alpha-syntrophin knock out mouse model and promotes α-synuclein pathology and aggregate propagation.</title>
 <link>https://www.alzforum.org/papers/aquaporin-4-mis-localization-decreases-glymphatic-clearance-synuclein-alpha-syntrophin-knock</link>
 <description>Brain Commun. 2026;8(5):fcag327.  Epub 2026 Aug 26&lt;br&gt;Authors: Braun M, Simon MJ, Jang J, Sanderson K, Swierz J, Sevao M, Pincus AB, Schaser AJ, Elliott JE, Lim MM, Unni VK, Schindler AG, Keene CD, Latimer CS, Iliff JJ&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712833&quot;&gt;42712833&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/aquaporin-4-mis-localization-decreases-glymphatic-clearance-synuclein-alpha-syntrophin-knock#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/aquaporin-4-mis-localization-decreases-glymphatic-clearance-synuclein-alpha-syntrophin-knock#comments</comments>
</item>
<item>
 <title>Anesthesia, perimortem conditions, and brain harvest method govern the measured metabolome: analysis of substandard samples generates flawed metabolite levels.</title>
 <link>https://www.alzforum.org/papers/anesthesia-perimortem-conditions-and-brain-harvest-method-govern-measured-metabolome-analysis</link>
 <description>Oxf Open Neurosci. 2026;5:kvag011.  Epub 2026 Aug 26&lt;br&gt;Authors: Dienel GA&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712815&quot;&gt;42712815&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/anesthesia-perimortem-conditions-and-brain-harvest-method-govern-measured-metabolome-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/anesthesia-perimortem-conditions-and-brain-harvest-method-govern-measured-metabolome-analysis#comments</comments>
</item>
<item>
 <title>Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/brain-multiomic-profiling-identifies-tau-related-transcriptomic-dysregulation-alzheimers</link>
 <description>Brain Commun. 2026;8(5):fcag326.  Epub 2026 Aug 27&lt;br&gt;Authors: Oatman SR, Quicksall ZS, Wang X, Bergman J, Reddy JS, Vanelderen F, Nguyen T, Malphrus K, Lincoln SJ, Martens YA, Zhao N, Yamazaki Y, DeTure M, Murray ME, Liu CC, Bu G, Kanekiyo T, Dickson DW, Allen M, Ertekin-Taner N&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712681&quot;&gt;42712681&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/brain-multiomic-profiling-identifies-tau-related-transcriptomic-dysregulation-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/brain-multiomic-profiling-identifies-tau-related-transcriptomic-dysregulation-alzheimers#comments</comments>
</item>
<item>
 <title>Acute taVNS modulates lateralized hypoactivity in the right cerebral hemisphere in individuals with subjective cognitive decline.</title>
 <link>https://www.alzforum.org/papers/acute-tavns-modulates-lateralized-hypoactivity-right-cerebral-hemisphere-individuals</link>
 <description>Front Neurosci. 2026;20:1884933.  Epub 2026 Aug 25&lt;br&gt;Authors: Li X, Huang J, Zhou L, Liu B, Zhou K, Lin S, Qin H, Sun R, Wei Y, Liu Y, Huang J, Deng D, Liang L&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712668&quot;&gt;42712668&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/acute-tavns-modulates-lateralized-hypoactivity-right-cerebral-hemisphere-individuals#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/acute-tavns-modulates-lateralized-hypoactivity-right-cerebral-hemisphere-individuals#comments</comments>
</item>
<item>
 <title>Evaluation of distinct and similar pathological features between diabetes and Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/evaluation-distinct-and-similar-pathological-features-between-diabetes-and-alzheimers-disease</link>
 <description>EXCLI J. 2026;25:1124-1170.  Epub 2026 Jul 17&lt;br&gt;Authors: Reed J, Bain SC, Kanamarlapudi V&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712645&quot;&gt;42712645&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/evaluation-distinct-and-similar-pathological-features-between-diabetes-and-alzheimers-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/evaluation-distinct-and-similar-pathological-features-between-diabetes-and-alzheimers-disease#comments</comments>
</item>
<item>
 <title>Correlations of PSEN1, PSEN2, and APP missense variants on the production of Aβ peptides against variant effect prediction.</title>
 <link>https://www.alzforum.org/papers/correlations-psen1-psen2-and-app-missense-variants-production-av-peptides-against-variant</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70320.  Epub 2026 Sep 7&lt;br&gt;Authors: Song J, Yan S, Liu S, Sridhar A, Sung K, Pillai J, Wu C&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712639&quot;&gt;42712639&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/correlations-psen1-psen2-and-app-missense-variants-production-av-peptides-against-variant#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/correlations-psen1-psen2-and-app-missense-variants-production-av-peptides-against-variant#comments</comments>
</item>
<item>
 <title>Naringenin as a dual-target modulator of RAGE-NF-κB signaling and Aβ fibrillization in Alzheimer&#039;s disease: integrated computational and experimental analyses.</title>
 <link>https://www.alzforum.org/papers/naringenin-dual-target-modulator-rage-nf-kb-signaling-and-av-fibrillization-alzheimers</link>
 <description>Front Pharmacol. 2026;17:1901236.  Epub 2026 Aug 25&lt;br&gt;Authors: Bhogal I, Frydrych I, Modi A, Pankaj V, Kumar A, Khairnar A, Das V, Roy S&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712578&quot;&gt;42712578&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/naringenin-dual-target-modulator-rage-nf-kb-signaling-and-av-fibrillization-alzheimers#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/naringenin-dual-target-modulator-rage-nf-kb-signaling-and-av-fibrillization-alzheimers#comments</comments>
</item>
<item>
 <title>Natural microbial enrichment modulates microglial states and transcriptional programs relevant to Alzheimer&#039;s disease.</title>
 <link>https://www.alzforum.org/papers/natural-microbial-enrichment-modulates-microglial-states-and-transcriptional-programs</link>
 <description>Front Immunol. 2026;17:1843174.  Epub 2026 Aug 25&lt;br&gt;Authors: Lala Bouali M, Kezai AM, Bazin M, Badiane PY, Eskandari N, Lévesque V, Robillard J, Côté SD, Soulet D, Tremblay C, Calon F, Morin F, Vallières L, Hébert SS&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712554&quot;&gt;42712554&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/natural-microbial-enrichment-modulates-microglial-states-and-transcriptional-programs#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/natural-microbial-enrichment-modulates-microglial-states-and-transcriptional-programs#comments</comments>
</item>
<item>
 <title>Clinical utility of skin biopsy detection of phosphorylated alpha-synuclein in an outpatient practice.</title>
 <link>https://www.alzforum.org/papers/clinical-utility-skin-biopsy-detection-phosphorylated-alpha-synuclein-outpatient-practice</link>
 <description>Front Neurol. 2026;17:1868980.  Epub 2026 Aug 25&lt;br&gt;Authors: Levine T, Freeman R, Murray N, Swanson A, Gibbons CT, Crowell J, Phillips J, Gibbons CH&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712504&quot;&gt;42712504&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/clinical-utility-skin-biopsy-detection-phosphorylated-alpha-synuclein-outpatient-practice#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/clinical-utility-skin-biopsy-detection-phosphorylated-alpha-synuclein-outpatient-practice#comments</comments>
</item>
<item>
 <title>Exploring the research landscape of exosomes in Parkinson&#039;s disease: a bibliometric analysis.</title>
 <link>https://www.alzforum.org/papers/exploring-research-landscape-exosomes-parkinsons-disease-bibliometric-analysis</link>
 <description>Front Neurol. 2026;17:1880805.  Epub 2026 Aug 25&lt;br&gt;Authors: Liu Y, Liu Y, Li Y, Wang Y, Liu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42712434&quot;&gt;42712434&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/exploring-research-landscape-exosomes-parkinsons-disease-bibliometric-analysis#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/exploring-research-landscape-exosomes-parkinsons-disease-bibliometric-analysis#comments</comments>
</item>
<item>
 <title>Conscious vision: investigating visual hallucination awareness in Lewy body disease.</title>
 <link>https://www.alzforum.org/papers/conscious-vision-investigating-visual-hallucination-awareness-lewy-body-disease</link>
 <description>Brain Commun. 2026;8(5):fcag335.  Epub 2026 Sep 3&lt;br&gt;Authors: Conti D, Accinni T, Teghil A, Ffytche D, Zazzaro G, Panigutti M, Bechi Gabrielli G, Suppa A, Fiorelli M, Caramia F, Bruno G, Guariglia C, D&amp;#039;Antonio F&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719585&quot;&gt;42719585&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/conscious-vision-investigating-visual-hallucination-awareness-lewy-body-disease#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/conscious-vision-investigating-visual-hallucination-awareness-lewy-body-disease#comments</comments>
</item>
<item>
 <title>Elecsys pT181p immunoassay: Clinical performance for ruling out amyloid pathology.</title>
 <link>https://www.alzforum.org/papers/elecsys-pt181p-immunoassay-clinical-performance-ruling-out-amyloid-pathology</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70439.  Epub 2026 Sep 8&lt;br&gt;Authors: Ritchie C, Hortsch S, Quijano-Rubio C, Menzel P, Kirste I, Caley D, Burke AD, Rowe CC, Suárez-Calvet M, Aarsland D, Liss J, Boada M, Watson D, Rapp M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719535&quot;&gt;42719535&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/elecsys-pt181p-immunoassay-clinical-performance-ruling-out-amyloid-pathology#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/elecsys-pt181p-immunoassay-clinical-performance-ruling-out-amyloid-pathology#comments</comments>
</item>
<item>
 <title>Plasma GFAP and language-network tau mediate the effect of amyloid burden on semantic fluency: A mediation analysis.</title>
 <link>https://www.alzforum.org/papers/plasma-gfap-and-language-network-tau-mediate-effect-amyloid-burden-semantic-fluency-mediation</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70475.  Epub 2026 Sep 8&lt;br&gt;Authors: Han W, Li N, Wang P, An W, Han X, An Y, Alzheimer&amp;#039;s Disease Neuroimaging Initiative&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719511&quot;&gt;42719511&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/plasma-gfap-and-language-network-tau-mediate-effect-amyloid-burden-semantic-fluency-mediation#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/plasma-gfap-and-language-network-tau-mediate-effect-amyloid-burden-semantic-fluency-mediation#comments</comments>
</item>
<item>
 <title>Mitochondrial NMNAT3 reduces amyloid aggregates in Drosophila and alters the amyloid processing in the 3xTgAD mouse.</title>
 <link>https://www.alzforum.org/papers/mitochondrial-nmnat3-reduces-amyloid-aggregates-drosophila-and-alters-amyloid-processing</link>
 <description>Mitochondrial Commun. 2026;4:1-9.  Epub 2026 Feb 7&lt;br&gt;Authors: Yi Z, Juvvadi N, Zhai G, Moraes CT, Pinto M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719345&quot;&gt;42719345&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/mitochondrial-nmnat3-reduces-amyloid-aggregates-drosophila-and-alters-amyloid-processing#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/mitochondrial-nmnat3-reduces-amyloid-aggregates-drosophila-and-alters-amyloid-processing#comments</comments>
</item>
<item>
 <title>Comparative analyses of Alzheimer&#039;s disease blood biomarkers and cognitive domains.</title>
 <link>https://www.alzforum.org/papers/comparative-analyses-alzheimers-disease-blood-biomarkers-and-cognitive-domains-0</link>
 <description>Alzheimers Dement (Amst). 2026;18(3):e70471.  Epub 2026 Sep 8&lt;br&gt;Authors: O&amp;#039;Shea DM, Galvin JE&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719047&quot;&gt;42719047&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/comparative-analyses-alzheimers-disease-blood-biomarkers-and-cognitive-domains-0#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/comparative-analyses-alzheimers-disease-blood-biomarkers-and-cognitive-domains-0#comments</comments>
</item>
<item>
 <title>Remote digital cognitive assessment in a trial-ready Alzheimer&#039;s disease cohort: A scalable approach for early intervention studies.</title>
 <link>https://www.alzforum.org/papers/remote-digital-cognitive-assessment-trial-ready-alzheimers-disease-cohort-scalable-approach</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70311.  Epub 2026 Sep 8&lt;br&gt;Authors: Aschenbrenner AJ, Wilks H, Welhaf M, Katteri S, Stout SH, Sliwinski MJ, Benzinger TL, Gordon B, Li Y, Perrin RJ, Renton A, Wang G, Xiong C, van Dyck CH, Allegri R, Brooks WS, Bechara JA, Jayadev S, Levin J, Mummery CJ, Sanchez-Valle R, Aguillon D, McDade EM, Bateman RJ, Dominantly Inherited Alzheimer Network Trials Unit (DIAN‐TU), Hassenstab J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719037&quot;&gt;42719037&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/remote-digital-cognitive-assessment-trial-ready-alzheimers-disease-cohort-scalable-approach#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/remote-digital-cognitive-assessment-trial-ready-alzheimers-disease-cohort-scalable-approach#comments</comments>
</item>
<item>
 <title>Understanding dementia in Filipino Americans: risk factors, research gaps, and the role of community-based participatory research.</title>
 <link>https://www.alzforum.org/papers/understanding-dementia-filipino-americans-risk-factors-research-gaps-and-role-community-based</link>
 <description>Alzheimers Dement (N Y). 2026;12(3):e70319.  Epub 2026 Sep 8&lt;br&gt;Authors: Reyes RD, Guevarra A, Mamuyac E, Posis AI, Calderón Cuevas LM, Martinez Roman L, Suntay JM, Kintanar L, Caunca M, Tee BL, Windon C, Lanata S, Bondoc I, Europa E, de Leon J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719035&quot;&gt;42719035&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/understanding-dementia-filipino-americans-risk-factors-research-gaps-and-role-community-based#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/understanding-dementia-filipino-americans-risk-factors-research-gaps-and-role-community-based#comments</comments>
</item>
<item>
 <title>Age-dependent biphasic alterations and protein-activity decoupling of plasma BACE1 in major depressive disorder.</title>
 <link>https://www.alzforum.org/papers/age-dependent-biphasic-alterations-and-protein-activity-decoupling-plasma-bace1-major</link>
 <description>Front Psychiatry. 2026;17:1917834.  Epub 2026 Aug 26&lt;br&gt;Authors: Gao X, Li H, Sun Z, Liu M, Li Y, Zhang W, Chen J, Li R&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42719024&quot;&gt;42719024&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/age-dependent-biphasic-alterations-and-protein-activity-decoupling-plasma-bace1-major#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/age-dependent-biphasic-alterations-and-protein-activity-decoupling-plasma-bace1-major#comments</comments>
</item>
<item>
 <title>Two serial MoCA assessments may support biomarker-sparing triage between Parkinson&#039;s disease/Lewy body dementia and frontotemporal dementia: a progressive inclusion analysis of 1,129 participants.</title>
 <link>https://www.alzforum.org/papers/two-serial-moca-assessments-may-support-biomarker-sparing-triage-between-parkinsons</link>
 <description>Front Aging Neurosci. 2026;18:1848105.  Epub 2026 Aug 26&lt;br&gt;Authors: Lin W, Grewal SS, Byrne RW&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42718894&quot;&gt;42718894&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/two-serial-moca-assessments-may-support-biomarker-sparing-triage-between-parkinsons#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/two-serial-moca-assessments-may-support-biomarker-sparing-triage-between-parkinsons#comments</comments>
</item>
<item>
 <title>Editorial: Computational approaches to neurodegenerative diseases.</title>
 <link>https://www.alzforum.org/papers/editorial-computational-approaches-neurodegenerative-diseases</link>
 <description>Front Comput Neurosci. 2026;20:1952655.  Epub 2026 Aug 26&lt;br&gt;Authors: Antonijevic M&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42718832&quot;&gt;42718832&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/editorial-computational-approaches-neurodegenerative-diseases#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/editorial-computational-approaches-neurodegenerative-diseases#comments</comments>
</item>
<item>
 <title>Language comprehension in mild cognitive impairment: a bibliometric study of research trends and thematic structures.</title>
 <link>https://www.alzforum.org/papers/language-comprehension-mild-cognitive-impairment-bibliometric-study-research-trends-and</link>
 <description>Front Psychol. 2026;17:1886461.  Epub 2026 Aug 26&lt;br&gt;Authors: Fan Y, Guo L, Fan L, Qiu J&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42718810&quot;&gt;42718810&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/language-comprehension-mild-cognitive-impairment-bibliometric-study-research-trends-and#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/language-comprehension-mild-cognitive-impairment-bibliometric-study-research-trends-and#comments</comments>
</item>
<item>
 <title>Impaired behavioral flexibility and coping strategy shifts in 5xFAD mice in the novel Destruction-Building Test.</title>
 <link>https://www.alzforum.org/papers/impaired-behavioral-flexibility-and-coping-strategy-shifts-5xfad-mice-novel-destruction</link>
 <description>Front Behav Neurosci. 2026;20:1877086.  Epub 2026 Aug 26&lt;br&gt;Authors: Ahremenko E, Andreev A, Chaprov K, Korkotian E&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42718779&quot;&gt;42718779&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/impaired-behavioral-flexibility-and-coping-strategy-shifts-5xfad-mice-novel-destruction#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/impaired-behavioral-flexibility-and-coping-strategy-shifts-5xfad-mice-novel-destruction#comments</comments>
</item>
<item>
 <title>Multi-regional transcriptomic analysis reveals early nociceptive and neuroinflammatory alterations in APP/PS1 mice.</title>
 <link>https://www.alzforum.org/papers/multi-regional-transcriptomic-analysis-reveals-early-nociceptive-and-neuroinflammatory</link>
 <description>Front Immunol. 2026;17:1937738.  Epub 2026 Aug 26&lt;br&gt;Authors: Sheng Z, Xu F, Yan Y, Chen L, Dou B, Liu N, Zhou S, Zhu X, Tao YX, Xu Y&lt;br&gt;PubMed: &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/42718603&quot;&gt;42718603&lt;/a&gt;&lt;br&gt;&lt;a href=&quot;https://www.alzforum.org/papers/multi-regional-transcriptomic-analysis-reveals-early-nociceptive-and-neuroinflammatory#comments&quot;&gt;Submit Comment&lt;/a&gt;</description>
 <comments>https://www.alzforum.org/papers/multi-regional-transcriptomic-analysis-reveals-early-nociceptive-and-neuroinflammatory#comments</comments>
</item>
</channel>
</rss>
